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Autografted cancellous bone is the current gold-standard for maxillofacial 
reconstruction surgery (MRS), where it is used to fill in small defects. These grafts 
still pose several drawbacks, including the need for an additional surgical wound 
at the grafting site, and inadequate bone density at the repaired site. Both 
situations can have chronic medical and surgical implications, especially in 
paediatric patients since they are still growing. Cancellous bone, additionally, is 
not structural, so its applications are limited to non-load bearing sites. 
This research aimed to developing a bone regeneration material for 3D-printing, 
which could potentially address these issues. A polylactic acid (PLA) and 
hydroxyapatite (HA) composite was developed, which is usable in commercial-
grade Fused Filament Fabrication (FFF) 3D-printers. FFF allows for the 
reproduction of any geometry necessary to treat a given bone lesion. PLA 
provides a biocompatible and resorbable structure for the material, while HA 
works as a functionalisation agent to induce a cellular response.  
These composites were studied for mechanical, chemical, thermal, and 
degradation properties as per ISO-10993-13-2010. In vitro biocompatibility for the 
material included cell-viability and extracellular-matrix deposition using the MG-
63 cell line. The composite behaved as expected during characterisation, and was 
also found to perform equivalent to tissue-culture plastic in regards to in vitro 
biocompatibility. Degradation results showed that 3D-printing of these materials 
will likely result in faster in vivo resorption than current PLA implants, and a 
mathematical model was proposed from these results. This research suggests 
that 3D-printable PLA-HA composites are a viable material for therapeutic 
implants for bone-regeneration.  




GLOSSARY OF ACRONYMS 
Term Definition 
3DP 3D-printing 
ADT Accelerated degradation test 
AM Additive manufacturing 
ANN Annealed 
ARS Alizarin red staining 
ASCII American standard code for information exchange 
BFB Bits from bytes 
CAD Computer-assisted design 
CAE Computer-assisted engineering 
CAE Computer-assisted engineering 
CLP Cleft lip and palate 
CNS Central nervous system 
CP Cleft palate 
CPX X-linked cleft palate 
Cr Crystallinity 
CT Computer-assisted tomography, computed tomography 
DSC Differential scanning calorimetry 
DTA Differential thermal analysis 
DTA/TGA Differential thermal analysis/Thermogravimetric analysis 
E Elastic modulus 
EDS Energy dispersive spectroscopy 
EM Expansion medium for cell culture 
EOS Ethylene oxide sterilisation 
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FDA United States's Food and Drug Administration 
FFF Fused-filament fabrication 
FFF3DP Fused-filament fabrication 3D-printing 
GPC Gel permeation chromatography 
mADT Modified accelerated degradation test 
MRP Medical rapid prototyping 
MRS Maxillofacial reconstruction surgery 
Mn Number-average molecular weight 
Mw Weight-average molecular weight 
NADH Nicotinamide adenine nucleotide 
NADPH Nicotinamide adenine nucleotide phosphate 
NIST National Institute of Standards and Technology 
NSCP Non-syndromic cleft palate 
PBS Phosphate-buffered solution 
PDLA Poly-D-lactide 
PLA Polylactic acid 
PLLA Poly-L-lactide 
PRP Platelet rich plasma 
ReSKY Revised Smith-Hernahan striped "Y" classification system 
RRA Resazuring reduction assay 
RSET Real-time simulated environment test 
SEM Scanning electron microscopy 
SLM Selective laser melting 
SLS Selective laser sintering 
SM Mineralisation-supplemented medium for cell culture 
SRS Siruis red staining 
STL Standard tessellation language 
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TCP Tissue culture plastic 
Tf Fusion temperature 
Tg Glass-transition temperature 
TGA/DTA Thermogravimetric analysis/differential thermal analysis 
UTS Ultimate tensile strength 
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Craniofacial reconstruction, perhaps more than any other discipline within 
healthcare, has been actively taking advantage of overall developments in 
biomaterials and manufacturing processes. Such developments have been 
aimed towards producing therapeutic implants, since bioactive bone 
substitutes are a relatively straightforward and well-studied means of 
implementing tissue regeneration technologies [1–8]. The patients dealt with 
in this context are exposed to a wide range of secondary morbidities, including 
a potential toll on their psychological health due to the origin of their injuries – 
usually traumatic – and the impossibility of concealing them from others [9]. 
The impact of the aesthetic outcomes of these treatments has also been noted 
and frequently listed as one of the key points to improve upon in the 
development of new reconstructive surgical implementations. In this regard, 
healthcare professionals who treat congenital deformities and lesions of the 
skull – and their iatrogenic secondary ailments – emphasise attention on 
improving the final aesthetic results of new techniques. These particular 
outcomes have been a gradually growing concern, since aesthetic 
consequences for young patients happen to align with active anatomical and 
social developmental stages [9–14]. 
Although a plethora of conditions can require skeletal reconstruction early in 
childhood, cleft palate is an excellent benchmark for the challenges that 
development of artificial implants must overcome. Reconstruction of an 
infant’s growing skull has the explicit drawback of requiring implants and 




solid inert implant substituting missing bone tissue can have detrimental and 
life-long effects on craniofacial growth [17–20]. An especially vulnerable age 
range is found around 8 and 12 years of age [15], when skull bones tend to 
grow fastest. For these reasons, and due to its high incidence in the general 
population, Cleft Lip and Palate (CLP) was used as a reference clinical 
application to guide the development of the basic science established in this 
project. 
Craniofacial clefts are the most common congenital deformity of the skull 
worldwide [21,22], with an incidence rate ranging around 0.2-1.9 per 1000 live-
births. These incidences depend on several environmental factors but are also 
well correlated with pathologic and race-related genetic heritage [23–30]. In 
the European Union, this range narrows down to 0.5-1.4 per 1000 live births, 
with the United Kingdom ranking at the higher end [31,32]. Notably, defects of 
this kind outnumber cardiovascular ones – globally the most common [33] – in 
the general Mexican population, although with wide variations in between the 
Republic’s states [22,23,34]. The former is expected given the wide region-
dependent genetic diversity within the country [35]. The treatment of these 
patients is lengthy – spanning over probably a third of their lifetime – involves 
high costs, longitudinal follow-up, and usually more than two surgical 
interventions, where most of the surgical time will focus on the reconstruction 
of the bone defects inherent to this clinical entity [25,32,36].  
This disorder is reflective of the broader challenge posed by bone 
reconstruction in paediatric patients. Depending on local CLP treatment 




year of life to 16 years of age – even later in some cases –, posing a unique 
challenge for the development of artificial grafts that must take in account their 
effect on bone-growth (especially between ages 8 to 12) [15]. Artificial grafts 
have the potential to produce functional bone on the injured site while avoiding 
the side-effects and costs of grafting surgery [14,25,37]. The mainstay of 
treatment for the maxillary malformations commonly found in these patients is 
autologous grafting of cancellous bone from the iliac crest [14,25,38]. This 
procedure in itself raises some concern regarding extended surgery times, 
secondary morbidities (lifelong chronic pain at the donor site, weakening of the 
harvested pelvic bone at the ilium, surgical wound infection, or scarring), and 
variable clinical outcomes – in regards to density of the regenerated bone at 
the treated site, which tends to be low, and can even require a second graft 
[14,32,38]. 
The present research is concerned with implementing the still-growing field of 
Fused Filament Fabrication (FFF) 3D-printing (3DP) technologies into 
addressing the unique challenges posed by alveolar reconstruction for CLP 
patients. Implementing advanced manufacturing technologies could allow for 
improvement of this treatment through the production of patient-specific, 
image-study-based custom implants [8,13,39,40]. Since the introduction of the 
first stereolithography techniques in 1988 by Charles Hull, medical rapid 
prototyping has looked into its potential for developing new treatments and 
devices [41]. FFF systems launched in the last decade of the last century – 
coupled with their commercial availability and affordability being improved 
during recent years – have had their role in medical research and applications 




– namely computed tomography – has a potential that is just beginning to be 
explored for the production of long-awaited patient-specific devices and 
implants [13,40,43–48]. 
The need for this research arises from the relatively recent introduction of 
consumer-level 3D-printing. There are few data available the literature on the 
potential adverse effects of FFF as a medical manufacturing process. These 
are concerns in terms of medical materials regulation, since well-evidenced 
good-manufacturing practices are as necessary for clinical application as 
medical-grade raw material [49]. The main points of consideration for this work 
are focused on the effects of FFF on the mechanical, molecular, and 
biocompatibility properties of lactide polymers, and specifically polylactic acid 
(PLA), which is widely used in medical implants. Additionally, a compositing 
method was developed for integrating hydroxyapatite (HA) as a bioactive 
ceramic into PLA FFF 3D-printing materials. Both objectives were addressed 
through mechanical, thermal, chemical testing, as well as through in-vitro 
degradation and biocompatibility studies. Finally, drawing from the data 
produced, a final proposal documented the development of general guidelines 
for the production of absorbable maxillofacial reconstruction materials for 
implant production through 3D printing, which allows for patient-specific 
solutions in the context of both CLP and craniofacial reconstruction in general. 





2. LITERATURE REVIEW 
2.1.1. A BRIEF HISTORY OF ORGAN REPAIR AND REPLACEMENT 
 
Organ replacement has been a long-standing dream for humanity (and 
engineers), probably since the advent of any notion of healthcare some 10,000 
years ago, just after the establishment of sedentary settlements birthed the 
millennia-long age of infectious disease that would – in turn – culminate on our 
modern medical practice [50]. Along with the much-expected animal-mauled 
and battle-wounded amputees, classical texts were among the first recount 
anecdotal resection procedures, as well as wood-crafted prosthetic limbs with 
fixation arrays and straps of varying complexities and materials to allow for 
everyday use [51] (though Greeks were not the first to implement a rough form 
of prosthetics [52,53]). These very set-ups would then be referred to as cork 
legs as they were implemented throughout the 19th century [54], reflecting just 
how little net advance this particular techné made throughout two millennia 
[51,55].  
The former is but an example of successful anatomy replacement at its 
simplest possible iteration, yet one must bear in mind that less than two human 
lifetimes ago that was the only instance of it we could aspire to. This is by no 
means a random timeframe, since many of the now-given scientific advances 
were just emerging through the 1800’s, and modern medical practice – roughly 
recognised as such with the start of asepsis, microbiology, and biochemically-




based pharmacology – is currently just halfway through its second century of 
existence [50,56,57]. 
As physiological functions and anatomical structures were more widely 
understood (and understood to be heavily intertwined) during the 20th century, 
it became clear that the recently-born field biomedical engineering would be 
tasked with implementing and capitalising on such advances for the benefit of 
the niche of medical technologies. It also became obvious that those 
physiological functions were a lot more complex to mimic than mere structural 
features, and even harder it would be to match Nature’s efficiency at it [58].  
The scientific and technological expertise that goes into creating a 
replacement organ – under the modern expectations of the regenerative 
medicine field – is predictably broad [55], posing a challenge for research and 
development groups in that they require large, flexible, and multidisciplinary 
teams to effectively keep track and assess the impact of emerging – and 
especially of disruptive – technologies [42,45]. Achievements in this respect, 
thus, have advanced side by side with the knowledge-base on the broad fields 
of physiology, electronics, manufacturing, and materials up to its current 
achievements: artificial substitutes for renal, circulatory, and pulmonary 
functions, as well as cardiopulmonary bypass devices, and implantable 
artificial kidneys and hearts [59]. Further still, these accomplishments have 
moved onto future goals as proposed by the American Society for Artificial 
Internal Organs on their 2005-2055 Phase 2 aims, which refocuses their view 
towards therapeutic artificial organs, addressing cardiac therapeutics, and 




well with current healthcare research trends heavily embracing regenerative 
medicine and tissue engineering. 
 
2.1.1. AN OVERVIEW OF BONE LESION REPAIR 
 
Osseous tissue is one of the few instances in humans – and higher-order 
vertebrates – of naturally-regenerating organs. Commonplace examples of 
other such tissues include the skin, which is highly specialised in the process 
of wound-healing since its main function is protection of other organ systems 
from the environment [62]. The endometrium is similarly differentiated towards 
constant regeneration, albeit from cyclical decay driven by the hypothalamic-
pituitary-gonadal axis [63]. Less obvious cases of extensive regeneration 
occur in the liver, where remaining tissue can respond to even catastrophic 
organ damage by replication and repopulation of lost volume with functional 
tissue [64]. The myth of Prometheus is frequently quoted at this point on 
tissue-regeneration pieces, but it is worth noting that archaeological and 
historical evidence suggests his immortal liver is likely a coincidence rather 
than a reflection of ancient Hellenic physiological awareness [65]. Notably, 
distal hand phalanxes have also been reported to completely regenerate after 
avulsion, even in adult patients [66–68]. 
This phenomenon of natural organ reconstruction can be broadly understood 
under the concept of tissue-healing, and it encompasses a vast array of sub-




and stem-cell lines [62,66,69,70]. Healing is highly dependent on paracrine 
signalling and chemotactic markers released by damaged cells from the tissue 
in distress, as well as by platelets and other blood cells as they stream out of 
broken capillaries and onto exposed collagen of injured connective tissue 
[67,69,70]. Given their crucial role in coagulation as an initiation of damage-
control measures at injury sites, platelets and other blood-borne products are 
thought to be central to any healing effort [62,69]. This is the reason why 
Platelet-Rich Plasma (PRP) has been of consistent interest as an agent for 
injury healing in general [71–73], for treatment of chronic tissue damage 
[71,74–76], and for bone regeneration in particular [25,77,78].  
As part of this cascade of responses, pro-inflammatory factors are released by 
damaged tissue and vasculature, as well as by local tissue-resident 
immunological cells from the surrounding sites [79,80]. These cells – most 
from the phagocytic macrophage and neutrophil varieties, along with some 
myeloid-line cells – are activated via two routes: through damage/danger-
associated molecular patterns [80,81], and through pathogen-associated 
molecular patterns [81–83]. Their release of numerous cytokines (such as 
interleukins 1, 6, and 8, and tumour necrosis factor α) mediates the initial 
vasodilation and further recruitment of immunological cells, along with the 
complement system [82,84], and coagulation processes [85,86]. 
Appropriate coagulation marks one of the milestones of healthy injury-
response [85,86]. As the formation of platelet-mediated thrombi and fibrin clots 
stabilise homeostasis and mechanics at injured site, they also further signal 
the recruitment of fibroblasts with subsequent differentiation to myofibroblasts 




collagen, which restores the structure of the damaged site. Being contractile, 
myofibroblasts are also involved in approximation of injury-separated tissue, 
and alignment of collagen fibres [88]. 
The rate and extent to which myofibroblasts manage to secrete collagen matrix 
seems to affect the degree of regenerated and scarred tissue achieved during 
the repair [62,70,89]. All non-regenerating tissues in humans undergo some 
degree of scarring during healthy healing – which implies that at least some of 
the lost tissue is replaced by non-functional fibrous patches. Rapid and 
extensive secretion of collagen is thought to be linked with the scarring 
process, as is the density of differentiated myofibroblasts at the injured tissue 
[88]. Research on animal models suggests that foetal wounds – which heal 
without scarring – do so in the absence of myofibroblasts [88]. 
Healing of osseous injuries is dependent on similar factors to the above, since 
an important part of the functional aspects of the skeleton depends on its 
extracellular matrix – apart from its metabolic and haematopoietic activities 
[90,91]. By weight, this extracellular matrix is up to 70% bone-mineral, 
comprised of hydroxyapatite (HA): a form of calcium phosphate organised in 
both an amorphous phase, and a crystalline phase of carbonate-apatite [91–
93]. Though analogous to geological calcium-apatites, biological crystalline 
HA follows a different synthesis pathway, dependent on acidic phosphate and 
carbonate precursors [92]. The formula for HA is usually written as: 
Ca5(PO4)3(OH), but it should be noted that this refers to the repeating 
molecular unit [92,94]. In contrast, the crystal unit cell is actually pairs of these, 
thus some sources report it as Ca10(PO4)6(OH)2.The remaining mass of bone 




These tend to orient themselves parallel to the direction of usual mechanical 
load of a given bone – commonly along its longest axis [91].  
Osseous, endometrial, and dermal tissues undergo constant loss of functional 
tissular mass, while maintaining a balanced rate of replenishing of such loss. 
Relying mostly on epithelial tissue, the endometrium and dermis achieve this 
through a highly-mitotic basal layer [62,63,89]. In contrast, healthy bones are 
subject to remodelling: a cell-mediated process balancing resorption of 
existing mineralised tissue, and ossification (generation of new extracellular 
matrix with subsequent mineralisation) [90,91]. 
This on-going remodelling process in bones allows for the repair of 
microfractures that occur due to normal locomotion and interactions with the 
environment [91]. This adaptation is one of the mechanisms that allow bone 
to heal as often and as effectively as it does. It must be noted that most of the 
load-bearing tissue of bone is non-cellular, and this fact also contributes to the 
relative ease with which osseous tissue achieves true regeneration [91].  
Even though there is some evidence of involvement of stem cells in post-
embryologic skeletal development [95], bone remodelling is mainly driven by 
differentiated cell-lines. Pre-osteoclasts are distributed in the outermost layers 
of bones in structures known as lacuane of Howship, while osteoblasts are 
evenly scattered through the tissue. Damage and inflammation signals trigger 
pre-osteoclasts to become osteoclasts, and osteoblasts near the injury site to 
activate [91]. Osteoclasts then degrade and resorb the tissue around the 
damaged site, while active osteoblasts secrete a new collagen matrix to fill in 




mineralisation of this protein matrix, and deactivate while embedded inside it 
[91,96,97]. Harnessing and directing these former processes is the ultimate 
goal of bone-regeneration materials and devices. 
2.1.2. BIOMATERIALS IN HISTORIC SKULL REPAIR 
Just as the techné around organ replacement grew, so did the knowledge 
regarding materials for this purpose. Beyond functional limb prosthetics, there 
is evidence of dental replacements, and even full-thickness skull implants 
documented archeologically for civilisations as far back as seven millennia 
from now [52,53,98–100]. Not only does this speak highly of the 
resourcefulness of human minds – even amidst the darkness of vast scientific 
naivety –, but it is also humbling to think that prosthetics of these sorts would 
be amongst the very – very – few pre-modern medical interventions that 
actually solved the problem they treated [50]. This would hold true until 
surprisingly recent times: somewhere around the 19th century [51,54,55]. Even 
so, the current concept of “biomaterial” as part of the collective scientific 
imaginarium did not really emerge until halfway through the 20th century [101].  
Though the nuances of physiology and pathology remained beyond 
understanding during the process, trial and error (and coincidence) helped 
establish the usefulness of several commonplace materials as adequate for 
implants or prosthetics. As for most other manufacturing applications of old, 
wood was one of the recurrent materials – and probably one of the first – to be 
implanted for medical purposes [52]. Though wooden prostheses became 
commonplace for limbs, the material has also seen use in contact with 




attempted limb fracture stabilisation have been found documented as 
treatment procedures – using wooden blocks fixed directly in contact with bone 
[52]. This is just an instance of how early prosthetics and implants must have 
been developed: not as a discipline within healthcare, but as one more task 
for craftsmen – who used whatever material they were skilled at working [101]. 
It is likely that the most common site for ancient bone-repair was the skull. 
Trepanation appears to be the main reason for development of early 
cranioplasty, though that remains open for interpretation, since in many cases 
implants could have been scavenged post-mortem, making a successful skull 
repair appear archeologically like a peri-operative death [100,102,103]. This 
trend led to other plant-based materials becoming widely popular 
[52,53,100,104]. Dried shells of Curcurbitaceae plants and coconuts were 
employed for cranioplasty in several parts of the world, most frequently in 
treatment for common folk [53,100,103,105], which may hint at some success 
in their application.  
The higher, richer classes, in contrast, founded a trend that still stands today: 
the use of metallic bone substitutes. Precious metals saw a lot of use in bone 
repair, with silver and gold skull-implanted plates appearing consistently all the 
way from Incan exhumed skeletons (Figure 2.1), to proper surgical texts 
during the 14th century [100,101,105]. These have clear advantages over any 
presentation of cellulose or lignin in that the so-called noble metals (classified 
on corrosion resistance and/or d-shell nobility) are chemically more stable than 
organic compounds, and display some antibacterial properties. Recently, 
these have fallen out of use within medical materials due to their price, high 




complex metallic alloys with titanium, steel, and aluminium. The main 
advantages of metals come from their large tensile and compressive strengths 
when compared to bone, and from them being bioinert (eliciting little to no 
immune response at the implantation site) [47,106–109]. 
 
 
Along with treatments for the cranial vault, dental and maxillofacial repair 
procedures have been a constant through virtually every early civilization. 
Metals were also prominent in these applications, as were some polisheable 
minerals like quartz. Similarly, pre-colonial Latin-American cultures were no 
strangers to using xenografts on these kinds of repairs. Human remains 
throughout this large region have been discovered with intricate dental-work 
using seashells, as well as other animal osseous tissue and dentine (ivory). 
 
 
Figure 2.1. Gold plate in frontal bone-trepanation repair. Notice the smooth edges at the transition 
between bone and implant: these suggest adequate post-operative osteointegration. The subject must 
have survived several months post-operatively for this to be observable. Skull on display at Museo del Oro 




As one could expect, these materials were also a logical choice in Europe, 
Asia, Africa, and the islands of the Pacific [100,110].  
Even later, formal medical practice experimented with bone from readily-
available mammals and birds for reconstruction of the skull [100,111]. In one 
of the more bizarre treatment protocols documented, a 14th Century text 
recommends a chicken-breast graft – freshly harvested and bleeding – for cleft 
lip and palate repair [112]. The author of this recommendation – a Catholic 
archbishop – appears to have been inspired by contemporary superstitions 
surrounding birth defects [113]. This position on animal tissues apparently was 
reversed by the 15th century, when the Dutch physician Meekeren used dog 
bone for a skull implant, much to the dislike of his church [111]. Xenografts 
may still pose a viable option for some types of grafting in humans, but 
immunological limitations remain a challenge to be consistently overcome by 
research [114]. Cases of successful xenografting of bone are not unheard of, 
but the clinical outcome is limited by severe immune rejection – as happens 
with other tissues –, and rapid resorption of the graft – a problem particular to 
osseous grafts [105,111]. 
Regarding polymers, pre-Columbian Mexican cultures are well known to have 
used Castilla elastica-derived rubber balls for their ceremonial juego de pelota, 
and production of other goods like rubber bands; no direct medical use is 
currently reported [115]. This kind of natural rubber was virtually the only type 
used for most of human history, until 1865, when Alexander Parkes developed 
parkesine: the first synthetic polymer [116]. He was followed by John Hyatt in 
1870, who patented the material originally known as celluloid – a stabilised 




it was the first to achieve widespread adoption in several branches of industry. 
Just as the eventual creation of medical polymers aimed to replace hard-to-
secure natural materials, celluloid was developed initially as an affordable (and 
less regulated) substitute for ivory. 
Since then, countless different synthetic polymers have been created with ever 
more application-specific adjustments to their properties for every branch of 
industry [118]. Unlike medical-grade metals, medical polymers have a natural 
tendency to degrade when exposed to biological systems – a property so-
called biodegradability. This follows from the fact that their molecular super-
structures are held in place by the same types of bonds that biological 
materials share. In the case of polymers (both biological and petrochemical), 
polymerisation occurs either via several types of carbon-carbon bonds, or 
some weaker carbon-oxygen bonds (as polyesters), or carbon-nitrogen bonds 
(as polyamides) [49,119–121]. Biodegradability, while being an industrial 
disadvantage for early plastics, proved to be useful in medical devices. By 
1962, polyglycolic acid absorbable sutures were already implemented in 
clinical practice, soon followed by others made with polylactic acid (PLA) [121]. 
A variety of polymeric medical devices are currently used for surgical 
reconstruction, including that of the head and face bones, in the form of 
surgical instruments, guides, fixtures, and bone implants [122–128]. The 
different polymers currently in use for surgical purposes would fill a list too long 
to detail in this review. Some of the most common examples include medical-
grades of familiar commodity plastics (such as polyvinyl chloride, polyethylene 
teraphtalate, polyurethane, and silicone) [118,129]. Some others are popular 




bone fillers, blood-contact coatings, dermal fillers, and dental crowns [130]), 
polyamides – especially Nylon – (used in sutures, hernia-repair meshes, and 
recently in additive manufacturing [131]); and polytetrafluoroethylene (used in 
vascular grafts, orthopaedic devices, and some dermal implants [132–134]).  
Of interest of the present project is PLA, which has also been used in the 
manufacture of bone implants and fixtures, as well being a standard material 
for commercial Fused Filament Fabrication (FFF) [135–138]. Its role in this 
form of 3D-printing, coupled with its history of application as a resorbable 
implantable material, make it a natural choice for this research on resorbable 
bone-repair and regeneration materials. As a benchmark of sorts, Cleft Lip and 
Palate (CLP) – and specifically the maxillary bone-defects associated with it – 
was used in this work as a reference in terms of its clinical bone-repair needs.  
Alveolar bone-defect repair for CLP has been attempted with a variety of 
materials through history [14,139–141], with one of the earliest recorded being 
gold plates, back in the 14th century [53,105]. However, non-degrading rigid 
bone-implants are incompatible for current standards of care for CLP. The fact 
that most maxillary-cleft repairs are done in children is largely to blame, and 
the evidence leading to this – and eventually relating to the present research 
– is discussed in the following sections. 
 






The structure and location of the palate make it important for two processes: 
language production, and deglutition. Its essential functions derive from it 
being a barrier between the nasal and oral cavities [142], and its barrier and 
support functions enable – along with the tongue, lips, respiratory system, 
vocal chords – for manipulation of matter (liquids, and edible items), as well as 
pressure gradients within the cavity, and between the respiratory and digestive 
systems. While the hard palate provides a passive barrier between the oral 
and the nasal cavities, the soft palate allows for managing of pressure waves 
during speech by means of the velopharyngeal valve and its muscular bundle 
(the palatopharyngeal muscles). Unfortunately, a palate with compromised 
integrity usually fails in performing at least one of its intended tasks, with 
various degrees of dysfunction depending on the portions of it involved, as well 
as the severity and extent of the lesions (though, admittedly, some instances 
of CP are asymptomatic) [143,144].  
CP can appear in a variety of ways, with affected structures ranging from the 
upper lip (sometimes with nasal involvement), maxilla, hard palate, and soft 
palate all the way back to the uvula [145]. These lesions, in turn, can range in 
width, depth, length, and location, manifested at any point along the fusion 
borders of the primary and secondary palates and their neighbouring soft-
tissue. The involvement of these numerous structures results in the 
geometrically complex lesions which are relevant for the clinical application of 






2.1.4. RISK FACTORS: GENETICS AND TERATOGENICITY 
Palatoschisis, more often referred to as cleft palate (CP), covers a range of 
congenital orofacial deformities that arise from faulty fusion of the pharyngeal 
arches during embryonic development [146]. These result in fissures that are 
classified together as they affect the primary and secondary palates, leading 
to a diverse array of subsequent complications that depend on the type and 
extent of these defects. Traditionally, there are two main groups of factors 
thought to be responsible for this kind of abnormal development of the palate: 
teratogenic substances and genetic defects [21]. Even though a range of 
genetic alterations and defects have been hypothesised to contribute or 
 
Figure 2.2 Facial growth after primary bone grafting. A, perioperative view of unilateral complete cleft patient. B, Eight-
year postoperative result. Alveolar defect is evident on the perioperative presentation of the patient. Treatment including 
grafting resolves the bony lesion, but some degree of midface retrusion is observable in the patient’s postoperative profile. 




decisively lead to CP [27,146–150], research has led to a modern consensus 
in that the underlying genetics of CP are a complex and multifactorial 
predisposition [21,147,151–154], and its ultimate mechanisms have yet to be 
described [27]. This predisposition, in turn, is accentuated – or maybe enabled 
– by the developmental environment of the embryo [26,152–155], the sum of 
which culminates in the aforementioned palatine fissures. It is noteworthy that 
these deformities are linked (through some shared risk and preventive factors, 
such as maternal diet) to neural tube defects, which have also been widely 
studied and are equally complex in aetiology [26,154,155]. 
Some presentations of CP are mostly genetically-driven. In studies of cases 
of X-linked cleft palate (CPX), for instance, the malformation was found to have 
an autosomal-recessive inheritance pattern [27], while CPX with ankyloglossia 
has been described as an autosomal-semidominant mutation [156]. CPX is a 
type of non-syndromic cleft palate (NSCP), meaning it does not appear 
concomitantly with more than two additional malformations as a consistent 
entity [27,151]. The most recent research has shed light about the TBX22 T-
box transcription factor gene and its promoter to be the most direct causal 
agents known of so far [27,149,156]. In cellular terms, alterations to these 
genes are theorised to interfere with mesoderm growth, migration, and 
apoptosis, thus altering normal palatogenesis [156]. Syndromic CP variants, 
on the other hand, occur within a given set of deformities, the most common 
of these being the van der Woude syndrome (VWS), which was found to be 
an autosomal-dominant condition. It is also linked to a single gene defect in 
the transcription factor IRF6 [150]. Several other syndromes that feature CP 




[157–159]. CP itself, however, manifests similarly within syndromes as it does 
as an isolated entity. 
There is a group of environmental factors that mostly encases teratogens 
related to orofacial clefting. It must be noted that not all of these are causally 
linked to such malformations, but have been found to contribute to their overall 
occurrence risk when used during pregnancy or near conception [151]. Some 
heavily teratogenic drugs are capable of inducing CP or CLP amongst their 
spectrum of deformities; such is the case of anticonvulsants like phenytoin, 
valproic acid and oxazolidinones [160]. Other substances are less strongly 
implicated with CP, like tobacco and benzodiazepines, and might also depend 
upon genetic predisposition to yield their full effects [161–164]. Maternal 
alcohol use and steroids are dose-dependent and well-documented causal 
agents for CP [165,166].  
Maternal nutrition encompasses a noteworthy set of factors balancing the risk 
of CP and other such abnormalities [148]. Folic acid has been prescribed for 
decades now as a nearly mandatory prescription for pregnant women, as 
studies have found it to reduce the overall risk of birth defects when used in 
doses well above the average dietary intake [167]. It was shown to reduce the 
incidence of CP and CLP in mothers with increased risk when taken as part of 
multivitamin supplements [24]. In contrast, however, increased vitamin A 
intake might also facilitate the appearance of CP [153], as do abnormally low 
erythrocyte zinc levels [154]. Glucose has been theorised as a teratogen [168], 
but thus far the evidence is inconclusive at best [154], but more likely pointing 




– as the actual culprits, as their presence accompanies an increased risk for 
congenital anomalies, including CP [26,155]. 
Palate clefting can be also acquired from lesions secondary to bacterial 
infection: this has been observed in both humans [169] and mice [170]. 
Trauma, naturally, can also lead to structural damage that mimics congenital 
CP. Other mechanisms are known, such as chronic cocaine use, which 
necroses palatal tissue and eventually erodes a deep lesion that requires 
surgical treatment [171]. However, in these cases the aetiology is relatively 
simple to explain, and their literature focuses on procedures for repair derived 
from those developed for congenital CP. 
2.1.5. PALATOGENESIS AND ITS DISRUPTION 
Development of the palate can be understood in three broad phases: 
proliferation, elevation, and fusion. It is worth noting that these processes 
occur simultaneous to the development of the rest of the structures in the 
head, neck, and central nervous system (CNS), from around the fourth to the 
twelfth week of gestation [153,172,173]. All these structures are very close by 
and many – namely the oral cavity, middle and inner ear, neck, and face – 
derive mostly from the pharyngeal arches and the frontal process: this is partly 
why any deviation from normal cellular mechanics, local genetics, or local 
growth factors can lead to a plethora of craniofacial malformations, and why 
several forms of CLP occur within a syndrome along with other anomalies 
[153,155,172,174]. Less specific mutations, however, can result in CP or CLP 
along with defects at more distant sites, as is the case for popliteal pterygium  




The proliferation phase of palatogenesis starts around the end of the 5th 
gestational week. By this moment, the pharyngeal arches are eight bilateral 
collections of tissue protruding inferior to the cephalic structures, closely 
packed along the lateral margins of the ventral portion of the embryo (Figure 
2.4). These arches are composed of a mesoderm core covered by an 
ectoderm layer on the outer surface, and an endoderm one on the inner side. 
Portions of the core differentiate into nervous, vascular, and cartilaginous 
tissue, which will give rise to skull vasculature, bones, and cranial nerves 
[172,175].  
 
Any alteration on tissue and cellular growth factors – genetic or environmental 
– will necessarily affect this process, as well as the later ones since all happen 
as every structure of the head is beginning to form [153,172]. Shortly after the 
6th gestational week, the mandibular processes on either side of the first 
pharyngeal arch meet at the medial plane of the foetal skull and start 
ossification. Around this time, the medial nasal processes – coming from the 
first pharyngeal arch – have similarly extended medially, forming the 
 
Figure 2.3. Diagram of early development of the pharyngeal arches. Lateral (left) and anterior (right) views 




intermaxillary process which will start to ossify by the 7th gestational week. The 
intermaxillary process, in turn extends posteriorly to form the premaxilla [176].  
Notably, this previous step is a crucial point where alveolar clefts can 
commence, as precise coordination in cell proliferation, death, and 
differentiation is needed to achieve healthy tissue architecture. Molecular 
signals on cell growth, migration, extracellular matrix production, and death 
(like those of the TGB-β superfamily) are at play along with nutrients derived 
from maternal intake (like vitamin A, zinc, myoinositol, or folic acid), and have 
been studied as linked to CP when they suffer alterations on their balance 
[24,153,154,167,174,177]. Teratogens, as mentioned in the previous section, 
are thought to affect such balance to varying extents [147,161,162,177,178].  
Around the end of the 12th to 14th developmental week, the elevation phase is 
complete, and the base of the tongue differentiates into the genioglossus 
muscle and its supporting structures, and these help pull the tongue down into 
its final (horizontal) position [28], moving out of the way of the recently-formed 
shelves. Several other mechanisms are thought to be involved in the 
reorientation of the palatal shelves, but tongue withdrawal – which coordinates 
with mouth opening – is considered a crucial event as it preludes the 
observation of horizontal shelves which then grow medially towards fusion 
[28,153,172]. Whether these movements themselves or the physiological and 
mechanical events around them are directly involved in palatine shelf elevation 
remains unknown, but their disruption has been shown to impair this stage of 




Palatine shelf fusion is a rather complex phenomenon (Figure 2.5), since it 
occurs late relative to organ genesis and tissue on the shelves themselves is 
already vastly differentiated at this point: their integration becomes less 
straightforward. Even though this process shares some of the regulatory 
conditions that dictate primary palate fusion, additional mechanisms become 
necessary for their successful integration into a single continuous structure. 
This is likely why fissures on the lip, alveolus, and palate are closely 





Figure 2.4. Scanning electron microscopy (top row) of mouse palatal development. Progress in time (A) depicted from 
left to right (B to F), corresponding to human 4th through 13th weeks of development (mouse E11.5 to E15.5). Letters G 
through U are corresponding histologic coronal sections of the SEM images. MxP: maxillary process; MNP: medial nasal 
process; PS: palatal shelves; MdbP: mandibular process; NS: nasal septum; PP: primary palate; SP: secondary palate. 




Not only is apoptosis of the epithelium at the medial edge of the shelves 
needed for their mitotically active inner layers to contact, but selective 
adhesion of these layers to each other is also imperative for successful fusion 
[142,172]. Fusion begins in the central portion of the shelves, and the process 
is then completed at the frontal and dorsal portions, with the former also fusing 
with the primary palate [172]. Subsequently, further differentiation occurs at 
the epithelial surfaces of the complete palatal shelf, with distinct epithelial 
types appearing at the lower and upper sides of it, formally separating the 
nasal and oral cavities [177]. The relatively high incidence of CP is probably 
also due to the fact that ossification of the cranial structures is already 
underway when fusion is completed [172], which usually signifies the end of 
differentiation for the internal tissue of the palatine shelves as the final 
anatomical structures and geometries are close to be achieved: any fissure or 
fistula that is still unclosed after this point will remain part of the embryo’s 
anatomy. 
 
2.2.1. AIMS AND TECHNIQUES 
There are three aspects that cleft palate repair should take into account: 
speech development, deglutition capacity (together comprising 
velopharyngeal function), and cosmetic facial features (including dentition) 
[21,152,179]; all of it in the context of continuing craniofacial growth, since 
most patients will not be fully developed during their treatment [180–182]. Four 




structures are primarily involved in this type of malformation: the lip, the 
alveolar bone, the soft palate, and the hard palate. Secondary structures 
affected vary from case to case, but most commonly include the Eustachian 
tubes, the nose, and the velopharyngeal muscles [21,172]. It is evident that 
these functions and structures are affected differently depending on location, 
extent, and severity of a given fissure. In virtually all its presentations, 
treatment of CP and CLP is comprised of an extended series of medical and 
surgical interventions all the way through the teen years of the patient (when 
treatment starts during the first months of life) [25,181,183,184]. Breathing 
alterations, nasal deformities, and middle ear anomalies and infections are 
also amongst the possible and common side effects of some clefts [185–187].  
Early CP repair procedures as described by Dieffenbach [188], Warren [189], 
LeMonnier [190,191], and von Langenbeck [192] were later revised by Veau 
[193]. All such procedures follow a straightforward objective: to reconstruct the 
palatal anatomy with the tissues actually present on-site – exclusively soft 
tissues. These surgeries eventually integrated a bone autograft to close down 
the alveolar gap while trying to prevent maxillary retrusion [194,195]. Currently, 
grafting is performed from ages 10 to 14, though some studies recommending 
the eruption of the central incisors as a timing indicator [38,196]. Closure of 
the alveolar gap was at first done with gingivoperiosteal tissue; similarly, 
mucoperiosteal flaps and reorientation of the vault were also used for hard 
palate lesions [25,196,197]. Although the main objective is achieved through 
these means, they only accomplish successful function restoration to some 
degree due to excessive scarring, infections, tissue contraction, insufficient 




presentations [198,199], adding to abnormal development of facial features 
into adulthood [20,200].  
The need to overcome these limitations furthered experimentation and the 
creation of the V-Y incision techniques and their variants – namely the Veau-
Wardwill-Kilner one – that were predominant through the 20th century and are 
still are used today [25,171,180,183,198,199,201]. More modern takes on this 
treatment were developed by Bardach (two-flap palatoplasty) [202] and later 
Furlow (double-opposing Z-plasty) [197], with divergence on what soft tissues 
to manipulate and how to handle them for better healing and overall outcome. 
These techniques are presently the most commonly reported [25,36,180,203], 
though, as often happens, slight variations and preferences appear amongst 
healthcare centres and surgeons, and sometimes even depending on case-
specific circumstances, including call-backs to Veau’s and Lagenbeck’s 
methods (usually in the form of their respective revised versions) [36,183,184]. 
2.2.2. GENERAL TREATMENT SEQUENCE LAYOUT  
Though the surgical treatment of soft tissues (lip and soft palate) takes care of 
most of the immediate aesthetic and functional issues, closing the hard palate 
and alveolar fissures plays a decisive role on patients’ post-surgical evolution 
[20,36,184,200,204], as well as in how post-closure treatment will be handled 
(which mainly involves orthodontic interventions, plastic surgery, and attention 
to closure-derived complications) [184]. The treatment outcome has to be 
balanced between development of speech and compromise of craniofacial 
growth, with earliness on hard palate repair – closure performed between two 




208], since the shape of the hard palate is usually narrowed medially during 
reconstruction  [184,197]. Current consensus on an optimal age for alveolar 
and hard palate defect repair can range from 18 months to 14 years, since 
previous closure of the soft tissues (at 6 or 18 months) already reduces the 
width of bony tissue fissures [28,196,209], though this age will vary according 
to local practice [208,210]. If delayed until dentition has ensued, facilitation of 
eruption of the lateral incisors and/or canines is a reliable indication for alveolar 
repair through grafting, so this helps narrow down the timeframe for treatment 
of bone fissures as, in some cases, it can be convenient to perform this 
procedure along with the hard palate closure. This is currently performed from 
ages 10 to 14 in the United Kingdom [32,36,38,184,196,211]. 
The two-stage repair protocol was envisioned to address the above issues, 
with the more immediate aesthetic and soft-tissue features repaired during the 
first year of life, and the bony defects treated once the patient’s development 
has progressed [19]. Hard palate closure under this scheme was delayed to 
ages between 12 and 14, and even later in some patients [19,212]. This 
timeframe allows for normalisation of palatal anatomy, but comes at the 
expense of speech proficiency unless speech therapy is included in the 
treatment regime [196]. It is remarkable that, even though analysis shows that 
two-stage repair yields better overall results [196], a recent report found that 
only about 14% of (non-syndromic) CP and CLP patients in the US receive 
treatment in two stages, with most practices looking towards avoiding multiple 
surgical interventions [36]. This is also a tendency in developing countries 
where the monetary burden – personal or public – of chronic treatment poses 




do not seem to report any adverse long term problems, but studies on this 
respect do not advocate for this protocol [20,184,196,200,205,213,214]. 
2.2.3. POST-REPAIR COMPLICATIONS 
Adverse events as consequence of surgical repair of CP have motivated the 
study and development of the techniques up to the current state-of-the art. The 
gradual refinement of the main objective from closing the fissures to recreating 
the normal architecture of the oral, nasal, ear, and pharyngeal complexes has 
improved the overall outcome of the treatment and reduced secondary 
complications. Such complications can be divided into two broad groups: 
immediate and long-term, though it is evident that they can also be understood 
in terms of functional and structural compromise [183].  
The most common serious functional complication is post-surgical respiratory 
problems, which arise from either perioperative airway management, 
inflammation of the involved tissues, persistent bleeding into the nasal cavity, 
haematomas, or secondary to wound infection [183]. It is worth mentioning 
that otitis media and upper respiratory infections are even more common, 
albeit much less serious [215]. These can result in anything from pulmonary 
infections to respiratory obstruction [183,216]. On the same line, other 
common structural issues derive from surgical wound complications, with 
failure of repair being caused by necrosis of manipulated tissue, graft or 
prosthesis failure, as well as infections [183,216]. Some have even reported 
death as a possible complication, most likely as a result of perioperative 
management, but at least one study hypothesises patient intraoperative 




Formation of oronasal fistulae [183,216,218], and mucoperiosteal flap 
detachment (hanging palate) [219] are possible structural complications that 
become evident in the following weeks as the patient recovers from surgery; 
both are caused by faulty surgical wound healing. Incidence for this 
complication has been estimated between 5.4% and 23% [180,218]. These 
happenings are considered an indicator for repair success [216], and they 
require additional medical and/or surgical intervention. It is known that most 
fistulae develop at the border between hard and soft palates [180], though 
decisive measures to prevent post-palatoplasty fistulae formation remain 
elusive at present [218]. One case report suggests that injections of human 
platelet-rich plasma (PRP) around the areas to be operated might reduce the 
chances of tissue failure and fistula formation though hyperplasia and 
hypervascularisaton of the zone [25]. Though healing adjuvants might be a 
possible solution to this issue, surgical wound healing has been found to be 
more complex than just biological factors, with even the phycological state of 
the patient playing a prominent role in effective healing [220,221]. 
Long-term complications are all related to how the surgery affects normal 
craniofacial anatomy and development. Maxillary hypoplasia and speech 
abnormalities have drawn the most attention during development of surgical 
techniques for CP and CLP repair, but others are also relevant – albeit less 
dramatic in presentation – such as velopharyngeal dysfunction, recurrent otitis 
media, obstructive sleep apnoea, and dental alignment disruption 
[20,183,222]. Although lip and alveolar deformities are alarmingly obvious in 
new-borns, these do not worsen with normal craniofacial growth 




cause of aberrations on facial skeleton development in these patients [20]. The 
maxillary and the mandibular bones are almost exclusively affected [17,20] 
due to tissue contraction and scar formation lowering the palatal height after 
repair. In turn, all of this leads to abnormal facial features due to maxillary 
retrusion, especially affecting its vertical proportion [184,223]. 
2.2.4. BONE GRAFTING: ISSUES, OUTCOMES, AND SECONDARY 
MORBIDITIES 
Applied to alveolar repair for CP patients, autologous grafting was first 
documented by Schmid in the middle of the 20th century [224], and this early 
approach harvested tissue from the ribs [208]. Bone grafts, in virtually any 
surgical context, are indicated with the aim of establishing a normal 
architecture of the skeleton which could have been disrupted due to a variety 
of reasons (Figure 2.6). From this perspective, it was only logical that 
autologous bone became the reference material to fill in any gaps, resections, 
and fractures, since it should naturally comply with the patient’s immunological 
requirements [159,195,225] – arguably the harshest limitation for an 
implantable material. Once past biocompatibility issues, five types of 
properties determine if a material is suitable for a given bone reconstruction 
application: manufacturing, mechanical, osteogenic (viability of intrinsic bone 
formation within the material), osteoinductive (capacity for mesenchymal stem 
cell recruitment and differentiation), and osteoconductive (capacity to support 
angiogenesis) [195]. Bioresorbability is desirable as well, as the ultimate goal 





Cancellous bone is the most used form of autograft, though not without the 
limitation of lacking mechanical integrity [90,195]. It does excel at all other 
characteristics; though in applications like those requiring a fixation or load-
bearing device, cortical bone is preferred, since a cancellous graft is not at all 
structural [195], and it is simply applied by packing it into a defect and soft 
tissue is sutured around it [226]. A cancellous graft integrates readily with the 
host site’s tissue, with resorption and bone neogenesis occurring as soon as 
one month after grafting, completing integration after one year [90]. Cortical 
implants, on the other hand, have adequate mechanical properties to begin 
with, but will start being resorbed around the second week after being 
implanted, which is usually faster than the rate at which the surrounding bone 
will be able to integrate it, as its compact internal structure makes it unsuitable 
for angiogenesis and osteoblast recruitment [90,195]. By the sixth month after 
 
Figure 2.5. Postoperative (6 year) maxillary arch form. A, Initial unilateral cleft deformity. B, Postoperative maxillary 
aspect with grafting. C, Initial unilateral cleft deformity. D, Postoperative maxillary aspect with complete crossbite after 




grafting, cortical implants will have weakened beyond the mechanical 
performance of surrounding bone, with this problem persisting for years [90]. 
Secondary morbidity of a grafting site is harvested-volume dependent, with as 
high as 25% of patients presenting persisting severe pain following tricortical 
full-thickness iliac grafts (Figure 2.7) [227]. Depending on individual surgical 
circumstances, major secondary morbidity rates range from 8.6 to 17.9%, 
including requirement of additional surgery, haematomas, chronic pain, deep 
infections, chronic paraesthesia, and additional wound treatment [228]. About 
20.6% of patients, in turn, develop minor complications which include 
superficial infections, and non-chronic paraesthesia and pain. Chronic pain, 
being one of the most disrupting complications, ranges in reported incidence 
rate from 3% to 26% [225,227–229]. Additional complications of grafting are 
linked to the surgical circumstances of each case, where the Veau-Wardwill-
Kilner technique has been implicated in higher incidences of persistent 
bleeding and post-operative fistulae [215,230], although other studies claim 
there is no clear rate-to-technique correlation [218]. One possible and serious 
side-effect of cancellous grafts on alveolar fissures, for instance, is dental root 
resorption, which normally requires extraction [194]. Synthetic implants have 
been explored as an alternative to address the issues highlighted in this 






2.3.1. STEREOLITHOGRAPHY AND THE BASIC PRINCIPLES OF 3D 
PRINTING 
All 3D printing techniques started as derivatives of the stereolithography 
technology developed by Charles Hull in 1983 [41]. This method relies on 
photo-curing powdered resins through focused UV-lasers in order to generate 
flat plastic shapes [41]. This patterning process introduced many of the now-
familiar elements of a 3D printer: the resin was laid out in a flat and levelled 
printing bed, with a movable toolhead suspended on top of it (or a movable 
bed in some setups). In the case of stereolithography, the toolhead houses the 
lasers, which it then focuses along the areas to be cured in the intended shape. 
Once one such layer of resin has been polymerised, a new layer of resin is 
2.3. FUSED FILAMENT FABRICATION FOR CRANIOFACIAL 
RECONSTRUCTION APPLICATIONS 
 
Figure 2.6. Autografting from iliac bone. Left, operative removal of a tricortical graft including the iliac crest. Right, a bicortical graft 




laid on top and cured, stacking these flat projections until the final volume is 
obtained [45].  
Arguably the most important piece of technique from the early days of 
stereolithography is the standard tessellation language (STL) used for 
programming the process. This programming language stores a standardised 
representation of coordinates that make up a given volume and shape [231]. 
These coordinates are further processed by a 3DP system – through a so-
called slicing software – to generate a series of contours and cross-sectional 
surfaces that will form a desired geometry when stacked on top of each other. 
Not only do 3DP systems rely on STL coding, but most computer-assisted 
engineering (CAE) and computer-assisted design (CAD) software packages 
are able to work with its file extension (*.stl) to this day [231]. This part of the 
whole method is key and common to all modern 3DP techniques: in principle 
any STL file can be turned into a real model through this technique. 
Tessellation procedures convert a modelled 3D shape into a mesh of triangular 
polygons warped around the surface of the model in question [232]. This 
processing step is crucial in that it allows for a mathematical parametrisation 
of any given geometry in a standardised, scale-independent way. 
Mathematically, this mesh is broken down to a matrix of coordinates and 
vectors that provide enough information to locate any single triangle within the 
whole arrangement, while also locating them in reference to other adjacent 
polygons. Each individual triangle is represented by a vector normal to its 









]                                Equation 2.1 
Where f is a given triangle (or facet), and v values stand for vector magnitudes 
parallel to the i, j, and k unit vectors, while p values stand for vertex coordinates 
along the designated axes. Coordinates and magnitudes are formally floating-
point variables, and are expressed as significands followed by signed 
exponents: it follows that each coordinate can only assigned a positive value 
by definition [233], though vector magnitudes can naturally be negative. In 
terms of coding, a given geometry A consisting of the single f facet just 
described can be written in American Standard Code for Information 
Interchange (ASCII) as follows: 
solid A 
facet normal vi vj vk 
 outer loop 
  vertex p1x p1y p1z 
  vertex p2x p2y p2z 







It is noteworthy that it is possible and correct to represent any n-vertex polygon 
in this fashion by describing its corresponding number of vertices but, 
traditionally and for practical reasons, STL files deal exclusively with triangles 
[232,234]. In regards to this, modern digital modellers usually avoid working 
with triangular polygons in the initial stages of the creation of a solid, in favour 
of quadrangular polygons. This is owed to the fact that many digital processing 
methods – especially those involving deformation of a solid – will complicate 
calculations when dealing with triangles, and often yield unpredictable results. 
Errors in meshing are a common issue and have been subject to study as 
digital modelling technologies have evolved [232,235,236]. Loading digital 
models into rendering software, for instance, will triangulate their surfaces, 
resulting in unnecessarily increased polygon counts. This happens as their 
procedural algorithms divide the model’s polygons. This is optimal on 
quadrangular ones – which will usually be divided in two triangles –, but 
redundant and detrimental in triangular ones – which will be only divided into 
smaller triangles. Broadly speaking, a higher polygon count usually means 
smoother surfaces closer to real curved shapes. This comes, however, at the 
expense of longer processing times [234]. This is but one issue of the many 
that can arise when triangulating surfaces, and modern 3D printing software 
will generally have built-in functions to deal with mesh correction and 
optimisation [232–234]. 
In general, the processing of a model prior to additive manufacturing (AM) 
suffers from loss of information on two stages: during the surface triangulation 
processing, and at the cross-section slicing step [233,235,237]. Slicing is 




inputted geometry into a program cycle for a given AM device. The contour of 
a given cross-section can be derived from the definition of its STL facets, and 
reproduced in terms of displacements from a point on the printer bed. It 
becomes evident that any curved shape along the vertical direction of the 
construction process will only be as smooth and accurate as the resolution of 
the given AM technique and device allow [233]. 
2.3.2. 3D PRINTING TECHNOLOGIES 
Section 2.3.1 illustrates the driving principles behind all modern 3DP 
technologies: that the intermediate steps between CAD and a final product can 
be cut down to a minimum through adequate implementation of technological 
advances. These AM processes aim to remove the need of indirect methods 
like casting, and subtractive ones like tooling, which were virtually the only 
options for industrial manufacturing up to the beginning of stereolithography. 
This preference was reflected on the role AM methods held as rapid 
prototyping technologies through most of their existence in industrial 
applications, since the quality they could provide was not up to the standard 
of finished parts made through other means [41,42,45]. It has only been in 
recent years that finished (or near-finished) products have been producible 
through AM methods, likely through the affordability and proliferation of 
consumer-level devices [42]. 
Shortly after the introduction of stereolithography, research from the University 
of Texas resulted in the selective laser sintering process (SLS), which is very 
similar to the former [238]. In this form of AM a layer of polymer powder on a 




temperature in order to bond the polymer particles without melting the material. 
As in stereolithography, a laser patterns a given layer into the required shape, 
with more powder added on top at the end; the process also bonds each layer 
to the previous one. Once all layers have been laid, the part is subject to 
thermal treatment to consolidate the bonding between particles. Selective 
laser melting (SLM) follows the same logic, but employs a high-power laser to 
fuse the powder. This technique is only applicable to materials with sharp 
melting ranges, which makes it suitable for ceramics and metals [231]. 
Ink-jet 3D printing relies on the same basic technology as standard ink-jet 
paper printing, and was developed at the Massachusetts Institute of 
Technology during the early 90’s. Its procedure is also based around a powder 
bed, with an ink-jet actuator delivering a binder solution on the desired cross-
sectional shape. More powder is added on top after each layer is finished, and 
the process is repeated throughout the desired volume. This method is 
naturally limited by the existing suitable combination of powdered materials 
and liquid binding agents, though it makes it possible to introduce different 
materials into the production of a single part [45,231]. 
At the turn of the century, 3D plotting techniques were introduced by the 
Freiburg Materials Research Center, which integrate hydrogels and high-
viscosity liquids into a process similar to ink-jet 3D printing [239]. The main 
difference from the former is that 3D plotting delivers the whole of its materials 
in the liquid phase. This method was specifically developed for use in 
construction of tissue engineering scaffolds made from naturally-occurring 
materials such as fibrin, collagen, agar, or gelatin [45,239]. These materials 




discussed methods, but can be argued to be the best choices for tissue 
scaffolding, since they most closely resemble the make-up of an extracellular 
matrix. This technique allowed for the eventual development of bioprinting, 
which refers to the integration of live cells to the printing process with the aim 
of recreating tissues more accurately, though with limits on its resulting 
geometries [239]. 
The present research is based around fused deposition modelling (FFF) since 
this method allows handling of plastics without intervening chemical agents 
that could complicate biocompatibility. Polymeric implants are best suited for 
maxillofacial reconstruction since they allow for good control over the desired 
complex shapes. The major limitation of this technology is that the material 
must be a thermoplastic, but this also opens up other possibilities for thermal 
processing of the input materials and finished parts. A detailed review on this 
manufacturing technique follows. 
2.3.3. FUSED DEPOSITION MODELLING, ITS ISSUES AND LIMITATIONS 
FFF was introduced shortly after stereolithography by Scott Crump, and 
patented in 1992 [240]. As with the methods already described, FFF follows 
on the same layer-by-layer construction protocol, but it does so using molten 
polymers extruded into thin fibres that form a given contour [241]. As a general 
reference frame, the X and Y axes in most 3D printers are commonly those 
parallel to the printer bed, while the Z axis would be perpendicular to it. The 
toolhead in FFF devices usually consists of an extrusion system movable on 
the XY plane, whereas the printer bed can be adjusted along the Z axis [240]. 




printer bed. Currently, the preferred input material for these devices is 
purpose-specific cylindrical plastic filament, commonly found packed into a 
spool of a given weight. Most commercially available FFF printers are 
standardised towards either 1.75 mm or 3 mm filaments, with some requiring 
proprietary brands that might deviate from these measurements [237,241]. 
This filament is driven by means of a press or worm drive into a heating 
chamber that is set above the melting point of the material in question [237]. 
The softened plastic accumulates at the bottom of the extruder and is finally 
forced through a nozzle with typical diameters ranging from 0.4 mm to 1 mm 
[240]. 
As with any iterative process, it is bound to be subject to inaccuracies arising 
from its practical resolution limits. The ideal AM device would be capable of 
differential increments along any reference axis, as well as differential 
deposition of material. In the case of FFF, it is evident that its resolution is 
inherently anisotropic: one limit is given by precision and accuracy on 
positioning of the extruder on the XY (horizontal) plane, while the other 
depends on the printer-bed’s controlled movement along the Z (vertical) axis 
relative to the extruder [233,242]. The resolution on the horizontal plane is 
directly dependent on the drive motors and positioning mechanism of the 
toolhead. The type and quality of these elements translates to the smallest 
displacement in the X or Y direction that the toolhead is capable of achieving 
[233,240]. It can also be argued that the control loops and electronics in place 
can make the system drift from its theoretical highest resolution. Similarly, the 
resolution along the Z axis depends on the setup of its respective drive motors, 




Even though the system for vertical positioning is simpler — in that it handles 
movement in a single dimension — it has been pointed out that the Z axis is 
further limited on its delivered resolution by the thickness of the deposited 
plastic fibre [233]. Commercial FFF printers control fibre widths through the 
separation of the nozzle from the printer bed, with most models being 
calibrated to work under settings of 0.125 mm, 0.25 mm, or 0.5 mm [233,243]. 
The larger fibre widths are used to speed up printing while sacrificing vertical 
resolution, since the number of layers forming the geometry — and therefore 
construction time — is directly proportional to this value. Nozzle diameter must 
also contribute to variations in resolution, as it will alter the rate at which 
material can flow through the extruder, all other settings being equal [242,243]. 
In practice, however, little can be done to enhance a printer’s performance in 
this respect without modifying it. Some control can be achieved through 
detailed characterisation, since a number of other variables are programmable 
through printer-specific software [240,242], ranging from extrusion rate, 
filament feed rate, density of fibres in the internal geometry of the cross-
sections, extrusion temperature, toolhead displacement speed, printer bed 
offset, amongst several other predetermined by each manufacturer. 
 
2.3.4. IMPLANT MANUFACTURE AND MAXILLOFACIAL 
RECONSTRUCTION 
Since the advent of Rapid Prototyping (RP) in the early 80’s, its potential for 




prototyping (MRP) as a catch-all category for custom models produced for 
clinical use [42,125,244]. As the technology evolved, its potential within the 
field of tissue engineering was also expanded and explored in applications 
ranging from surgical guides [245],  orthopaedic prosthetics [246] to 
regenerative medicine [247]. Maxillofacial surgery and facial reconstruction 
have certainly been identified as an area to benefit from modern MRP 
techniques. There is much room for improvement on problems that have been 
identified on current practices, which rely on metallic implants and surgical 
plates of standardised shapes which can only be deformed intraoperatively to 
reasonably match the required anatomy. In terms of geometric accuracy of the 
final product, quality can be greatly improved by FFF techniques 
[40,47,125,248], which themselves are a subset of RP technologies. 
Maxillofacial reconstruction applications tend to deal with very complicated 
geometries where standardisation is complicated – and many times 
impractical – [45], and where an intraoperative stage for implant adaptation 
becomes necessary, increasing surgical times [39]. Advances in 
manufacturing technologies throughout the last century widened the reach of 
bioengineering in prosthetic devices, which has been of interest for MRP and 
has made possible to reproduce geometries straight from medical imaging 
studies [125]. Research on this respect has proved computed tomography 
(CT) scans to be accurate enough on reproducing bone anatomy for surgical 





Tissue engineering has also found AM to be of great interest for production of 
clinically sound implants to improve upon bone autografts: the current 
standard-of-care for CP and many orthopaedic applications [108,180]. 
Common issues in terms of implant biocompatibility, biodegradation, and 
biomimetic activity are looking to be addressed and resolved through 
advances in tissue engineering [45,247,251]. The use of scaffolds for the 
purpose of cellularisation (or functionalisation) is nowadays the preferred 
method to apply tissue engineering to regenerative medicine [3]. These 
techniques, however, are still in development and would pose significant 
complications and additional costs to the manufacturing of an implant for 
clinical use. New polymers and AM methods – which are now commonplace 
in scaffold construction – have led to the development of current medical 3DP 
technologies and bioprinting: bringing the promise of organ replacement closer 
to reality [3,45,252]. By themselves, however, a polymeric bioactive implant 
could be an adequate solution for some applications, since it cuts out on the 
fore-mentioned complications and costs of ex vivo culture and growth of 
adequate quality and quantity of tissue(s) on a given scaffold [37]. Moreover, 
cell or tissue culture on a three-dimensional structure is possible, and recent 
research has shed light on the application of MRP implants for craniofacial 
reconstruction [103], [114], [115], as well as on the paradigms of using plastic 
implants [8]. 
It is worth noting that dimensional error would be a concern to manage during 
design for FFF. Given the slicing algorithms used for production of the base 
code necessary for FMD printers to operate – which breaks down a digital 




–, it is expected that the scale of the printed structure affects the precision of 
the printing, as it is expected that the printer performs with varying accuracies 
depending on this same factor. Error on CT scans is reported around 0.9 to 
2.16% on linear measurements to reproduce anatomical bone structures 
[254–256]. These are to be considered while deciding the geometry for an 
implant based on CT images and produced by FFF, as errors in manufacturing 
will add up to those of the scans. The principles used for modular designs for 
scaffolds have proven to be an efficient way to tackle scaffold design through 
3DP [108]. By introducing a repeating patter or subunit, it is possible to more 
closely control some of the parameters of the printed structure, while allowing 
to flexibly adapt the geometry to the shape of any given defect – while also 
avoiding scale-dependent variations to a certain extent. In the case of the 
present design guidelines, applying this idea will focus on handling void 
content, material porosity, and accuracy of printed measurements. For these 
reasons, it was considered is that FFF was a viable line of research for 
addressing this clinical need. 
Additive manufacturing techniques (like FFF, selective laser sintering, and 
bioprinting) have found applications as a production method for regenerative 
medicine plastic implants in research on reconstruction of cranial bones and 
bone regeneration in general [1,7,262–265,44,123,138,257–261]. For clinical 
use, it is far more common to find metallic implants – usually titanium based – 
made through other additive manufacturing techniques,  such as selective 
laser melting [135,250] or 3D-fiber deposition [266]. Powder-based techniques 
tend to be more accurate in reproducing geometries since their resolution is 




FFF is limited in this respect by nozzle calibre, which for desktop 3D-printers 
is usually 0.4 mm (referring to the diameter of the opening of the extruder) 
[243], with other commercially-available choices being 0.25 mm and 0.6 mm. 
This limits the amount of small details that can be accurately reproduced by 
FFF from a 3D-model – especially in the sub-millimetre range. However, one 
of the strong advantages of FFF over selective laser sintering/melting is that 
the technique is not as material-intensive. This is due to the fact that FFF only 
requires material within the geometry being printed, while selective laser 
sintering/melting need to fill up the entire print-volume with powder. This 
makes these techniques less suitable for testing new developed materials, 
since large batches must be prepared for each single print-run. In contrast, 
FFF can produce single, small-sized samples, and material tests only require 
the production of some dozens of grams a time.  
Recently, implants made through additive manufacturing specifically for 
reconstruction of the alveolus – from either CLP or other diseases –  are also 
found in the literature. Patryk, et al. report a preliminary clinical study on five 
patients who received 3D-printed titanium scaffolds for alveolar reconstruction 
[267]. Berger et al developed a 3D-printing process for calcium phosphate 
using powdered ceramic with a liquid binding agent to produce a porous 
scaffold in custom fitted to a sample CT-scan [268]. Hixon et al described a 
method for using 3D-printed moulds used to cast a chitosan-gelatin hydrogel 
[269]. Coelho et al. published an animal study on rabbits with a surgically-
created alveolar cleft that was repaired using a 3D-printed bioceramic scaffold 
[270]. Reports on alveolar cleft repair using FFF-produced implants are not 




2.3.5. APPLICATION-SPECIFIC CONSIDERATIONS ON MATERIALS AND 
FFF 
The FFF device selected for the initial phase of this project is the BFB-3000 
Triple Head Clear Case (3D Systems) manufactured by Bits from Bytes from 
2002 to 2012. It is configured and tuned to extrude PLA out of the box, and 
runs on proprietary build files (*.bfb) generated through the Axon 2 slicer 
software provided, which are in turn based upon STL files from CAD or CAE 
models [41]. This machine is considered to be reliable and overall sturdy [246]. 
More modern printers might prove more accurate and better at reproducibility 
and resolution, but the present application does not require high-precision 
machinery-like components as much as organically shaped and reproducible 
geometries. Though the materials usable for scaffold construction are varied 
and rather diverse, FFF 3D printing has the obvious disadvantage of requiring 
a thermoplastic, as well as an innate incompatibility with bioprinting methods 
that use live cells [45]. A list of thermoplastics – alone, as composites, or as 
co-polymers – that have been reported for FFF in regenerative medicine is 
detailed on Table 2.1. 
As is, the BFB-3000 should be able to handle any of the listed materials given 
proper calibration, while still being customisable and troubleshot in-house if 
needed. This particular printer has seen very little use in the literature, as a 
single article reports its application on geometric evaluation for orthopaedic 
implants [246], though another model from the same manufacturer has been 
documented for tissue engineering scaffold production [271]. Its merits are 




time users. It is regarded as being highly reliable, having a sturdy platform, as 
well as being easily repairable and modified while running in low upkeep costs. 
Support for this equipment, however, has been discontinued as of 2012, 
though third-party spares are available on-line.  
The printer was considered to be accurate and precise enough for an initial 
approach to this application. One of the main disadvantages of this model 
comes from its use of induction sensors for positioning. The “zeroed” position 
of the printer tends to drift slowly from calibration each time it resets the 
extruder to its home position – this is likely to interference from the magnetic 
field of the motors and fans on the extruder, which are very close to the 
sensors. Modern printers avoid this issue by using mechanical end-stop 
switches. Many of the printing parameters (such as printing speed, infill speed, 
outer walls speed, flow rate, jerk, and retraction) are not configurable from its 
proprietary software, which limits configurability for different situations and 
materials. Relative to more modern FFF printers, this device prints faster, but 
at cost of print-quality, probably due to excessive vibrations from sudden 
deceleration of its heavy triple-extruder head. These disadvantages were 
considered minor given the sturdiness of construction of the printer, the 
availability of components and ease-of-access to its internal systems if in-
house repairs were necessary during the project, and its good track record 
within the laboratory. 
Given that a material is biocompatible and otherwise suitable for scaffold or 
implant fabrication, porosity becomes one of them main concerns when 




range of an adequate porosities, on average of about 0.4 mm in diameter, in 
order to allow bone regeneration. Meanwhile, 0.3 mm is suggested to facilitate 
angiogenesis [8,276], which is relevant since its deficiency is certain to limit 
tissue growth and viability, as observed to happen with non-vascularised 
cortical bone grafts [90]. Moreover, adequate vascular supply is essential for 
clearing metabolic waste anywhere in the anatomy, and especially at implant 
sites where degradation by-products will build up. Even though all lactide 
polymers degrade into metabolically-occurring lactic acid, the compound is 
capable of inducing chronic inflammatory response when implanted, and build-
up of degradation products is likely to blame [277]. 
With a bone regeneration implant, tissue growth is sought after within a three-
dimensional space, and cells and their extracellular matrix should be able to 
infiltrate down to the innermost part of the geometry. Taking cortical bone 
grafts as a reference, low vascularisation and high density cause the graft to 
fail from the inside out, and the extracellular matrix to be slowly removed, with 
the zones furthest in from the graft’s surface becoming an expanding necrotic 
core [90]. Both in culture and upon implantation, cells tend to prefer attachment 
to the surface of the any material rather than infiltration into its internal 
structure or porosity network [273]. Maximising surface area and accessibility 
to the inner spaces of the material have been taken in account for the design 








2.4.1. LACTIDE POLYMERS 
As shown in Table 2.1, polylactic acid polymers and its isomers present a 
more than viable and convenient choice – namely the L-isomer poly-L-lactide 
(PLLA), preferred for implantable devices due to its slower degradation profile 
(probably due to higher crystallinity). The 3D printer used for this study was 
Table 2.1. Published thermoplastics applied through additive manufacturing techniques in 
regenerative medicine 
Material Authors Year Application 
PLGA with type II collagen Yen, et al [257] 2009 FFF hybrid scaffold 
chondrogenicity testing 
PCL/PLGA Kim and Cho [258] 2009 Multi-head FFF printer 
characterisation 
PCL/tricalcium phosphate Probst, et al [1] 2010 Calvarial reconstruction 
implant 
PMME Espalin, et al [44] 2010 Anatomical and mechanical 
evaluation of FFF printed 
implant  
PCL Teo, et al [259] 2011 Drug delivery device 
PCL Kang, et al [260] 2012 Seeded scaffold for critical-
size defect in animal model 




Shim, J., et al [262] 2012 Non-seeded implant for 
critical-size defect in animal 
models 
PCL S. Van Bael, et al [263] 2013 Biocompatibility testing 
PCL composite with bioactive 
glass, PCL/PLA, PLA 
Korpela, et al [271] 2013 FFF 3D printer 
characterisation 
PLA/HA Esposito, et al [264] 2017 FFF PLA/HA composite 
PLA/HA Esposito, et al [265] 2018 FFF PLA/HA composite 
ABS, PLA Rosenzweig, et al[138] 2015 FFF scaffold osteogenicity 
testing 
PCL, polycaprolactone; PLA, polylactic acid; ABS, acrylonitrile butadiene styrene; PLGA, 
Poly(D,L-lactide-co-glycolide); PMME, polymethylmethacrylate. 
2.4. LACTIDE POLYMERS: PROPERTIES, PROCESSING, AND 




calibrated to use PLA (with PLLA having similar thermal properties), and 
virtually all commercial printers are factory-compatible with it. It has also been 
extensively documented in the literature regarding implantable-device 
production [11,138,247,278–282], as well as characterization as a degradable 
biomaterial [283–285]. These include techniques and reports on the material’s 
relevant characteristics such as crystallinity [286,287], porosity 
[44,108,257,288], molecular weight [283,285,289], and calorimetric values 
[283,284,289,290], and processing [49,282,291,292]. Moreover, lactide 
polymers have been found to arguably be the most biocompatible of all 
printable thermoplastics due to their monomer being a common metabolic by-
product [271]. 
It must be noted that PLA usually refers to the D isomer of the molecule 
(PDLA), while its enantiomer is designated PLLA. These and the L-D 
composite, known as PDLLA, differ in mechanical properties and degradation 
rates – probably due to differences in crystallinity [49,293,294]. Their 
biocompatibility and degradation products are nonetheless equivalent [137]. 
Medical grade PLA and PLLA are commercially available, and cleared by the 
FDA for use in implantable devices, though concerns might arise about new 
regulations required for FFF medical applications, as the process might have 
unexpected effects on the materials [295]. Though, in principle, much of the 
data on this respect could be extrapolated and deduced from previous 
research regarding other manufacturing techniques [49], the impact of FFF on 




To this author’s knowledge, the present work is the first formal attempt at doing 
this kind of characterisation for FFF specimens, which follows the challenges 
perceived by industry and research alike [296,297]. A need for further testing 
dealing with thermal and molecular properties has been pointed out by the 
National Institute of standards and Technology (NIST) of the US Department 
of Commerce, for instance [297]. There are currently no official standards 
specifically issued for the evaluation of 3D-printed parts and devices. Many of 
the ASTM and ISO procedures deal already with measurement, processing, 
and evaluation of the materials suitable for the diverse forms of 3D printing 
currently available, and these should reasonably apply and be followed [297]. 
PLA is one of the most widely-available printing materials, and virtually all 
commercial 3D printers are pre-configured to work with it. Additionally, PLA 
has been successfully composited with HA in published literature 
[136,283,298], with positive results relevant for bone-regeneration. It is being 
taken in account that the proposed battery of tests must be achievable in 
relatively brief time-windows, since custom geometries may not reflect testing 
done on standardised models — which is the current industry norm —, and 
applicable standards suggest device-specific dismantling properties is 
convenient, and is likely crucial on load-bearing implantable devices. 
2.4.2. COMPOSITING AND SELF-REINFORCING OF LACTIDE POLYMERS 
In general, biodegradable polymers are less resistant to mechanical stress – 
by a wide margin – than bone and other stress-bearing-implantable materials 
(mostly metals), although they are comparable or superior to other bone 




strength in the range of 5-15 GPa, while tensile resistances of 7-30 GPa (in 
the direction parallel to the load) are desirable for bone implant purposes [247]. 
High-molecular weight lactide polymers yield an average of 2-3 GPa [136], 
with a maximum of 7 GPa for very high molecular weight (>1,000,000 g/mol) 
[136,247]. There are several documented techniques to improve tensile 
properties of lactide polymers – and polymers in general – [247], and, two are 
of relevance to the present application: compositing with hydroxyapatite (HA), 
and Self-Reinforcing (SR). 
HA-PLA composites have been explored to address the mechanical 
resistance issue in applications where bone regeneration – as opposed to 
orthopaedic reconstruction – is the main priority. These require the implanted 
device to be biodegradable and its degradation products to be physiologically 
safe. Moreover, the implant is meant to fulfil the roles of an extracellular matrix, 
providing support, tissue scaffolding, osteoconduction, and osteoinduction, 
while still maintaining the adequate geometry and placement to bear the 
mechanical load the repaired tissue is supposed to withstand [247]. This last 
point, although it might not be instinctively evident, is one of the main variables 
to ensure the newly formed tissue develops under the right conditions to 
withstand its nominal load [299,300].  
Integrating HA crystals into a PLA matrix has yielded an increase in tensile 
strength up to ~12 GPa [136,298]. The use of nano-scale hydroxyapatite 
(nHA) seems to allow for similar results in other polymers, but at the expense 
of ductility and impact strength [301]. Additionally, functionalisation of 




and new-bone formation [250,302–307]. In-house production of nHA through 
a simple and reproducible precipitation pathway is possible [308,309], and was 
explored in this research. SR, on the other hand, is achieved through the 
manufacturing and/or machining processes the polymer undertakes. The 
macroscopic and microscopic alignment of the polymer matrix and the nano-
crystals enhance the mechanical properties parallel to them; the former is 
achieved through the controlled deformation of the material during processing 
[282,291,292], which FFF intrinsically does. Both processes have been 
successfully tried in implants, and HA by itself has FDA clearance for this 
application, though some production processes of nHA might be of concern in 
this regard due their use of hazardous solvents [247,282,292]. 
It is notable, however, that mechanical considerations arise from the demands 
of orthopaedic implants, which usually deal with the repair of long bones and 
other load-bearing sections of the skeleton which would require an implant due 
to a compromised structure: after fractures, resections, or neoplastic 
destruction, for instance [45,310], where the implant also acts as a fixation 
device [12]. Cleft palates should not be treated as such, since the missing 
tissue is not compromising the load-bearing duties of the maxillae, as 
evidenced by the fact that alveolar fissures can be left untreated for more than 
a decade in some schemes [196,211]. Mechanical strength of PLLA is a very 
valid concern in load-bearing applications, since studies show that in vivo 
tensile strength of bone fixation plates deteriorates more rapidly than both in 
vivo plates implanted without load, and in vitro PBS degradation setups 
[126,311,312] Velopharyngeal function, on the other hand, is very restricted 




closure of the palatal shelves, where grafts are not currently indicated 
[25,198,222,313].  
2.4.3. DEGRADATION AND ENHANCEMENT OF LACTIDE POLYMERS: 
ANNEALING AND SELF-REINFORCING 
Polymer breakdown is a concern that comes along with the use of plastics. 
Implementing polymeric biomaterials requires that this issue is given 
importance as it arises from the conditions within a given host organism, which 
tend to favour polymer erosion: the main mechanism of breakdown on plastic 
degradable biomaterials [314]. Bone illustrates the complexity of this issue, as 
organic molecules are intrinsically fragile, and only exist within a limited range 
of environmental conditions, exhibiting their biological activity through an even 
narrower range of these [294,315]. This is why all connective tissues – which 
are naturally-occurring polymers and composites – require constant upkeep 
processes, and why bone physiology responds and relies heavily on being 
subjected to constant mechanical stress [90]. Bodily fluids and immune-
response-molecules – both humoral and cellular – are chemically aggressive: 
this adds a complex physiological component on top of every polymer’s 
variable molecular arrangement and their tendency to lyse when exposed to 
solvents, radiation, heat, and mechanical stress [311,312,314–316]. 
Manufacturers state a range of degradation periods of PLLA and other lactides 
above 24 months [317,318]. In vivo testing shows high-crystallinity remnants 
persisting for almost six years [279,283,319,320], with in vitro data suggesting 
very long water penetration periods along with a slow  initial scission of long 




autocatalytic hydrolysis due to the release of oligomers and pH-lowering 
monomers [321]. This results in early degradation through surface erosion 
(causing the geometry to shrink from the outside), followed by later stages of 
bulk degradation (which eventually causes dismantling). Degradation is highly 
dependent on crystallinity, and amorphous regions are thought to fail first and, 
moreover, the first stage of degradation of these polymers predominantly 
involves reduction of molecular weight and increases in crystallinity 
[137,283,321]. By the end of this stage, further oligomer breakdown will 
eventually yield soluble monomers, as well as effective loss of mass on the 
structure with deterioration of its mechanical properties [283,321]. Molecular 
weight reduction during the first stage of degradation can be linearly related to 
molecular weight at a given time during degradation (Mnt) such that: 
𝒍𝒏(𝑴𝒏𝒕) = −𝒌𝒕 +  𝒍𝒏(𝑴𝒏𝟎)   Equation 2.2 [284,321,322] 
Where Mn0 is the initial (number average) molecular weight and k is the 
degradation rate constant for a given experimental setup, and t is time. For 
semi-crystalline lactides like PLLA, several studies place this threshold roughly 
after the material’s mechanical strength drops below 70-80% of its original 
value during in vitro degradation [2,283,323,324]. Furthermore, an estimated 
dismantling period for medical-grade-PLLA (Mw ~ 400 kg/mol) is clocked at 
three to six months [317]. 
During this subsequent phase, monomers can accumulate in cavities and 
other such low-recirculation spaces inside a specimen, locally reducing pH and 
catalysing further hydrolysis from within the geometry [283,289,294]. It is 




erosion accounts for the very first stages of polymer degradation, with bulk 
degradation taking place as water infiltrates and accumulates through small-
scale defects on a specimen’s topology [137,294]. Polymer chains in the 
crystalline region are more tightly packed, fixed in place by intermolecular 
forces, and arranged in a lower flexibility superstructure, where water will not 
penetrate easily [319]. Amorphous regions, however, are less dense, smaller 
in size, randomly oriented, and more free to displace – therefore easier to 
infiltrate by water and able to harbour a larger amount of it – [2], contributing 
to the aforementioned degradation pattern [49], and the ultimate prevalence 
of high-crystallinity remnants in long-term studies [319,320]. 
Annealing and SR of FFF parts can help tailor – to a certain extent – the 
degradation and dismantling profile of an implant, in a similar way as how 
crystallinity and polymer blends are used for drug-delivery purposes – where 
amorphous PDLLA is preferred amongst lactides [137,321]. Thermal 
processing at 120 ºC for 4 hours after machining yields increases in 
crystallinity and mechanical strength at the expense of elastic modulus [49]. 
Treatment at 200-250 ºC of a very high molecular weight PLLA coating (Mw 
1000 kg/mol) on cell-culture plates also proved to stimulate osteoblast 
differentiation, apparently by facilitating monomer release from lowered 
molecular weight sections during the early stages of degradation [325]. Self-
reinforcing, on the other hand, is achieved through aligning polymer chains 
into macroscopic structures through processing of the material [12,326], with 
best results – doubling or even tripling tensile strength – achieved with different 
drawing techniques, as well as high-pressure moulding of heat-softened 




(Tm) [327]. FFF, in principle, can be used as a SR process, since it complies 
with the requirements of the technique. More than improving the material 
mechanically, aligned structures on small scales also increase degradation 
times by easing water flow along the surfaces, directing shearing into causing 
erosion, and thus presumably retarding infiltration [283,290]. 
2.4.4. DEGRADATION PROFILES: REAL-TIME SIMULATED-
ENVIRONMENT TEST AND MODIFIED ACCELERATED DEGRADATION 
TEST 
Lactide polymers are well documented to be bioresorbable and widely used in 
implantable devices and absorbable sutures [127,280,283–285,289,290]. In 
vivo, implants made out of these polymers take anywhere from two years to 
five or more to degrade completely, while in vitro tests and manufacturers’ 
specifications place that time in ovBer three years [279,280,285]. This is 
dependent on factors like implantation conditions, with fixation devices holding 
a fracture together, for instance, deteriorating overall faster than controls 
implanted on healthy bone [126]. However, for resorbable devices – as 
opposed to the material itself – in accordance with ISO-10993-13-2010 [328], 
testing can be conducted up to the point where the implant’s structure is 
compromised: its dismantling point. This is suitable for the present research, 
since degradation data for PLA is available, and the current focus lies around 
the effects of FFF on the manufactured parts. After implantation, the implant’s 
mechanical characteristics become irrelevant once its structural features 
break down. Given that, the main interest in these experiments is how long the 




it is safe to assume that degradation will proceed as expected, in theory with 
healthy bone growth happening around its debris [8]. 
Resorbable materials have been extensively studied in regards to their 
breakdown both in vitro and in vivo. The in vitro procedure is addressed by the 
ISO-10993-13-2010 standard, with an emphasis on identifying rates of mass 
loss, molecular structure deterioration, and potential accumulation of 
degradation products. It is noteworthy that, though the procedure focuses on 
determining the amount of time it takes for a material specimen to completely 
dissolve into a medium, it also recognises the relevance of functional 
breakdown of a resorbable device. This can apply to a number of current 
applications, such as resorbable sutures and drug delivery devices, but as well 
to bone-fixation mechanisms and implants, which have been reported to 
exhibit drastically different chemical and mechanical degradation profiles 
when implanted as compared with in vitro data, likely due to mechanical wear 
[2,137,284,329]. These discrepancies show up despite the protocol using 
phosphate-buffered solution (PBS) at 37 ºC as its degradation medium in its 
real-time simulated environment test (RSET) iteration to introduce part of the 
effects of bodily fluids on the material. 
RSET, moreover, takes over a year to complete when following the ISO 
standard, but polymers like lactides, taking over three years to degrade in vitro, 
have brought attention to the accelerated degradation test (ADT) variant also 
listed within the standard. In ADT, the reaction rate is sped up by holding the 
experiments at a higher temperature, which should be decided in accordance 




decomposition [294]. Studies done in this respect found, as expected, that 
degradation tests of lactides above their Tg (which, at around 60 ºC, is 
relatively near the physiological temperatures on the RSET setting) induce a 
much faster decay of all measured variables, probably due to thermal 
degradation [283,290], setting a limit to the applicability of this option for 
lactides. 
Most published degradation tests for PLA follow the procedure described in 
ISO-10993-13-2010, or some variation of the methods thereby described 
[2,283–285,289,290,314,325,330]. However, many of these publications pre-
date the standard, and others are not completely detailed regarding 
methodologies when not directly citing it as the procedure followed. At least 
one study [2] has compiled and compared degradation profiles for lactides in 
vivo and in vitro, but direct comparison is questionable given such 
methodological variations. Notwithstanding, the overall patterns registered are 
similar, and they seem to follow the expected sequence of events for polymers 
degraded in exposure to aqueous media. It becomes clear that in vitro 
degradation data does not directly mimic the effects of devices in vivo, 
especially for mechanical testing since implants’ geometries and chemical 
exposure are very far from standardised specimens and conditions. In short, 
their testing results should be compared with caution as factors such as 
implantation site and load-bearing affect their deterioration, speeding it up to 
as little as six months [126,137,331]. Since crystallinity is observed to relate 
closely to the degradation behaviour of polymers, it follows that promoting 
further crystallisation through an appropriated annealing process (posterior to 




their mechanical resistances. The effects of annealing in degradation tests of 
compression-moulded lactides has been studied by past research [49,290]. 
FFF might have unexpected effects on the materials being used, as the fusion 
of each layer of polymer happens from seconds to hours apart, and stochastic 
factors can vary unforeseeably during the whole process. Moreover, layers on 
asymmetric structures are allowed to cool down differently as the succeeding 
softened polymer is added on top, usually well above their Tg, transferring heat 
to the lower levels. While most applications are likely to disregard the resulting 
intermolecular disturbances these processes can cause, these might be 
significant in settings sensitive to crystallinity (CR) and molecular weight (MW) 
changes, such as biocompatibility cell cultures, or in vitro and in vivo 
degradation tests, as others have pointed out [49,137,247,283]. Additionally, 
mass-transfer devices which operate in high heat-transfer-to-mass ratios have 
been found to be prone to errors due to hysteresis, and, depending on their 
severity, sometimes might require built-in temperature regulators, or even 
closed-loop temperature and extrusion controls [225]. Implementation of these 
kinds of advanced automatic control systems might eventually prove to be 
necessary to improve the quality and reproducibility of FFF manufacturing.  
PLA components manufactured through other means, for instance, suffer 
deterioration on mechanical and molecular properties upon ethylene oxide 
sterilisation (EOS), or even simple oven-drying: processes regarded as mild 
for most plastics and other materials [49]. Keeping these facts in mind, the 
effects FFF must have on thermoplastics – and particularly on lactide polymers 




knowledge, and are mostly extrapolated from other bulk extrusion techniques 
[297]. As the technology becomes ubiquitous thanks to consumer-grade 
products lowering the overall price of 3D printers, new ways for standardisation 
will have to be developed to keep quality control on products, as well as to 
promote scientific rigour and allow for directly-comparable results. The 
following procedure is presented so as to fulfil the aforementioned objectives, 
but as well as a proposal for a standardised approach to evaluate and 
characterise 3DP technologies in regard to dimensional accuracy, as the 
method allows for most variables to be controlled so as to make reasonably 
quantifiable the effects of varying the FFF device, its settings, or the material 
used. 
Given the fact that degradation tests are lengthy and provide information on 
the bulk properties of standardised samples, a modified accelerated 
dissolution test (mADT) will be explored in this work, which aims to provide a 
fast way to retrieve mode-of-breakdown (meaning the way in which a given 
geometry suffers structural failure) data by introducing acetone as a test 
medium to replace PBS without modifying the testing temperature. Acetone 
has been used in past research to determine molecular weight deterioration of 
PLA [2], as it readily dissolves it at environmental temperature. In the absence 
of water, pure acetone attacks the material immediately, without the need for 
reduction of its molecular weight: this reveals the sites for weakest 
intermolecular interaction. An accompanying series of ADT is also presented 
so as to attempt correlation mADT data and past publications. The 
experimental procedures on this project are also designed to assess the 




Ultimate Tensile Strength (UTS), E, Cr, and mass loss) of annealing and 
hydroxyapatite (HA) compositing on specimens produced through FFF. 
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3. AIMS AND OBJECTIVES 
There are several basic considerations kept in mind before tackling the design 
and guidelines for the production of CP implants through FFF. One of the main 
issues to be addressed is the fact that patients receiving these prosthetics will 
still be growing [200], and that the repair process itself disrupts normal 
craniofacial development [18,20,204]. This problem is present even with 
autografting – at least for alveolar defects –, which is the current standard of 
care [25]. It is reasonable that it can be addressed through FFF by selecting a 
lactide polymer for construction of the implant, since they are estimated to 
suffer structural failure (their dismantling point) about six months after 
implantation [2,126,331], which coincides well with the required time for new 
bone formation to be well on its way [90]. 
Recent research has focused on the application of AM techniques and lactide 
polymers for the fabrication of implants and other orthopaedic devices, and 
most of it envisions a double function for the implant as a fixation means, as 
well as a bone regeneration scaffold [8,36,333,43,46,48,77,107,126,245,303]. 
Promising results have surfaced from such projects, and both the technique 
and material have potential clinical significance. Furthermore, compositing 
lactides with hydroxyapatite has been shown to positively affect the adhesion, 
proliferation, and differentiation cellular responses on in vitro tests [298,334]. 
PLA by itself has been used successfully on resorbable devices for 
implantation, and integration of HA can potentially enhance bone growth, and 
therefore the overall therapeutic performance of a bone implant. 
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The aim of this project was to investigate the production process for PLA-HA 
composites suitable for FFF-based bone-regeneration applications and to 
explore FFF as a manufacturing technique for therapeutic implants for 
complex lesions such as those found in CP. 
The following objectives were identified in order to accomplish these aims: 
• To develop a practical method for assessing dimensional reproducibility 
and precision of 3DP devices. 
• To measure effects of the FFF process on PLA parts, in terms of 
mechanical properties, temperature-dependent phase changes, 
molecular weight, and biocompatibility. 
• To develop a production method for a PLA-HA composite filament 
usable on FFF devices. 
•  To characterise such composite filament in regards of mechanical 
properties, temperature-dependent phase changes, and molecular 
weight. 
• To determine the potential for bone-regeneration of this composite 
material by exploring the optimal PLA-HA ratio for in vitro cell response, 
while taking in account manufacturing limitations. 
• To measure the in vitro response of MG-63 cell-lines to FFF surfaces 
as an initial approach to assessing their bone-regeneration potential, 
both in PLA and PLA-HA variants. 
• To propose general guidelines and considerations for the design of 
FFF-compatible patient-specific resorbable implants for complex 
geometries. 
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• To determine the degradation profile of 3DP parts in relation to current 
published data on parts manufactured through other methods. 
• To propose alternative abridged degradation test for rapid evaluation of 
the degradation characteristics of FFF-produced geometries. 
• To produce a mathematical model of molecular weight degradation for 
PLA. 
 
The knowledge gained upon completion of this project was condensed into 
practical recommendations for the production of clinically relevant FFF-
compatible composites. This research hoped to highlight the convenience and 
relative simplicity of producing new blends of materials for FFF. This can be 
done in low volumes and allows for quick iterations. Methods for evaluating 
relevant mechanical and molecular parameters of structures fabricated 
through FFF, as well as detailed information on the effects of FFF on inputted 
materials were developed. The potential of FFF-processed PLA-HA composite 
blends for bone regeneration applications was also documented and 
compared to pure PLA. Practical guidelines for digital design of FFF-
compatible geometries – to be subsequently implemented to implant design 
based on imaging studies – were produced. The viability and osteogenicity of 
this composite material in 3D cell-culture scaffolds was also be tested in vitro. 
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4. MATERIALS AND METHODS 
Tests were performed comparing specimens made from two FFF PLA 
filaments of the colourless (natural) variety. Samples made from the first 
material are labelled BFB-PLA (purchased from 3D Systems Inc., UK), and 
those from the second are referred as VB-PLA (purchased from Verbatim, 
UK). The molecular weight of these polymers was determined through gel-
permeation chromatography (GPC, as shown in section 4.2.4), their 
crystallinity through differential thermal analysis (DTA, as detailed on section 
4.2.2), their tensile strength and elasticity modulus were measured according 
to ASTM D638-03 (detailed on section 4.2.3). Their properties are listed in 
Table 5.1. 
The FFF device selected for this project is the BFB-3000 Triple Head Clear 
Case (3D Systems, USA) manufactured by Bits from Bytes from 2002 to 2012. 
It is configured and tuned to extrude PLA out of the box, and runs proprietary 
build files (*.bfb) generated through the Axon 2 slicer software. No formal 
characterisation of this particular printer could be found on the literature. 
4.1. DETERMINING THE PRINTER’S RESOLUTION LIM IT AND 
PRINTING ACCURACY 
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Figure 4.1 shows negative space tolerance model used for characterisation 
of the printer. Each inner cylinder in the model is an independent geometry, 
as well as concentric with its surrounding rim: scaling down the model will 
eventually cause both structures to fuse during printing, obliterating the gap 
between them, and marking an approximate resolution limit for the printer. The 
separation between the pieces is 10% the length of the cylinder’s diameter.  
Note also that this particular test is designed so that orientation variability on 
the horizontal axes is cancelled out by the circular geometries. Ten BFB-PLA 
samples of this model were printed. These and all subsequent tests are done 
under the highest fill setting (95%). Consequently, a tolerance test formally 
characterised the accuracy and precision of the equipment, as well as its 
smallest feature resolution. Measurements done with Draper Digital Metal 
Callipers (Part No. PDVC150M) and weights measured with Mettler-Toledo 
Mettler BB2400 digital balance. Volumes were computed in accordance to 
ASTM F2450-04 and Equation 4.5. Expected volumes for error calculation 
were derived from CAM models. The models used are depicted in Figure 4.2, 
 
Figure 4.1. Negative space tolerance test model. Isometric (A) and top view (B). Model file modified from 3D 
Printer Shoot Out Test Models byMAKE, licensed under the Creative Commons - Attribution - Share Alike license, 
2015, retrieved from www.thingiverse.com. 
Materials and Methods 
80 
 
Table 5.2 and Table 5.3 compile these findings on the 20 samples of each 
printed for this experiment. 
 
 
In vitro degradation tests are meant to simulate the chemical (and by extension 
thermal) stresses implanted polymers and polymeric devices undertake upon 
integration to an organism. For PLA, the main degradation mechanism is chain 
scission through random ester-group hydrolysis along the main polymer chain 
[2,12,137]. This reaction is spontaneous in aqueous medium, such that at a 
given ester bond along the polylactide chain (R): 
R-COO-R + H2O → R-COOH + HO-R 
4.2. ACCELERATED DEGRADATION OF FFF PLA 
 
Figure 4.2. Dimensional accuracy test models. A, vertical pyramid dimensional test model, and B, horizontal half-
pyramid dimensional test model. Model file modified from 3D Printer Shoot Out Test Models by MAKE, licensed under 
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The spontaneous cleavages through this route result in a net decrease of ester 
groups, implying an increase in carboxyl end-groups, which are prone to 
ionisation in aqueous solution, becoming a source of hydronium ions [137]: 
R-COOH → R-COO- + H3O+ 
Free hydronium ions, in turn, are capable of protonating carbonyl groups at 
ester bonds, further facilitating hydrolysis: these phenomena comprise the 
mechanism for autocatalysis of ester polymers.  
In an aqueous solution, the surplus of water molecules drives the main 
reaction forward, while temperature increases the reaction rate [137]. For 
these reasons, degradation tests according to the ISO-10993-13-2010 [328] 
standard control for these reaction rate variations and autocatalysis by 
requiring constant pre-defined temperatures and the use of phosphate-
buffered solution as degradation medium.  
 
Figure 4.3. Specimens used for ADT and mADT procedures. Tensile specimen 
type V model designed on Blender 2.76b, according to specifications under ASTM 
D638-03 standard. (A) The solid CAD model (B). G-code sliced file represented as 
toolpaths. (C)  Fill patterns are readily visible on finished prints (D), and very likely 
contribute to lowering the apparent density of a 3DP geometry, as visible variations in 
opacity throughout the prints suggest (D). 
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Tests were run in 3DP tensile bars made of BFB-PLA, VB-PLA and 
composites based on VB-PLA as noted (Figure 4.3 and Figure 4.4). Samples 
for testing were spread in triplicates throughout eight time (at 1, 3, 5, 9, 14, 18, 
21, and 23 days, based on previous reports [283,290]) of controlled-
temperature incubation, accounting for 24 samples per instance of the 
experiment. In every instance of Real-time Simulated Environment Test 
(RSET) and Accelerated Degradation Test (ADT), each specimen is put inside 
an individual vial where it must be completely submerged in test medium on a 
ratio of at least 10 ml per gram of material. The temperature suggested by the 
standard for RSET is 37 ºC, with any different value selected properly justified: 
by this definition, ADT runs take place at temperatures >37 ºC. For the present 
research, molecular weight deterioration, drops in crystallinity, mass change, 
and melting range alterations are sought after quantitatively, as they reflect 
effects on the material’s intermolecular organisation. Qualitatively, mode of 
structural breakdown is also of interest in the context of exploring the effects 
of FFF on implant fabrication so as to derive design guidelines from these 
observations. 
Prior to degradation, every specimen is dried at 50 ºC for 24 hours so that any 
humidity trapped within the material is removed to prevent it from interfering 
with the test [290,318]. Manufacturers recommend 80+ ºC for 2-4 hours [318], 
and other polymer drying schemes have been published with higher 
temperatures [320], but the 50 ºC figure poses better conditions for lactides 
since it is well under their expected Tg range of ~58-65 ºC [294,335]. This 
assures intermolecular interactions remain reasonably undisturbed, especially 
since oven drying at higher temperatures – and even ethylene oxide 
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sterilisation [49] – is reported to lower molecular weight and overall mechanical 
integrity on polymers [282,283,294,320]. Once dried, sample weight was 
recorded (Mettler Toledo Mettler BB2400 digital balance) as their initial value 
(w0). 
ADT data presented for this project used a testing temperature of 70 °C, which 
has previously been shown to enhance the degradation reaction rate while still 
correlating well with tests performed under the Tg of lactides [283,290]; it is 
also well below the average melting point and annealing temperatures of these 
materials. ADT was performed on VB-PLA. 
Test periods of 2 days and 60 days were required for ADT by the standard, 
and additional 24 hours and 2 week periods help monitor structural decay. 
However, previous research suggests that the above ADT conditions reach 
the dismantling point for PLA within 23 days [290], while preliminary testing for 
the purpose of the present study found the specimens reached it within the 
first 48 hours. In light of this, the ADT tests done in the interest of correlating 
with mADT were done in triplicate through 23 days, with testing periods based 
on previous reports [283,290]. The periods chosen for mADT were 0.5, 1, 1.5, 
2, 24 and 48 hours, based on preliminary tests (which yielded an approximate 
dismantling time of 2 or 3 days). Based on the overall behaviour of degradation 
tests on PLA [283,289,290,329,336], these periods would allow to survey the 
overall shape of the degradation curve, and determine the need for additional 
time periods. Each period was run with triplicate samples, with each of the 
three specimens set apart in independent vials and each analysed separately.  
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After each test period was concluded, its respective specimens were taken out 
of the test medium, dried again on the above conditions, and measurements 
were taken. Weight was once again recorded as the specimen’s final value 
(wf). Tensile strength (St) and elastic modulus (E) were measured according 
to ASTM D638-03. Thermogravimetric Analysis (TGA) was used to determine 
both thermal behaviour [283,284,289,290] and crystallinity (Cr) 
[286,287,337,338]. Molecular weight (Mw) was determined through gel 
permeation chromatography (GPC) [137,247,280,281,293,298,328,339]. 
These methods were selected so as to keep in line with the most common 
techniques reported in the literature, as well as those recommended in the 
appropriated standards. 
Data gathered through several time points (such as mass-loss or melting 
points) was compared through Two-Way ANOVA with Sidak hypothesis 
testing for multiple comparisons. Data gathered on a single time point (such 
as initial crystallinity or mechanical testing) was compared through One-Way 
ANOVA with Tukey hypothesis testing for multiple comparisons. 
 
 
Figure 4.4. 3D-printed tensile specimen used for 
degradation tests. The off-whitish aspect of the material is 
characteristic of semicrystalline PLA, with amorphous blends 
being colourless and transparent. The corresponding 3D 
model used is detailed in Figure 4.3. Standard deviation  
based on dimensional testing. 
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4.2.1. MASS CHANGE 
The main stages of polymer degradation were measured through mass loss, 
as bulk degradation and erosion ensue and large polymer chains are broken 
down along with the structure of the device or specimen in question 
[294,314,340]. Mass change (Δm) was reported as a per-cent of the starting 
specimen weight (w0) when compared to the final weight after the degradation 




% Equation 4.7 [2,283,285,290] 
All values were taken as averages of triplicate samples for each time period, 
as weighed on a Mettler Toledo Mettler BB2400 digital balance. The results of 
this comparison were then plotted over the time periods studied, so that any 
trend can become noticeable, as reported in the literature and recommended 
on ISO-10993-13-2010. 
4.2.2. CRYSTALLINITY AND THERMAL ANALYSIS 
The preferred method for determining crystallinity (Cr) for polymers in the 
literature – which is also the one recommended in ISO-10993-13-2010 – is 
differential scanning calorimetry (DSC), which can be derived from Differential 
Thermal Analysis/Thermogravimetric Analysis (DTA/TGA) data 
[286,287,337,338]. Through this method, heath flow curves can be used both 
for analysing the thermal properties, and for estimating the relative crystalline-
amorphous mass ratio from the crystallisation (ΔHc) and fusion (ΔHf) 
enthalpies [341]. This was accomplished by comparing those enthalpies with 
Materials and Methods 
86 
 
known values for fusion of a 100% crystalline sample of PLA (ΔH100): 
reportedly 91.3 J/g [293,341]. From TGA data-derived enthalpies, the degree 




%   Equation 4.8 [137,286,287,338] 
For this study, samples were analysed in a Diamond TG/DTA (Perkin Elmer). 
Aluminium sample pans with a 40 µl capacity held ~10mg of polymer for each 
analysis. Sampling on the specimens took the form of a transversal cut 
perpendicular to the X-Y printing plane, so as to include equal proportions of 
material from all layers of the printed specimen. Similarly, samples from FFF 
filaments consisted of a ~10 mg cut perpendicular to the length of the filament 
itself. For every test run, the sample was held at 40° C for one minute to 
stabilise the system, and then thermal scanning took place at 10° C/min up to 
350° C. Reported values for crystallinity with standard deviation are averaged 
from samples studied in triplicate. 
 
4.2.3. MECHANICAL PROPERTIES AND VISUAL INSPECTION 
After their respective degradation period, specimens were oven-dried at 50°C 
and then subjected to tensile testing on a Lloyd Instruments LRX tester, as 
described in ASTM D638-03 in order to determine their tensile strength (St) 
and elastic modulus (E). An elongation rate of 1 mm/min was applied to the 
specimens along their longitudinal axis up to their point of mechanical failure. 
The data points are automatically recorded by the instrument, and values for 
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tensile strength and elastic modulus are also calculated automatically. For 
each time period on the degradation tests, three specimens were subjected to 
tensile testing. 
4.2.4. MOLECULAR WEIGHT 
Molecular weight measurements were outsourced to the Department of 
Chemistry at The University of Sheffield. The measurements were done 
through Gel-Permeation Chromatography (GPC), in a 1090 HPLC with UV-Vis 
and Differential Refractive Index Detectors (Hewlet-Packard). Measurements 
were made in triplicate per time period, as laid out in the ADT experimental 
setup. Samples were dissolved in chloroform to a concentration of 0.10 mg/ml 
before being injected into the system. The measurements were calibrated 
against a polystyrene reference, and results are thus reported with respect to 
this equivalence. 
4.2.5. ACCELERATED DISSOLUTION TEST 
Tensile bars made from BFB-PLA and VB-PLA were used for the mADT 
protocol here proposed. This protocol is also based upon ISO-10993-13-2010 
[328] recommendations, with the main difference being that at least 12.5 ml of 
acetone per gram of sample replaces the test medium, thus maintaining the 
1:1 weight ratio described in the standard. The temperature was kept at 37 ºC 
to make the results relatable to RSET and ADT settings. Measurements on 
mass loss, crystallinity, mechanical properties, and thermal properties were 
carried out through the same methods described earlier in this section. 




Thermal treatments and compositing are frequently resorted to in order 
enhance desirable properties on medical polymers. Unfortunately, many of 
these processes can detriment the molecular qualities of a polymer, and some 
others involve the use of solvents that would rise concern about their safety 
for clinical use or animal testing [136,325,327,334,342]. Annealing of samples 
is used in this research as a means to enhance the crystallinity of 3DP 
structures in order to assess the relevance of this parameter in the 
manufacturing and biocompatibility characteristics of PLA. This is considered 
relevant as 3DP requires melting of the polymer, which could have some effect 
in variables like crystallinity and molecular weight. Similarly, a solvent-free 
method for compositing PLA with hydroxyapatite (HA) and extruding it into 3D-
printable filament was developed as part of this project. This compositing 
procedure also involves repeated melting of the material – hence annealed 
samples were deemed relevant for comparison. 
Data gathered from these methods on a single time point was compared 
through One-Way ANOVA with Tukey hypothesis testing for multiple 
comparisons. 
4.3.1. ANNEALING 
The annealing protocol used in this research requires the specimens to be 
heated to 120 ºC for 4 hours in a pre-heated oven It has been previously 
reported to yield consistent results for lactide polymers [49].  Pre-heating of 
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the oven to the treatment temperature proves to be essential, since gradual 
heating of the polymer along with the oven might cause printed parts to soften 
too drastically and deform. Samples were cooled by powering down the oven 
and letting it reach uncontrolled environmental temperature while sealed, 
typically taking under three hours. A total of 18 specimens were annealed for 
each material, accounting for the eight degradation time periods that were ran 
in triplicate. Degradation and measurements for mass loss, Cr, St, and E were 
conducted as described formerly for mADT in Section 4.2.  
 
4.3.2. PLA-HA COMPOSITE FILAMENT PRODUCTION 
Compositing PLA and HA into an usable FFF filament was achieved in a three-
step process. VB-PLA filament was first pelleted into <5 mm pieces. These 
were then mixed with Captal S hydroxyapatite powder (sintered, D50 = 3.59 
µm) (Plasma Biotal Ltd, UK) in a PTFE container to distribute the HA powder 
as uniformly as possible on the surface of the pellets. The mixture was then 
molten in a drying oven at 185 ºC over 3 hours with overnight cooling to 
ambient temperature inside the closed oven. 
The composite disc obtained is finally pelleted into pieces smaller than 5x5 
mm, which are in turn fed to a Filabot Original Filament Extruder (Filabot). The 
unit used for this work was modified with an external extrusion-rate regulator, 
as it was found that the factory-set rate was too high for the PLA-HA mixture. 
The composite filament was processed at 190 ºC, with a variable air-cooling 
system fitted at the output nozzle of the extruder.  
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The output filament from this setup was set to 2.85 to 3 mm in thickness, which 
is suitable for the BFB-3000 printer used. For this research, three HA 
concentrations were trialled: 5%, 10%, and 20% weight by weight in proportion 
to PLA. The filament was manually pulled from the extruder’s nozzle and 
spooled in order to ensure consistency in its quality, curvature, and diameter. 
  




4.4.1. DESIGN OF A BASE GEOMETRIC UNIT 
Given the intrinsic limitations of FFF 3DP (such as wall-fill disparity in printing 
settings, overhang limits of 45º, and overall better performance on printing 
highly geometric shapes), a modular design protocol was developed to tackle 
these challenges in the reproduction of complex geometries of the craniofacial 
bone structures. The idea revolves around generating a repeating unit that can 
be stacked into any 3D shape. Additionally, making these units 
macroscopically porous increases their surface area, while reducing the 
amount of material required to fill the required space; this could facilitate cell 
attachment, as well as post-implantation degradation of a device.  
The overall procedure to generate the proposed units is based on generating 
a mesh’s geometry. The overall stages of this method are depicted in Figure 
4.5. A 50 mm cube was used as the base for the generation of a 3D lattice. 
This lattice consisted of 1.5 mm diameter cylinders, with a 2 mm separation 
from centre to centre of each cylinder. Starting out perpendicular to the faces 
of the original cube, the lattice was tilted 45º around every axis, and it was 
then substracted from the cube to form the internal channel system of the 
resulting mesh. The mesh’s 45º inclination allows for at least one printing 
orientation in which there are no cantilever structures parallel to the printing 
bed, which would require the printer to lay material in mid-air and are 
commonly accomplished using additional support structures foreign to the 
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desired print. The desired geometry for this test was a 11x15x22 mm prism-
like structure with the frontal surface arbitrarily substituted with a 50 mm 
sphere section to emulate an organic shape (Figure 4.5B). This desired shape 
is used to cut a section of the base cube to produce a meshed version of itself. 
This new meshed geometry was enclosed within a more geometric frame. The 
frame’s pillars are within the 2mm limit described in Section 5.1, which is 
congruent with scale of the mesh so that their porosities are similar to those of 
the internal mesh. 
The test geometry trialled was created taking in account adult average 
measurements of the maxillary bone around the root of adult incisors [343,344] 
such that most child alveolar clefts would fit within the test mesh’s volume. The 
volume selected was 11x15x22 mm, corresponding to a prism which can fit 
the volume of alveolus around the root of an adult incisor tooth. The present 
design was implemented in Autodesk Meshmixer V. 11.0.544 by realising the 
mesh pattern and then subtracting it from a desired geometry. The desired 
shape used here represents the maximum limits that can be expected to 
contain a cleft (11x15x22 mm), with the frontal face of that prism replaced with 
a spherical section with 50 mm diameter. This was chosen arbitrarily to include 
a more organic shape into the prototype, and to roughly approximate the 
proportions of a maxillary bone section. 








Figure 4.5. stages of base-3D mesh procedure. A. 50 mm cube used as the base fot he generation of the 3D 
lattice. B. The test geometry: an 11x15x22 mm prism-like strucutre with the frontal surface arbitrarily substituted 
with a 50mm sphere section to emulate an organic shape. C. Closeup to material to be substracted in the form of 
a cylinder lattice with 1.5 mm diameter and 2 mm separation. The lattice was tilted 45º around every axis. D. 
Resulting mesh from substracting the lattice from the base cube. E. The desired shape is used as a pattern to cut 
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4.5.1. COMPOSITE FORMULATION SELECTION 
Data gathered from biocompatibility studies was taken in account to select the 
optimal HA concentration to use for the remainder of this study. These 
observations were coupled with practical issues found when handling each of 
the three candidate concentrations during compositing and 3D-printing. This 
led to the selection of the 10% HA by-weight formulation as the most adequate 
for our processing and manufacturing setup. 
Table 4. 1. Composite Formulation Ease of Handling 
Material Brittleness Ease of 
extrusion into 







BFB-PLA * N/A * ***** * 
VB-PLA ** N/A **** ***** * 
VB-PLA Annealed *** N/A ** ** * 
VB-PLA + 5% HA by 
weight 
**** **** *** **** ** 
VB-PLA + 10% HA by 
weight 
**** *** *** **** ** 
VB-PLA + 20% HA by 
weight 
***** * ** * ***** 
Qualitative rating from one star to five stars. Brittleness referring to how likely the material 
is to break during normal use. 
 
4.5.2. COMPOSITE HA CONTENT MEASUREMENTS 
Data from TGA analysis was used to determine the concentration of HA found 
throughout each step of the compositing process: pre-extrusion, composite 
filament, and composite 3D-printed parts. The procedure used was as 
described in Section 4.2.2, but with the upper temperature changed to 500 ºC 
so that the polymer would undergo full decomposition. The remaining 
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measured weight was taken as the mass of HA in the sample, and this value 
was compared to the sample’s initial weight. For each stage of the compositing 
process, this test was run in triplicate.  
Additionally, Scanning Electron Microscopy (SEM) was done on samples of 
the different stages of the production process to scrutinise the distribution of 
HA particles within PLA matrix. These images were generated on an FEI 
Inspect F50 scanning electron microscope, and then analysed via Electron 
Dispersive Spectroscopy (EDS). SEM was performed at 20 kV, with a spot 
size of 4.0, and at a magnification of 200X in order to survey a reasonably wide 
area. Samples for these experiments consisted all on cuts performed with a 
circular saw that allowed for imaging of their fractured face, in order to 
determine HA distribution within the volume of the composite. These faces 
were manually flattened and polished with silicone carbide sand paper as best 
as the material allowed. 
Finally, 3D-printed 1 cm disc samples and 3D-mesh structures (made from the 
10% HA composite) were analysed with Micro-Computed Tomography (µCT), 
using a Skyscan 1172.High Resolution Micro-CT (Bruker microCT). These 
samples were scanned at a source voltage of 50 kV, with 180º rotation, and 
1210 ms of exposure. This experiment was run to further characterise the 
distribution of HA within the polymer matrix’s volume. 
4.5.3. 3DP COMPOSITE MECHANICAL PROPERTIES 
Ultimate Teensile Strength (UST) and elastic modulus (E) were determined 
following the same procedure outlined in Section 4.2.3. Tensile bars were 
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produced through 3D-printing the PLA-HA10% in accordance to ASTM D638-
03; the printer’s settings used were its standard factory settings for PLA. The 
composite-filament used was produced through the procedure described in 
Section 4.3.2. Five tensile bars were then subject to pull-to break testing in a 
Lloyd Instruments LRX Universal Tester. 
 
4.5.4. COMPOSITE ACCELERATED DEGRADATION TEST 
Tensile bars made with the PLA-HA10% composite were subject to 
accelerated degradation as described for ADT in Section 4.2 in order to 
compare the results with those for pure VB-PLA. A total of 24 samples were 
arranged in triplicates and subjected to degradation through eight testing 
periods at 1, 3, 5, 9, 14, 18, 21, 23 days as per ISO-10993-13-2010. The test 
was performed on individual vials with PBS at 70 ºC, and the samples were 
measured for mass change, crystallinity, thermal properties, mechanical 
properties, and molecular weight was described in Section 4.2.  
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4.6.1. TISSUE ENGINEERING CELL-LINE PREPARATION 
In order to assess if the various processing steps of sample production were 
affecting the biocompatibility of PLA, surface biocompatibility tests were 
performed using the human osteosarcoma MG-63 cell line. This cell-line – 
although arguable – is considered an acceptable initial approach for human 
biocompatibility testing, and it is thus widely used for in vitro testing of novel 
medical materials. These cells are also well documented in regards to their 
interactions with both PLA and composites containing PLA and/or HA in the 
context of orthopaedic implant development, and are an accepted and widely 
used model for initial biocompatibility testing [345–347]. 
MG-63 cells with passage number 24 were cultured in a T-75 flask pre-treated 
with a 0.1% weight-to-volume gelatin solution for 30 minutes prior to seeding. 
They were fed with α-modification Eagle’s Minimum Essential Medium (α-
MEM) with added 10% foetal bovine serum (FBS), 10,000 units of penicillin, 
10 mg/ml of streptomycin, and L-Glutamine at 200mM, and incubated at 37 ºC 
in 5% CO2 until confluent. This expansion medium (EM) preparation was also 
used to prepare supplemented medium (SM) by adding 50 μg/mL of ascorbic 
acid and 10 mM -glycerophosphate to stimulate extracellular matrix 
mineralisation [348–350]. These cells were used for 21-day viability studies on 
the different versions of the PLA material studied. For experiments using SM, 
cells were kept in EM during the 24 hours after seeding. 
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Data gathered through several time points (such as 23-day cell-viability) was 
compared through Two-Way ANOVA with Sidak hypothesis testing for multiple 
comparisons. Data gathered on a single time point (such as collagen and 
calcium deposition) was compared through One-Way ANOVA with Tukey 
hypothesis testing for multiple comparisons. 
4.6.2. SAMPLE PRODUCTION AND PREPARATION 
As BFB-PLA was discontinued by the time of these experiments, only VB-PLA 
was used as raw polymer for the materials used in the cell culture work 
presented from this section on. Sample discs of 1 cm in diameter and 2 mm in 
thickness with flat surfaces were 3D-printed for this experiment. These discs 
were produced in the following materials for this study: pure 3DP-PLA (3DP-
PLA), annealed-3DP PLA (PLA-ANN), and 5%, 10%, and 20% PLA-HA 
composites (PLA-HA5%, PLA-HA10%, and PLA-HA20%, respectively). 
Additionally, 1x1x1 cm cube models were produced following the meshing 
procedure described in Section 4.4. Such meshed cubes were then 3D-
printed as samples for cell culture in 3D (4 4.7). This type of sample was 
studied in SM in the following material versions: 3DP-PLA, PLA-ANN, and 
PLA-HA10% 
Prior to cell culture, all samples were chemically sterilised in 2 ml of a 70% 
ethanol solution for 24 hours, and incubated at 37 ºC. Additionally, a 5% 
ethaneperoxoic acid (peracetic acid) solution for 30 minutes, or a 70% propan-
2-ol (propanol) solution for 15 minutes were also tested as sterilisation 
methods for these experiments. These three solutions were prepared as 
volume by volume ratios. The samples were subsequently washed twice with 
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PBS, and then further incubated in 2 ml of PBS for 1h to leach off residual 
sterilising solution. 
Disc samples were used for surface biocompatibility testing by placing sets of 
4 discs in a 12-well plate (three samples plus one blank control), with one 
sample per well. The discs were laid flat and then 50 µl of EM with 5000 MG-
63 cells were seeded on their up-facing side. These samples were then 
incubated at 37 ºC for 45 minutes to allow for cell attachment, and then 2 ml 
of EM were added to each well, leaving each sample completely submerged. 
The plate was then incubated at 37 ºC in 5% CO2 for the duration of the 
experiment. Two runs of this experiment were completed under this setup, 
each including all the materials tested (totalling n=6). An additional total of 6 
wells (3 per run) were seeded without samples for control measurements on 
tissue-culture plastic (TCP). This experimental setup was also repeated 
replacing EM with SM. 
The setup for mesh cube samples was modified in regards of seeding 
technique. In this case, the samples were put into their respective well oriented 
 
Figure 4.6.Mesh structure used for 3D cell culture samples. The structure is drived from  a 1x1x1cm cube. From  
lateral view (a), frontal view (b), top view (c), isometric view (d), to view of a printed part (e), printed part in 
comparison to a 1 mm cell culture disk (f), and isometric view of a printed part (g).  
a) b) c) d)
e) f) g)
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as shown in Figure 4.7, and 2500 MG-63 cells were then seeded from above 
in 25 µl of EM. After incubating at 37 ºC for 45 minutes, the samples were 
flipped upside down and an additional 25 µl of EM with 2500 cells were added 
from above. After a 45 minute incubation period, 2 ml of SM were added to 
each well, submerging each sample completely. The rest of the experiment 
proceeded as previously described (ran twice for n=6, with empty wells as TCP 
controls), except that it was only run using SM. 
4.6.3. MG-63 CELL VIABILITY 
In vitro testing for biocompatibility of the polymer and composites in this 
research was carried out by extrapolating cellular metabolic activity to cell 
population numbers via Resazurin Reduction Assays (RRA). RRA reflects 
mitochondrial metabolic activity through indirect detection of nicotinamide 
adenine nucleotide (NADH) and nicotinamide adenine nucleotide phosphate 
(NADPH). Being one of the main outputs of catabolic degradation of caloric 
molecules through the citric acid cycle, NADH is the substrate for the cellular 
oxidative phosphorylation process, and has therefore direct influence on the 
process’s initiation rate. On the other hand, NADPH is a high-demand co-
enzymatic factor for synthesis of biomolecules – including nucleic acids. This 
fact makes its presence indicative of anabolic activity, especially during cellular 
division – where nucleic acid synthesis is a metabolic priority. Both NADH and 
NADPH promote the reduction of resazurin to resofurin via their respective 
dehydrogenase enzymes, such that: 
NADH + H3O+ + resazurin →NAD+ + H2O + resofurin  
and: 
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NADPH + H3O+ + resazurin →NADP+ + H2O + resofurin  
Where resazurin acts as an electron acceptor. While being reversible through 
their dehydrogenases, abundance of NADH and NADPH drives these 
reactions forward. Extrapolation is then possible given that resofurin is a 
fluorophore and can be detected through its fluorescence to green light (~500-
580 nm), which can be measured at ~590 nm [351,352].  
For these assays, EM (or SM) was drained from each sample’s well, and they 
were then stained with 2 ml of EM with added 27.9 μg/mL resazurin sodium 
salt, and were incubated at 37 ºC for 4 hours. Afterwards, fluorescence 
measurements were taken in triplicate at an excitation of 540 nm and emission 
of 590 nm using an Infinite 200 Pro plate reader (Tecan Trading AG). The 
samples were finally washed twice in PBS to remove leftover RRA staining, 
and their 2 ml of medium were replenished. RRA measurements were taken 
at days 1, 4, 7, 14, and 21. Fluorescence measurements were compared to a 
standard curve to extrapolate an approximated cell-count.  
In order to produce such a standard curve, wells of MG-63 cells were seeded 
in triplicate with 5, 10, 20, 25, 50, 100, 150, and 200 thousand cells (as counted 
via an hematocytometer), incubated for 24 hours, then measured for 590 nm 
fluorescence as per the procedure described in this section. A correlation of 
fluorescence readings with cell counts was then produced through linear 
regression in Graphpad Prism 7.03. 
4.6.4. CELL ATTACHMENT 
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Cell attachment to both the disc and mesh samples was determined after the 
first day of the viability study. At this point, the samples were transferred to a 
new well-plate, and RRA was run on the wells where the samples had been 
seeded. These measurements were then compared to those of day 1 of the 
viability study to estimate the proportion of cells that had remained attached to 
the sample after that period of incubation. 
4.6.5. CELLULAR MATRIX DEPOSITION 
The cells’ production of extracellular-matrix compounds related to osteogenic 
differentiation was assessed through measuring the deposition of calcium and 
collagen after day 21 of the viability study. Alizarin Red S Assay (ARS) was 
used to measure calcium deposition. Alizarin red S stains calcium-salt 
containing tissues through the general substitution reaction: 
2(C14H7NaO7S) + Ca(An) → (C14H7NaO7S)2Ca + 2Na(An) 
Where An is an anion ionically bonded to calcium. Calcium is able to bond with 
the sulphonic acid group in the staining. This reaction allows for detection of 
early-stage mineralisation on otherwise calcium-free tissue. Though calcium 
ions react readily with alizarin red S, their salts are precipitated and washed 
off during the staining procedure described below. Thus, only extracellular-
matrix-bound calcium should be stained and finally measured at spectroscopy, 
exhibiting absorbance at 405 nm [353]. 
Collagen deposition was measured using Sirius Red Staining (SRS). This 
staining reacts mainly with strongly basic sections of the collagen polymer – 
likely with histidine, arginine and lysine residues. As for ARS, de-staining and 
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washing of the treated samples allows for only matrix-bound collagen to 
remain along with its staining. This red staining is also known to show 
absorbance at 405 nm [354]. 
Once RRA for day 21 was completed, the samples were washed twice in PBS 
and then fixed in a 37% formaldehyde solution for 15 minutes. The fixing 
solution was removed and the samples were washed twice with deionised 
water (DI). They were then stained using 2 ml of a 1% weigh-by-volume ARS 
solution for 30 minutes. DI was then used to wash the excess staining solution 
along with 5-minute intervals of orbital shaking at 50 rpm, changing the DI after 
each interval until the dye was cleared from each well. Each sample was finally 
de-stained in 2 ml of 5% perchloric acid for 15 minutes in orbital shaking at 
100 rpm. Absorbance was then measured in triplicate in an Infinite 200 Pro 
plate reader at 405 nm, and compared to a concentration standard curve for 
ARS. 
An SRS staining solution was produced with a 1% weight-by-volume solution 
of Direct Red 80 in 1.3% picric acid (2, 4, 6-trinitrophenol). After completing 
ARS measurements, the samples were washed with DI twice, and then put in 
2 ml of SRS solution for one hour in an orbital shaker at 100rpm. Orbital 
shaking at 50 rpm was once again used to wash the excess staining solution 
with DI in 5 minute intervals, changing the DI after each interval until it 
appeared clear. The samples were de-stained using 2 ml of a 0.2 M 
NaOH:methanol solution, with orbital shaking at 100 rpm for 20 minutes. 
Triplicate absorbance measurements were then made in an Infinite 200 Pro 
plate reader at 405 nm, and the results were compared to a standard curve for 
SRS.  









4.7.1. MODELLING FROM MOLECULAR WEIGHT BEFORE MASS-LOSS 
Molecular weight data from the ADT experiments performed during this study 
was processed through Microsoft Excel 2010 and GraphPad Prism 7.03 to 
look for mathematical relationships among the measured parameters. 
Although number-average molecular weight (Mn) has been found to best 
correlate with degradation parameters in experiments on lactide polymers 
[290,355], calculations were also performed using weight-average molecular 
weight (Mw) to look in to further evidence in that regard. Both measurements 
are carried out during the same GPC run.  
Two probable models were explored for modelling of the initial phase of the 
polymer’s degradation reaction: one assuming ester-bond hydrolysis of the 
polymer chains undergo autocatalysis, and one assuming hydrolysis proceeds 
without autocatalysis. Both models assume that the concentration of end-
group carboxyl groups remains relatively high in the solid phase of a given 
sample. The autocatalysed model is then described as: 
𝒅𝑪(𝒕)
𝒅𝒕
 = 𝒌 ∙ 𝑪(𝒕) ∙ 𝑺(𝒕) ∙ 𝑾(𝒕)                    Equation 4.10 [356] 
Where k is a generalised reaction rate constant, C(t) is the concentration of 
carboxylic-acid end-groups as a function of time (t), S(t) is the concentration 
of ester groups as a function of time, and W(t) is the concentration of water 
molecules as a function of time. The experimental set up of ADT allows for 
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control of the polymer and water quantities available for reaction, at least 
during the phase before the sample starts to experience mass-loss. The cutoff 
point for this section of the data was determined by fitting a plateau-
exponential decay model to the mass-loss data for each experiment: the cutoff 
point being the time after which the exponential curve-segment of the function 
starts. This is referred as the tipping point (tp) of the mass-loss plot in the 
literature [357]. Thus, a simplification of Equation 4.10 under these conditions 
can be rewritten as: 
𝒅𝑪(𝒕)
𝒅𝒕
 = 𝒌𝟏 ∙ 𝑪(𝒕)        Equation 4.11 [108,355,356] 
Where k1 is a case-specific reaction rate constant. From this point, it becomes 
evident that: 
𝑪(𝒕)  = 𝑨 ∙ 𝒆𝒌𝟏𝒕 + 𝑩                                   Equation 4.12  
Where the integration constants A and B must be constrained by the boundary 
conditions of the experiment. A must therefore be initial concentration of 
carboxyl-end groups (so A = C(0) = C0). Under these experimental conditions 
and before tp, it has been noted that C(t) keeps an inverse relation to Mn as a 
function of time (so C(t) = Mn(t)-1) [290,355,356]. Substituting and rearranging 






∙ 𝑒𝑘1𝑡 + 𝐵                                   Equation 4.13 
Where Mn0 will then be the initial value for the sample’s Mn. It can then be 
proven that B = 0, which – in this experimental context – is in accordance to 
the asyBBmptotic tendency to 0 that could be expected of the function as time 
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approaches infinity. In turn, this reflects the practical decrease in polymer-
chain size, and its theoretical and eventual fall to a negligible value. It can then 
be understood that: 
  𝑀𝑛(𝑡) = 𝑀𝑛0 ∙ 𝑒
−𝑘1𝑡;  𝑡 ≤ 𝑡𝑝    Equation 4.14 [108,355,356] 
Notably, a linear relationship can be established from this equation as follows: 
ln 𝑀𝑛(𝑡) = −𝑘1𝑡 + ln 𝑀𝑛0  ;  𝑡 ≤ 𝑡𝑝    Equation 4.15 [284,290] 
If a process is indeed autocatalysed, data will correlate well with this linear 
behaviour [355,356]. It can also be thought of k1 as a degradation constant in 
the context of ADT. Moreover, it could be feasible to predict such constant with 
two Mn measurements: one of the initial value, and one at a time ta before 







;  𝑡𝑎 ≤ 𝑡𝑝                           Equation 4.16 
The Anderson statistical model would describe this degradation phenomenon 
in the case that autocatalysis is negligible [358]. Such model would describe 






 ;  𝑡 ≤ 𝑡𝑝                 Equation 4.17 [358] 











;  𝑡𝑎 ≤ 𝑡𝑝                       Equation 4.18 
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Molecular weight data can further be utilised to predict mechanical behaviour 
during degradation experiments through the Flory relationship [359]: 
𝑆𝑡(𝑡) = 𝑆∞ −
𝐷
𝑀𝑛(𝑡)
;  𝑡 ≤ 𝑡𝑝                       Equation 4.19 [359] 
Where St(t) is the tensile strength of the polymer as a function of time, S∞ is 
the theoretical tensile strength of the polymer as its molecular weight 
approaches infinity, and D is a polymer-specific constant that relates number-
average molecular weight with tensile strength through time. If experimental 
data are available, the gradient of this function is also useful, since it does not 









;  𝑡 ≤ 𝑡𝑝                       Equation 4.20 
Which leads to two possible models for prediction of the rate of tensile strength 
deterioration during ADT. One if the initial stage of the process is 






𝑒𝑘1𝑡;  𝑡 ≤ 𝑡𝑝                          Equation 4.21 
Alternatively, if the degradation happens not to be autocatalysed, the relevant 
model would be: 
𝑑𝑆𝑡(𝑡)
𝑑𝑡
= −𝐷 ∙ 𝑘2;  𝑡 ≤ 𝑡𝑝                          Equation 4.22 
Extra-sum-of-squares F-test was used to compare suitable non-linear 
regression models that satisfied two or more data sets. 
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4.7.2. MODELLING FROM MOLECULAR WEIGHT AFTER MASS LOSS 
Molecular weight data from the ADT experiments performed during this study 
were processed through Microsoft Excel 2010 and GraphPad Prism 7.03 to 
look for consistent mathematical relationships that arose during the 
experiment. Non-linear regression was favoured, and segmented functions 
were also sought after, since – as mentioned in the previous section – 
variables are expected to behave differently during progressive stages of ADT 
when measured against degradation time. Additionally, data for Mn and Mw 
were plotted against mass loss, crystallinity, and melting temperature in order 
to look for trends that could be useful for describing degradation behaviour.  
Extra-sum-of-squares F-test was used to compare suitable non-linear 







Properties for the two different brands of PLA used are listed in Table 5.1 
Under the conditions mentioned in section 4.1, the printer was unable to 
successfully resolve features under 2 mm: this can be considered its resolution 
limit. Results for this testing are listed in Table 5.2 showing that the vertical (Z) 
was the least consistent (measurements H, h1, h2, h3, hb), with deviations in 
accuracy ranging from 0.56% to 18.18% (average 3.83%) from the inputted 
(expected) value. This axis has also the lowest precision, with deviations in 
reproducibility from ± 0.10 to ± 0.35 mm (± 0.23 mm on average). In light of 
these findings, a second test for the resolution limits of the X and Y-axes is 
summarised in Table 5.3. This test showed increased variability on the 
dimensions of the printed parts in all directions, with overall higher values 
along the Z axis of the printer. 
 
Table 5.1 Properties of PLA FFF filaments used for this project. 
  BFB-PLA Filament BFB-PLA 3DP VB-PLA Filament VB-PLA 3DP 
Mw[kg/mol] 91.08 ± 0.90 * 118.50 ± 3.80 97.08 ± 1.39 
Mn[kg/mol] 46.88 ± 0.62 * 53.46 ± 7.75 46.98 ± 1.39 
Polydispersity 1.93 ± 0.02 * 2.25 ± 0.27 2.04 ± 0.03 
Crystallinity [%] 21.38 ± 1.01 15.89 ± 0.51 29.26 ± 0.55 24.04 ± 1.84 
Tensile strength [MPa] - 31.39 ± 2.58 - 48.46 ± 3.23 
Elastic Modulus [MPa] - 88.65 ± 10.98 - 181.30 ± 7.95 
*This material was discontinued before measurements could be taken.  






Table 5.2. Vertical Pyramid Dimensional Tolerance Test 
Meas. Dx Dy H d1x d1y d2x d2y d3x d3y h2 h3 h4 h1 w[g] 
Expected[mm] 25.0 25.0 20.0 20.0 20.0 15.0 15.0 10.0 10.0 5.0 5.0 5.0 5.0 4.2 
Average 25.1 25.3 20.8 20.0 20.2 15.1 15.1 9.88 9.93 4.92 4.96 4.97 5.91 4.63 
SD 0.14 0.12 0.28 0.34 0.09 0.11 0.11 0.06 0.06 0.11 0.10 0.10 0.35 0.14 
%error 0.67 1.06 3.83 0.15 0.91 0.49 0.61 -1.18 -0.68 -1.53 -0.78 -0.56 18.2 10.06 
Expected values are as defined on the digital model. Measurements done in a sample of 20 specimens. Measurement labels 
reference to model in Figure 4.2A. Dimensions labelled x and y as measured parallel to that respective printer horizontal 
axis. Percent error (%error) is reported as the average percent difference from the expected value. 
 
Table 5.3. Horizontal Pyramid Dimensional Tolerance Test 
Meas.[mm] Dx H d1x d2x d3x d4x d5x h1 h2 h3 h4 h5 h6 w[g] 
Expected[mm] 12.50 15.00 10.00 7.50 5.00 2.50 1.25 2.50 2.50 2.50 2.50 2.50 2.50 0.38 
Average 12.36 15.58 9.85 7.48 5.13 2.71 1.42 2.93 2.70 2.49 2.52 2.45 2.51 0.44 
SD 0.08 0.38 0.14 0.05 0.12 0.13 0.10 0.24 0.12 0.11 0.11 0.08 0.22 0.02 
%err -1.09 3.89 -1.50 -0.29 2.57 8.57 13.60 17.09 8.06 -0.29 0.91 -2.02 0.29 15.41 
Expected values are as defined on the digital model. Measurements done in a sample of 20 specimens. Measurement labels 
reference to model in Figure 4.2B. Dimensions labelled x as measured parallel to that respective printer horizontal axis. 




Figure 5.1. Scale-Porosity dependence and expected volume percent error on 3DP PLA geometries. Points 




Semicrystalline PLA density of 1.27 g/cm3 [137,251,293,318,331,334] was 
taken in account when calculating the microporosity of the dimensional 
specimens. Under the setting of 95% material fill on the printer’s software 
configuration, the observed density of the prints was scale-dependent, with a 
highest density of roughly 1.14 g/cm3 on the smallest end of the printed range, 
from where it gradually drops to 0.63 g/cm3. This trend stabilises around a 40% 
porosity value for apparently solid prints Corresponding porosity 
measurements are available in Figure 5.1. 
 
5.2.1. MASS CHANGE 
Mass loss measurements for ADT are shown in Figure 5.2 on VB-PLA 
specimens over the course of 23 day. The plot can be fitted to an exponential 
decay model. In these experiments, the point where mass loss ensues was 
sharply evident between the 9th and 14th day of degradation, with non-linear 
regression to a plateau-exponential decay model setting it at 8.82 days (R2 = 
0.9789, Figure 5.2). The infiltration period appears to happen during the first 
two days of the experiment, with the plateau phase noticeable before mass 
loss starts. The small slope observed could correspond to surface erosion 
happening in parallel to this process [360]. The final measurements were 
consistent with other studies in that they appear to be heading for a second 
plateau phase, corresponding to the degradation of the remaining crystalline 
phase [290,361]. This is in line of what could be expected for bulk erosion of 




a poly-ester such as PLA, as the whole of the geometry undergoes 




The first crystallinity measurements for degradation experiments were made 
to determine the initial values for the materials as filaments and after 
undergoing 3DP. An immediate change in crystallinity was induced by the 
printer’s FFF process, with both tested filaments experiencing a significant 
(p<0.05) loss of crystalline mass with respect to their filament form. These 
observations are depicted in Figure 5.3. Both polymers are largely amorphous 
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Figure 5.2. Mass change measurements from ADT specimens. Data from degradation on PBS at 70 ºC. Points correspond 





(~70-80% by weight), since the filament presentation benefits from a more 
plastic behaviour. Notably, both PLA brands exhibit statistically significant 
differences among them when compared as filaments, as well as after 3DP 
(p<0.05).  
 
These data were used as initial values for the mADT (Section 5.26) and ADT 
experiments. ASTM tensile specimens (Figure 4.4) were subject to in vitro 
degradation, as described in section 4.2. Crystallinity changes during ADT 
experiments are shown in Figure 5.4. An exponential trend was well 
identifiable, without reaching a point of crystallinity loss within the span of the 
















































Figure 5.3. FFF-induced crystallinity loss. Filament values are 
measured on PLA filaments for FFF as provided by their 




these tests, corresponding to the crystallinity surge observed for mADT 
specimens.  
 
5.2.3.  MECHANICAL PROPERTIES AND VISUAL INSPECTION 
For ADT specimens, mechanical testing was impossible after the first day of 
degradation. Though geometrically intact, the specimens became too brittle to 
 
 
Figure 5.4. (A) Crystallinity loss and (B) detail photograph of resulting structural deterioration during ADT. 
Data from degradation on PBS at 70 ºC. Points correspond to means with standard deviation bars.  
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be loaded into the tester. Averaging the only two specimens that were testable 
from the repeats of the 1 day test period, an UTS of 1.06 MPa and an E of 
422.8 kPa were found. As can bee seen in Figure 5.4, the samples break 
down while on their degradation vials from the first time point, and lose 
structural integrity as degradation progresses. 
 
5.2.4. THERMAL ANALYSIS 
Data from DTA brings forward further confirmation for the role of crystallinity 
on in vitro degradation of PLA. Though there were only slight differences 
between the measurements for the filament and the post-3DP polymer, some 
of these were illustrative of what previously-discussed data has suggested. 
Figure 5.5 shows a comparison between the thermal properties of BFB-PLA 
and VB-PLA in filament form and after being processed through FFF. Changes 
were evidently less dramatic for VB-PLA, which was reflected in a drop in 
crystallinity proportionally smaller decrement from 29.26% to 24.04%, when 
 
Figure 5.5. Thermograms for BFB-PLA and VB-PLA as FFF filament and after 3DP. The curves for both materials are 
very similar, with that of VB-PLA displaying a smaller crystallisation peak, and a slightly higher fusion peak, consistent with 




compared to BFB-PLA dropping from 21.38% to 15.89% (Figure 5.3). Tg for 
both filaments was found to be higher than for the material after 3DP: 59 ºC 
against 46 ºC for BFB-PLA, and 64 ºC against 55 ºC for VB-PLA. This change 
can be attributed to the drop in crystallinity itself. Tg was undetectable 
throughout degradation tests. 
 For ADT experiments, DTA data were collected in Figure 5.6. Relatively little 
change was observed throughout the course of the time periods. One of the 
most noticeable was the increase in size and overall area of the fusion peak 
from 1 day to 3 days. After that event, the smaller variations were noted in the 
fusion peak, with some displacement of the fusion point from an initial 176 ºC 
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Figure 5.6. Thermograms for VB-PLA after 3DP and after several stages of ADT. The overall shape of the curves 
is maintained throughout the experiment. The most noticeable chBanges are in the size of the fusion peak, which is 






5.2.5. MOLECULAR WEIGHT 
Number average molecular weight (Mn) during ADT for VB-PLA tensile bars 
decayed in a well-defined exponential phase (R2 = 0.9691). This is shown in 
Figure 5.8. By 5 days, more than 90% of the samples’ Mn had been lost to 
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Figure 5.7. Changes in peak melting temperature for VB-PLA 







5.2.6. ACCELERATED DISSOLUTION TEST 
Mass change results for mADT experiments are collected in Figure 5.9, 
showing an exponential-like decay of bulk degradation, which could potentially 
be correlated with similar experiments as the shape of the trace appears to 
follow the expected degradation pattern for PLA [283,290]. BFB-PLA 
experienced mass loss instantly, with an untraceable infiltration period (which, 
on this particular setup, would appear as a near-zero mass change as it did 
for VB-PLA) occurring before the 30-minute reading, and roughly following an 
exponential trend. This was ultimately followed by a rapid mass loss, and a 
plateau by the end of the test periods, with a final mass loss of 10.85%. A 
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Figure 5.8. Changes in Number Average Molecular Weight (Mn) fro VB-PLA 
throguhout ADT. Points correspond to averages with standard deviation error bars, 
joined by the dashed line. The solid line depicts a one-phase exponential decay model 




faster rate of mass change was consistent with a more amorphous polymer 
structure, but the contrasting behaviour of VB-PLA, exhibiting a well-defined 
infiltration period where mass was actually gained, accounting to infiltration 
onto the internal geometry of the specimen [137,247,294].  
This phase is then followed by a plateau where mass loss and further 
infiltration change the values back and forth. Figure 5.10 shows a record of 
the wet weight of VB-PLA mADT samples, measured within three hours after 
blot-drying (in concordance with ISO-10993-13-2010), before their regular 
oven-drying cycle. An increase of 0.84% in mass was observed on VB-PLA 
even after oven drying the samples, which suggests medium intake into the 
geometry of the specimens. Both increments followed closely an exponential 
trend.  
 
Figure 5.9. Mass change measurements from mADT specimens. Data from degradation on 100.0% pure 
acetone at 37 ºC. Points correspond to means with standard deviation bars. Solid line denotes a non-linear fit to 





The results for crystallinity change in mADT are shown in Figure 5.11, where 
BFB-PLA experienced an increase from 15.89% to 51.86%, while a similar one 
happened from 28.15% to 47.19% for VP-PLA. In the subsequent time periods 
up to 2 hours, crystallinity dropped down to 38.64% for BFB-PLA and to 
45.78% for VB-PLA. By the final time period, the value was 44.94% for BFB-
PLA, and 29.92% for VB-PLA. The 24 hour time period shows an increase in 
crystallinity to 48.95% for BFB-PLA and 43.21% for VB-PLA. 
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Figure 5.10. Mass change from VB-PLA specimens specimens measured wet and dry after mDTA. Data 
from degradation on 100.0% pure acetone at 37 ºC. Data up to the second hour of degradation is used as it 
correlates well with the expected infiltration period. Solid line denotes a non-linear fit to an exponential curve. 





Related to this, the point of structural break down of BFB-PLA specimens was 
determined by these tests to be 1.5 hours under mADT testing, while VB-PLA 
reached it at some point between 2 hours and 24 hours – relating closely to 
the surge in crystallinity observed. After this point the geometries and 
mechanical resistances of these materials suffer changes too drastic to allow 
them to retain their original features. It is to be noted that after the dismantling 
point has been reached in one of these specimens, tensile testing becomes 
impossible. Figure 5.12 shows the progressive deterioration of FFF 
specimens subject to mADT. This deformation eventually leads to failure of 
the central shaft of the specimen after its dismantling period, while the 
individual layers gradually lose bonding with each other, especially near the 
perimeter of the model. Notably, layer fragments do not appear to detach 
completely until the 48 hour mark was reached.  
 
Figure 5.11. Crystallinity loss during mADT. Data from degradation on pure acetone at 37 ºC Points correspond to 




BFB-PLA specimens shown in Figure 5.12 display cracks on their surface on 
the later stages of the mADT experiments (6, 24, and 48 hours). There was 
also severe bending of the structure before large portions of the FFF layers 
begin to delaminate as the geometry curls around its transversal axis. Notably, 
layer fragments do not appear to detach completely until the 48 hours mark 
was reached. In contrast, as evidenced by Figure 5.13, VB-PLA undergoes 
similar changes, but to different magnitudes. While specimens show no 
significant changes during the first two hours of mADT, degradation becomes 
evident by the end of the first day. Their mechanical integrity was still good 
enough to allow handling without damaging them – unlike BFB-PLA 
 
Figure 5.12. Photograph of BFB-PLA tensile specimens at progressive stages of mADT. Depictions of frontal views are 
above, with their corresponding lateral views below. The dismantling period for this particular material under mADT conditions 
is considered to be 1.5 hours, since the specimen is far to deformed to conduct mechanical testing. The 4 and 6 hours 




specimens. The layers that have curled away from the main body of the 
structure, however, appear to have fused in – much like those on the major 
fragments of the BFB-PLA samples for 24 and 48 hours. Their deformation 
was too severe to allow for reliable tensile testing. An exponential decay trend 






Figure 5.13. Detail photograph of VB-PLA 63 mm-long tensile specimens at 24h (left) 
and 48h (right) after mADT. Depictions of lateral views. The dismantling period for this 
material under mADT conditions is considered to be 24 hours, since the specimens 







Thermal properties also reflect changes in crystallinity behaviour through 
mADT, which in turn can be related to these observed changes in mechanical 
properties. These slight differences can be appreciated in Figure 5.16 and 
Figure 5.5, corresponding to thermal analyses for the mADT series of BFB-
PLA, and a comparison of the properties of filaments before and after FFF. 
The first noticeable trend was the almost immediate deviation from the 
behaviour of the baseline materials (BFB-PLA 3DP and VB-PLA 3DP), 
followed by an overall similar curve in all subsequent measurements. The 
crystallisation peak found in the 3DP material was completely lost 30 min into 
mADT for both types of PLA. 
Tf suffered no important variation, remaining stable at average 164 ºC for BFB-
PLA. For VB-PLA, average Tf was 175 ºC, with a drop at the 2 hour mark to 
169 ºC (Figure 5.15). Crystallisation peaks were only present on undegraded 
 
Figure 5.14. Tensile strength and elasticity modulus deterioration during mADT on BFB-PLA and VB-PLA. Points 
correspond to means with standard deviation bars. Correlation coefficients respectively denote a non-linear fit to an 
exponential curve (tendency line not plotted for clarity). BFB-PLA specimens lost most mechanical integrity after 1.5 




BFB-PLA at 87 ºC, and on VB-PLA at 90 ºC. For BFB-PLA, Tg (reported as the 
peak value of the Tg range) was found at 46 ºC, but it was not reliably detected 
in degraded specimens (Figure 5.16). For VB-PLA, Tg was found at 69 ºC for 
the undegraded material, but subsequent values were not reliably detected, 
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Figure 5.15. Changes in peak melting temperature for BFB-PLA and VB-PLA throughout 
mADT. Data from degradation in pure acetone at 37 ºC. Points correspond to means with 
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Figure 5.16. DTA curves for BFB-PLA after 3DP and after several stages of mADT. Notice the complete 
obliteration of the crystallisation peak present at BFB-PLA – 3DP as early as 30 minutes into mADT. The overall shape 
of the curves after that point is maintained, without important displacement of the melting temperature. Endothermic 
processes are arbitrarily depicted downwards. The 2 hours time period is intentionally ommited for spatial convenience 
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Figure 5.17. DTA curves for VB-PLA after 3DP and after several stages of mADT. The crystallisation peak present at 
VB-PLA – 3DP is lost 30 minutes into mADT. The overall shape of the curves after that point is maintained, without 










The crystallinity values of both materials increased dramatically after 
annealing, more than doubling their initial values, while having a significant 
(p<0.05) negative effect on UTS, albeit not so (p<0.05) for E, probably due to 
the wide standard deviations on these values (Figure 5.17). The crystallinity 
values for BFB-PLA and VB-PLA after annealing rose to 56.92% and 48.58% 
respectively, with drops in UTS and E. It is also noteworthy that annealing 
seems to overall improve the reproducibility of the material in regards of 
crystallinity. Annealing has a negative effect on UTS, which was lowered in 




both materials. As evidenced by Figure 5.19, for both materials annealing had 
virtually no effect on mass loss over the sampled period (p<0.05). 
 Mechanical properties for BFB-PLA were improved in that its dismantling point 
shifted form 1.5 hours to over 2 hours, remaining over 2 hours for VB-PLA, 
which suggests that failure of mechanical integrity is very strongly liked with 
crystalline content, as both annealed materials display around the same 
proportion by weight (56.92% for BFB-PLA, and 48.58% for VB-PLA). Tensile 
strength and elastic modulus values were preserved better in both annealed 
materials, in general maintaining higher values before reaching their 
dismantling point. Although changes in deterioration of mechanical properties 
 
Figure 5.18. Changes in Cr, appearance, E, and UTS on BFB-PLA and VB-PLA at different processing stages. a) 
Large changes in cristallinity ensue after annealing, especially on BFB-PLA, rising to an average of 56.92%. Similarly, VB-
PLA exhibited a Cr value of 48.58% after annealing. b) The process’s effects are also apparent in visual inspection, as 
expected: the annealed material (shown on top) becomes noticeably more opaque than the 3DP one (on bottom). Elasticity 
modulus c) and tensile strenght d) are deteriorated by the treatment, which are likely due to the heightened crystallinity. 
Error bars denote standard deviation. Tests were conducted as described above for each type of measurement. 3DP, 3-D 







and mass loss were not significantly different (p<0.05) – except for E on VB-
PLA –, the macroscopic behaviour of annealed specimens diverged 
significantly from that observed for non-annealed samples (Figure 5.18), with 




Figure 5.19. Photograph of BFB-PLA tensile specimens at 
at various stages of mADT. Depictions of frontal (top) and 
lateral (bottom) views. The dismantling period for this material 
was considered to be 24 hour since the specimens fall apart 
during handling after this point, as evidenced by the 
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Figure 5.20. From top to bottom: mass change, crystallinity, tensile strength, and elasticity modulus 
measurements during mADT on BFB-PLA (left) and VB-PLA (right)-when 3D-printed (3DP), and when 3D-printed 
and annealed (ANN). Points correspond to means with standard deviation bars. Correlation coefficients respectively 
denote a non-linear fit to an exponential curve (tendency lines and error bars are not plotted for clarity). BFB-ANN and 
VB-ANN specimens reached their dismantling point after 2h. Measurements for each parameter were gathered with the 
aforementioned methods.Some connecting-lines and data points depicted in gray and/or dashed for clarity. Crystallinity 
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Figure 5.21. DTA curves for BFB-PLA 3DP specimens annealed and at progressive stages of mADT. 
Annealing (BFB-ANN) completely removes the crystallisation peak present on the 3D-printed samples (BFB-3DP). 
The overall shape of the curves after that point is maintained after annealing, without important displacement of the 
melting temperature.  After annealing, an endothermic peak appears as a shoulder on the main melting peak. This 
has been theorised to correspond to a melting peak of crystallised degradation products [290]. Endothermic 
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Figure 5.22. DTA curves for VB-PLA 3DP specimens annealed and at progressive stages of mADT. Annealing 
(VB-ANN) once again removes the crystallisation peak found on the 3D-printed samples (VB-3DP). The overall shape 





Crystallisation peaks are not observable after annealing, as shown in Figure 
5.21  and Figure 5.22. As with the thermal analysis presented in section 5.2, 
a shoulder becomes visible on the main fusion peak of all but the last two 
sampling periods (24 and 48 hours) during degradation. The other noticeable 
difference amongst the thermal analysis curves was the change in crystallinity, 
reflected on the size and area of the fusion peaks. 
Results for ADT measurements are found in Figure 5.22. The graphs for 
annealed specimens show no significant deviation (p<0.05) from those of 3DP 
specimens. It is also noticeable that the plots for both materials were  
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Figure 5.23. Mass change, crystallinity, and fusion temperature measurements during ADT on VB-3DP and 
VB-ANN. Points correspond to means with standard deviation bars. Correlation coefficients respectively denote 
a non-linear fit to a plateau-exponential decay curve. BFB-ANN and VB-ANN specimens reached their dismantling 
point before 24h of the experimetn had passed. Measurements for each parameter were gathered with the 
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Figure 5.24. DTA curves for VB-PLA annealed specimens annealed and at progressive stages of ADT. The 
overall shape of the curves after that point is maintained, much like for VB-3DP. Endothermic processes are arbitrarily 




very closely matched at every point. Annealed specimens, however, were 
found to be more brittle, being impossible to handle and load on the tensile 
tester without breaking them even after a single degradation time period had 
passed. The dismantling point for both materials can be safely assumed to be 
under 1 day for ADT settings. 
Plots for DTA through the ADT experiments are shown on Figure 5.24. These 
show a similar pattern to 3DP specimens, where the fusion peak increases in 
size after the first time period, with the overall behaviour of the curves being 
similar. Progressive changes in the size of the fusion peak were consistent 
with changes in crystallinity taking place throughout the experiments. 
Crystallinity for annealed specimens bega1n at 48.67%, and reached a final 
value of 89.89% by the 23rd day. Similarly, to 3DP specimens, the initial fusion 
temperature registered at 176 ºC dropped to 164 ºC. 
 
5.3.2. PLA-HA COMPOSITE FILAMENT 
Consistent production of 3DP composite filament was achieved with a 
extrusion temperature set at 190 ºC. Modifications to the Filabot Original 
Filament Extruder proved necessary to ensure reproducibility of filament in a 
quality adequate for our 3D printer. Hand-regulated extrusion rates, cooling 
intensities, and filament-pulling forces were all implemented for successful, 
reliable extrusion of print-worthy filament. Resulting outputs from the steps of 




In practical terms, the composite filament produced in this study proved to be 
more brittle than the raw VB-PLA filament, making filament rupture during 
printing a more common occurrence. The addition of HA also made the 
extrusion process more difficult to control, especially for the 20% 
concentration. Additionally, the 10% and 20% composites caused blockage on 
the printer’s nozzle, stopping any material from going through, and therefore 
stopping or even ruining the printing process at hand. The 10% composite 
would block the extruder after about 2-4 hours of continuous working, while 
the 20% would do so after less than 30 minutes. This fact added a further 
degree of technical difficulty for printing, since larger items – such as tensile 
bars – require the user to monitor and stop the machine mid-process in order 
to clean the nozzle. Smaller items – like cell-culture discs and mesh-cubes – 
would require cleaning after every individual sample is printed. 
  
 
Figure 5.25 .Composite filament production process. a. Pre-extrusion visibly heterogeneous composite 
10% HA composite disc (a); notice differences in translucency resulting from uneven PLA-HA ratios at 
this stage. b. Final 3mm-thick filament made of visibly homogeneous 10% HA composite. Notice the 









The characteristics of the designed lattice were compiled in Table 5.4. This 
particular geometry was chosen to roughly resemble a section of maxillary 
bone. Printing near this limit prevents the STL build from including fill patterns, 
likely helping to maintain uniformity in the material. With this lattice acting as 
the inner structure of an implant, its surface area becomes about eight times 
greater than that of a solid implant of similar dimensions. The openings within 
the mesh were designed within 2 mm. The final unit is portrayed in Figure 5.26 
and Figure 5.27. A series of 20 prints of this unit supports the claim that the 
structure can be manufactured through FFF in VB-PLA at a resolution of 0.125 
mm and the maximum 95% fill setting without supports. 
 
 
5.4. IMPLANT GEOMETRIC DESIGN 
 
Figure 5.26. Detail photograph of framed 3D-mesh prototype produced on VB-







Table 5.4. 3D mesh characteristics. 
Parameter Magnitude per cm3 Units Comments 
Material volume 0.35 cm3 Calculated in Meshmixer V 11.0.554 
Material surface 8.55 cm2 Calculated in Meshmixer V 11.0.554 
Mesh void content 64.23 % Calculated from Meshmixer V 11.0.554 data 
Material porosity 8.92 % Calculated from printer dimensional analysis data for 
PLA. Average for the 0-0.5cm3 range 
Mesh density 0.453 g/cm3 Calculated at 1.27g/cm3 for PLA 
 Measurements and calculations derived from a 50mm-sided cubic mesh. Mechanical properties for the lattice 
have not yet been determined. 
 
Figure 5.27. Framed 3D-mesh prototype for implant geometric design. 
The desired shape is once again used as a pattern produce an open frame 
based on its outline. This frame and the 3D-mesh are then superposed to 
generate this geometry. Depending on the software used, the precise steps 
to accomplish this can vary. Models generated in Autodesk Meshmixer V. 








5.5. COMPOSITE CHARACTERISATION 
Characterisation of the composite produced in this study was carried out so as 
to make the results comparable to those for the base polymer, which are 
detailed in Section 5.2. Where appropriated, the following results were 
therefore presented in comparison to those covered previously. 
5.5.1. COMPOSITE HA CONTENT MEASUREMENT AND DISTRIBUTION 
TGA data used to derive the composite’s ceramic content showed that ~7% of 
the HA would remain embedded in the polymer matrix after processing a 10% 
weight-by-weight formulation of HA (Figure 5.44). No significant differences 
were found between any of the processing steps of the 3DP composite 
filament production (p<0.05). Figures 5.45-5.49 show results of SEM-EDS 

































































C o m p o s ite  F ila m e n t P ro d u c t io n  -  H A  C o n te n t  (n = 3 )
 
Figure 5.28. Comparison of HA concentration during production phases of 3DP composite filament.  TGA 
was used to determine the ceramic content of composite samples by thermal decomposition of their polymer 







Figure 5.30. SEM-EDS images of VB-PLA filament.  SEM image (a) scanned at 20kV to a magnification of 200X. EDS 
was then performed to look for elemental signals of HA. The polymer matrix’s expected distribution of carbon (b) and 
oxygen (c) was readily apparent in the scan. Only noise-level traces of phosphorus (d) and calcium (e) were detected. 
 
Figure 5.29. SEM-EDS images of pre-extrusion PLA-10%HA composite.  SEM image (a) scanned at 20kV. EDS was 
then performed to look for elemental signals  of HA. The polymer matrix’s expected distribution of carbon as background 
reference (b) and oxygen (c) was readily apparent in the scan. Diffuse associated distributions of phosphorus (d) and 






Figure 5.31. SEM-EDS images of PLA-10%HA composite filament.  SEM image (a) scanned at 20kV to a magnification 
of 200X. EDS was then performed to look for elemental signals of HA. The polymer matrix’s expected distribution of 
carbon (b) and oxygen (c) was readily apparent in the scan. Uniform distributions of phosphorus (d) and calcium (e) were 
detected. 
 
Figure 5.32. SEM-EDS images of 3D-printed PLA-10%HA composite.  SEM image (a) scanned at 20kV to a 
magnification of 200X. EDS was then performed to look for elemental signals of HA. The polymer matrix’s expected 
distribution of carbon (b) and oxygen (c) was readily apparent in the scan. Uniform distributions of phosphorus (d) and 




SEM-EDS analysis showed that PLA filament has no detectable Ca or P 
content (Figure 5.45). Once mixed with HA and molten, the composite shows 
diffuse and heterogeneous zones where Ca and P were closely distributed, 
which suggests the presence of HA (Figure 5.46). After extrusion into 3DP 
filament (Figure 5.47), and processing through FFF (Figure 5.48), the 
samples were found to have a homogeneous distribution of both elements 
across the scanned area. 
 






C o m p o s ite  F ila m e n t P ro d u c t io n  -   E D S  E le m e n ta l A n a ly s is  S p e c tra






3 D P  C o m p o s ite
C o m p o s ite  F ila m e n t P re -E x tru s io n  C o m p o s ite
P u re  P L A  F ila m e n t
P C a
 
Figure 5.33. Comparison of EDS point-elemental content in SEM images between different stages 
of PLA-HA composite production.  Region in the spectra is zoomed in to the area of interest for 
energies characteristic of phosphorus (P) and calcium (Ca). These peaks were distinctly detected for the 
PLA10%-HA composite filament, as well as for the 3D-printed composite. They were less defined but still 
detectable by the software for the pre-extrusion composite, and overall indistinguishable from 




Figure 5.49 shows EDS data for elemental analysis for each stage of 
compositing, and Figure 5.50 summarises a comparison of how the different 
heat-based processes affect polymer crystallinity and molecular weight. Only 
controlled annealing as described in Section 5.5.1 was capable of driving a 
big enough change in the crystalline content of the PLA matrix to be 
statistically significant. The rest of the results showed no difference with 
respect to the values for the base VB-PLA filament, except for the composite’s 
Mn after being subject to 3D-printing (p<0.05). 
 
In contrast, calorimetric behaviour of the polymer was found to vary across 
processing. Figure 5.53 summarises the TGA-derived thermograms for each 
material version. Crystallization peaks can be observed at around 90 ºC – as 
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b )  C o m p o s ite  F ila m e n t  P ro d u c t io n  -
M o le c u la r  W e ig h t  (M n )  (n = 3 )
*
 
Figure 5.34. Comparison of a) crystalline content and b) number average molecular weight 
between different stages of PLA-HA composite production.  Crystalline content and molecular weight 
as PLA undergoes the compositing process studied. Annealed 3D-printed PLA was included as a 
reference for controlled thermal treatment above glass-transition temperature, and was found to be the 
only process to produce sitnificant differences in crystallinity with respect to the raw VB-PLA filament. 
Only after 3D-printing of the compostie were significant differences in Mn detected. Stars denote 





at 174.8 ºC for the 3D-printed composite, 176.0 ºC for the pre-extrusion 
composite, 176.8 ºC for the composite filament, and 175.8 ºC for the raw PLA 
filament. Notably, there was an upward shift in the curves as the material 
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Figure 5.35. Comparison of crystalline content between different stages of PLA-HA composite 
production. Slight shifts in melting peaks are noticeable as the material undergoes compositing. 





The µCT scans of samples made with the 10% HA composite show an uniform 
distribution of radio-opaque particles all over the visible surfaces of the sample 
(Figure 5.52 b, c and d). These are not present in the reference scan, which 
was printed with raw VB-PLA (Figure 5.52a). Filtering the more radiolucent 
grayscale values corresponding to the polymer matrix, it was possible to 
identify a uniform volumetric distribution of radio-opaque micron-sized 
particles, congruent with calcium atoms from HA (Figure 5.52d). Even though 
variations on polymer density are apparent as more opaque sections within 
the volume, these transitions are gradual. In contrast, particles with sharply 
defined edges are evident scattered through the projections (Figure 5.52d). 
Since most of the mass of the sample is polymer, and predominantly carbon 
 
Figure 5.36. Images from µCT of PLA-10%HA 3D-printed disc and 3D-cell culture samples. a.  Axial 
reconstructions of different disc samples. b. Lateral projection of a 3D cell-cult      ure sample showing 
embedded HA crystals. c. 3D reconstruction (of sample a) showing the entirety of the sample’s mass. d. 











and oxygen, these sharp edges indicate the presence of higher-atomic-
number atoms, which attenuate greatly the passing X-ray photons as 
attenuation is dependent on atomic number and atomic weight [362–364]. As 
these radio-opaque particles are visible throughout all the volume of the 
composite samples, they are likely to be hydroxyapatite particles, which 
contain Ca as the most attenuating element in the material (Figure 5.52a, b 
and c). The abundance of these particles (Figure 5.52c) made it impossible 
to parametrise the images for computation of porosity values, mineral density, 
mineral volume, and other such calculations. Bigger agglomerations, in the 
order of hundreds of microns, were also clearly visible even in the unfiltered 
reconstructions. 
5.5.2. 3DP COMPOSITE MECHANICAL PROPERTIES 
Mechanical testing (Figure 5.53a) revealed that the composite after 3D had 
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Figure 5.37. Comparison of mechanical properties between 3DP tensile bars on different PLA versions.  Tensile 
strength (a) and elastic modulus (b) measurements for pure PLA (as control group), annealed PLA, and the 10% HA 
composite used in this study. Pull-to-break testing was conducted on 3D-printed tensile bars (n=5), both with specifications 





similar for annealed tensile bars (27.7 MPa). In both cases, this meant a 
significant difference of more than 40% with respect to pure PLA controls 
(p<0.05). Additionally, there were no significant differences found between the 
composite and the annealed material (p<0.05). Figure 5.53b, in contrast, 
shows data for E which was similar between pure PLA (191.2 MPa) and the 
annealed tensile bars (178.0 MPa), with no significant differences (p<0.05). In 
contrast, the E of the 10% HA composite (126.5 MPa) was significantly lower 
than that of both of the other materials (p<0.05). This suggests the HA is not 
interfacing well within the PLA matrix. 
 
5.5.3. COMPOSITE ACCELERATED DEGRADATION 
To further illustrate the effects of the compositing process in VB-PLA, the 
following results are displayed as compared to values and trends explained in 











5.5.4. MASS CHANGE 
Data collected for mass loss of composite samples during ADT are shown in 
Figure 5.54. Comparison with this curve against that of pure VB-PLA shows 
that degradation behaviour starts out similar for both polymers during the first 
three days of the experiment – corresponding to their water-infiltration periods. 
The composite reaches its tipping point at some time before the fifth day, 
where statistical difference in their degradation profile was confirmed through 
ANOVA analysis (p<0.05). The tipping point was determined to be 2.65 days 
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Figure 5.38. Mass change measurements from ADT specimens on PLA-10%HA 
composite. Data from degradation on PBS at 70 ºC. Points correspond to means with 
standard deviation bars. Solid line denotes values for the composite, with values for 





Throughout degradation, crystallinity for the composite followed a noticeable 
exponential trend, similar to that found for VB-PLA. However, it experienced 
pronounced variations in this parameter, which made it difficult to evaluate 
statistical differences at each individual time-point. Fitting the data to an 
exponential model through non-linear regression, it became apparent that the 
composite underwent a more erratic degradation (R2= 0.6783) than the 
reference PLA (R2= 0.9833). Furthermore, the composite also displayed a 
larger time constant (τ =2.265) than pure PLA (τ =1.951), suggesting a slower 
increase in overall crystallinity for it (Figure 5.55). 
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Figure 5.39. Crystallinity change measurements from ADT specimens 
on PLA-10%HA composite. Data from degradation on PBS at 70 ºC. Points 
correspond to means with standard deviation bars. Solid line denotes an 
exponential fit for the composite’s data, with a fitting line for pure PLA shown 




5.5.6. MECHANICAL PROPERTIES 
Similarly to what was observed and described for ADT specimens of VB-PLA, 
mechanical testing was impossible after the first day of degradation. The 
specimens became too brittle to be handled, even though their geometry 
remained preserved.  
 
5.5.7. THERMAL ANALYSYS 
In line with what was observed for the other PLA versions trialled in Section 
5.2, the PLA-10%HA composite displayed no crystallisation peaks after the 
first day of ADT. A lowering of the melting temperature was another noticeable 
trend shared with the raw PLA: the composite starts out at a melting 
temperature of 175.9 ºC and ends the experiment with one of 144.5 ºC. This 
is 15.2 ºC below that of VB-PLA (which starts at a similar 176.3 ºC). Figure 
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Figure 5.40. Thermograms for the PLA-10%HA composite after several stages of ADT. The overall shape of the curves 
is maintained throughout the experiment. The most noticeable changes are in the size of the fusion peak, which is reflective 




As it can be noted in Figure 5.57, the melting temperature of the composite 
drops readily below that of pure PLA. ANOVA analysis of these data sets 
further confirmed that the processes were significantly different after the first 
day of degradation (p<0.05). 
 
5.5.8. MOLECULAR WEIGHT 
Closely to what was expected, number average molecular weight (Mn) during 
ADT for the PLA-10%HA composite adhered satisfactorily to an exponential 
non-linear behaviour (R2 = 0.9735). As shown in Figure 5.58, the agreement 
with this model was similar to that found for VB-PLA (R2 = 0.9691). More than 
90% of the samples’ Mn had decayed by day 3. By the end of the experiment, 
Mn was measured at 0.99% of its starting value. 
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Figure 5.41. Changes in melting temperature for the PLA10%-HA composite 
throughout ADT. Data from degradation on PBS at 70 ºC Points correspond to 
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Figure 5.42. Changes in Number Average Molecular Weight (Mn) fro the PLA-
10%HA composite throguhout ADT. Points correspond to averages with standard 
deviation error bars, joined by the solid line. The dashed line depicts a the Mn ADT 
data for VB-PLA as reference. Correlation coefficients refer to a non-linear fit to an 





5.6.1. 3D-PRINTED PLA STERILISATION 
The three sterilisation methods described in Section 4.5.2 were trialled in 
regards of suitability for preparation of 3D-printed discs for in vitro tissue 
engineering work. Results from a 24-hour cell attachment test and a 21-day 
viability study with MG-63 cells are shown in Figure 5.28 and Figure 5.29 
respectively. The study was performed on pure-PLA 3DP discs of 1cm in 
diameter.  
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Figure 5.43. MG-63 cell attachment comparison for sterilisation methods for 3DP-PLA items to be 
used for in vitro testing.  3D-Printed PLA discs were chemically sterilised in 2ml of a 70% ethanol 
solution for 24h, 5% ethaneperoxoic acid for 30 minutes, or a 70% propan-2-ol solution for 15 minutes. 
Triplicate samples were measured in one biological repeat (n =3). (p < 0.05) No significant differences 





For cell attachment, no significant differences were found among the three 
sterilisation methods (p<0.05). Similarly, no significant differences were found 
between ethanol and propan-2-ol sterilisation (p<0.05) in regards of cell 
viability. On the other hand, sterilisation with ethaneperoxoic acid performed 
significantly worse (p<0.05) than both ethanol and isopropanol after day 7 and 
into the end of the study. 
Results for measurements of cellular matrix components after 21 days are 
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Figure 5.44. MG-63 cell viability comparison for sterilisation methods for 3DP-PLA items to be used for in vitro 
testing.  3D-Printed PLA discs were chemically sterilised in 2ml of a 70% ethanol solution for 24h, 5% ethaneperoxoic 
acid for 30 minutes, or a 70% propan-2-ol solution for 15 minutes. Triplicate samples were measured in one biological 
repeat (n = 3). Stars denote significant differences with respect to ethanol sterilisation (p < 0.05) as found through ANOVA. 





on these samples, as the levels appeared to be below the detection limit for 
this experimental setup. Conversely, there was no significant difference 
(p<0.05) between the three sterilisation methods in regards of their potential 
effect on collagen deposition. 
 
 
5.6.2. INITIAL MG-63 CELL VIABILITY STUDY 
The different versions of the polymer and its composites were further tested 
for biocompatibility through the cell-viability experiment described in Section 
4.5.3. Results for a 24-hour cell-attachment test and subsequent 21-day 
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Figure 5.45. MG-63 21-day cellular matrix deposition comparison for sterilisation methods for 3DP items to 
be used for in vitro testing.  3D-Printed PLA discs were chemically sterilised in 2ml of a 70% ethanol solution for 
24h, 5% ethaneperoxoic acid for 30 minutes, or a 70% propan-2-ol solution for 15 minutes. Triplicate samples were 
measured in one biological repeat (n = 3). No significant differences were found (p < 0.05)  through ANOVA. Eror 




viability test for samples incubated in EM are shown in Figure 5.31 and Figure 
5.32. The cell attachment data only showed significant differences between 
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Figure 5.46. MG-63 cell attachment comparison between 3D-Printed composites.  3D-
Printed PLA and PLA-HA composite discs seeded with 5000 MG-63 cells, incubated at 37 ºC 
in EM and monitored through 21 days via RRA assays. Normalised fluorescence 
measurements were compared to standard curve data to generate approximated cell-counts. 
Triplicate samples were measured in two biological repeats (n =6). Error bars denote standard 





In contrast, the viability study showed significant differences (p<0.05) at day 7 
between the reference PLA and the 10%HA composite versions, with the 
composite performing better. On this same day, the 5%HA and 10%HA 
composites were higher than TCP on cell-counts. Similarly, on day 14 PLA 
showed significantly higher counts better than TCP (p<0.05). By day 21, the 
only results with significant differences between them were those between 
TCP and the 5% composite, with the composite performing better (p<0.05). 
Results for cellular matrix deposition are shown below in Figure 5.33. As with 
the sterilisation methods comparison described in Section 5.5.1, calcium 
deposition was too low to be measured through ARS assays for these 
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Figure 5.47. MG-63 cell viability comparison between 3D-Printed composites.  3D-Printed PLA and 
PLA-HA composite discs. Normalised fluorescence measurements were compared to standard curve data 
to generate approximated cell-counts. Triplicate samples were measured in two biological repeats (n =6). 




present statistical differences between the 5%HA and the 10%HA composites, 
favouring the latter (p<0.05).  
 
5.6.3. MG-63 CELL VIABILITY STUDY IN SM 
Given the results observed in the initial viability studies with MG-63 cells, it 
was deemed necessary to run repeats of these using supplemented medium 
(SM) in order to stimulate deposition of calcium and collagen as extracellular 
matrix components. The objective was to establish if the HA in the composites 
would stimulate mineralisation and osteoblast differentiation given the 
appropriated environment – which EM alone might not provide. Annealed 
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Figure 5.48. MG-63 21-day collagen deposition comparison comparison between 3D-Printed 
composites.  3D-Printed PLA discs. Normalised fluorescence measurements were compared to 
standard curve data for SRS to extrapolate collagen-bound stain Triplicate samples were measured in 
two biological repeats (n =6). No significant differences were found (p < 0.05)  through one-way-




of heat treatment and/or crystallinity on the material. Results are shown in 
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Figure 5.49. MG-63 cell attachment comparison between 3D-Printed composites in SM.  D-Printed PLA and PLA-HA 
composite discs. Cell attachment was then calculated as the percentage between the cells in the sample and the original 
seeded population. Triplicate samples were measured in two biological repeats (n =6). Error bars denote standard 




Only the 10% composite showed higher cell attachment than the reference 
PLA, while also displaying better results than the other two composites 
(p<0.05). Significant differences in viability (p<0.05) were found on day 14 
between PLA and the 10% and the 20% composites, with these composites 
displaying a larger cell population. On day 21 there were significant differences 
between TCP and every version of the sample discs, with the sample discs 
supporting higher cell counts. At this final time point, all versions of the material 
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Figure 5.50. MG-63 cell viability comparison between 3D-Printed composites in SM.  3D-Printed PLA, annealed 3D-
Printed PLA, and PLA-HA composite discs. Normalised fluorescence measurements were compared to standard curve 
data to generate approximated cell-counts. Triplicate samples were measured in two biological repeats (n =6). Error bars 





The higher concentrations of HA in the composites yielded significantly higher 
extracellular matrix deposition and mineralisation (p<0.05). Collagen 
deposition was significantly higher than PLA alone on the 20%HA composite, 
while calcium was so for both the 10%HA and 20%HA versions – with no 
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Figure 5.51. MG-63 21-day extracellular matrix deposition comparison between 3D-Printed composites in SM.  
3D-Printed PLA and PLA-HA composite discs. Normalised absorbance measurements were compared to standard 
curve data for SRS to extrapolate calcium and collagen-bound stain concentrations respectively. Triplicate samples 
were measured in two biological repeats (n =6). Stars denote significant differences with respect to PLA  (p < 0.05). 




5.6.4. EFFECTS OF OSTEOGENIC SUPPLEMENTS IN MG-63 CULTURE IN 
PLA AND PLA-HA COMPOSITES 
Since the only difference between the EM and SM experiments described in 
this section was the addition of ascorbic acid and β-glycerophosphate to the 
culture medium, their results can be compared to determine if the supplements 
have any effect on cell response. Figure 5.37 summarises cell attachment 
data comparison between the two culture-media. PLA showed a significantly 
less cell attachment (p<0.05) when cultured in SM, while the 10%HA 
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Figure 5.52. MG-63 cell attachment comparison between 3D-Printed composites in EM and SM.  3D-Printed PLA 
and PLA-HA composite discs. Normalised absorbance measurements were compared to standard curve data to 
generate approximated cell-counts, which were then compared with counts on each sample’s incubation well. Error 
bars denote standard deviation. Stars denote significant differences (p<0.05) with respect to EM measurements for 




Cell viability was not affected for the most part (Figure 5.38). Significant 
differences (p<0.05) appeared in day 14 for TCP (Figure 5.38a) and for the 
10%HA composite (Figure 5.38d), with the samples in supplemented medium 
measuring higher than those of the un-supplemented one. This apparent effect 
did not affect the final outcome of the experiment, with all 21 day cell counts 
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Figure 5.53. MG-63 cell viability comparison between 3D-Printed composites in EM and SM.  
3D-Printed PLA, annealed 3D-Printed PLA, and PLA-HA composite. Error bars denote standard 
deviation. Stars denote significant differences (p<0.05) with respect to  EM measurements. Data 
for days 1, 4 and 7 were ommited for clarity since no relevant variations could be observed. 




Collagen deposition was significantly enhanced in all materials, except for PLA 
(Figure 5.39). The reference pure PLA showed no statistical difference when 
cultured in SM as compared to EM (p<0.05). Conversely, all materials – 
including PLA – exhibited measurable levels of SRS-bound calcium when 
cultured in SM (Figure 5.36), while EM yielded amounts too small to quantify 
in this experimental setup. 
5.6.5. IN VITRO CELL CULTURE IN THREE-DIMENSIONAL 3D-PRINTED 
STRUCTURES 
Higher HA concentration did appear to play a role in better cellular responses 
according to results shown in Section 5.5.3. However, the 20%HA composite 
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Figure 5.54. MG-63 21-day collagen deposition comparison comparison between 3D-Printed composites 
in EM and SM.  3D-Printed PLA and PLA-HA composite discs. Normalised absorbance measurements were 
compared to standard curve data for SRS to extrapolate collagen-bound stain concentrations. Stars denote 
significant differences with respect to EM (p < 0.05). Error bars denote standard deviation. Triplicate samples were 




Results listed below therefore correspond to experiments performed on the 
5%HA and 10%HA composites as compared to pure PLA – all on SM. Figure 
5.40 shows results for cell attachment on these 3D models. The 10%HA 
composite retained significantly fewer cells than pure PLA, although no 
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Figure 5.55. MG-63 cell attachment on 3D-Printed Mesh Models on PLA-HA composites in SM.  3D-Printed PLA and 
PLA-HA composite 3D Mesh Models. Normalised absorbance measurements were compared to standard curve data to 
generate approximated cell-counts, which were then compared with counts on each sample’s incubation wells. Error bars 
denote standard deviation. Stars denote significant differences (p<0.05) with respect to PLA. Triplicate samples were 




Results for cell viability are depicted in Figure 5.41, showing cell growth on 
the structure’s surface, but no significant differences between any of the 
materials tested throughout the experiment (p<0.05). Cellular matrix 
deposition was measurable as both collagen and calcium, with the composites 
performing significantly better (p<0.05) than PLA alone (Figure 5.42). Within 
these measurements, there were no significant differences between the two 
versions of the composite. 
Though the results between experiments ran on the disc samples cannot be 
directly compared to those of the 3D mesh models, production of extracellular 
matrix components can be normalised to the number of cells in each sample. 
These data can then be directly compared: this analysis is summarised by 
Figure 5.43. 
Collagen deposition per amount of cells in a sample did not exhibit significant 
differences between the disc and the 3D mesh models (p<0.05) for any of the 
materials tested. In contrast, the 3D mesh models in all materials were 
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Figure 5.57. MG-63 cell viability on 3D-Printed Mesh Models on PLA-HA composites in SM.  3D-Printed 
PLA and PLA-HA composite 3D-mesh models. Normalised fluorescence measurements were compared to 
standard curve data to generate approximated cell-counts. Error bars denote standard deviation. Stars denote 
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Figure 5.56. MG-63 21-day extracellular matrix deposition comparison between 3D-Printed composites in 
SM.  3D-Printed PLA and PLA-HA composite discs. Normalised absorbance measurements were compared to 
standard curve data for SRS to extrapolate calcium and collagen-bound stain concentrations respectively. Stars 
denote significant differences with respect to PLA  (p < 0.05). Error bars denote standard deviation. Triplicate 
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Figure 5.58. MG-63 21-day extracellular matrix deposition normalised to cell number; comparison between discs 
and 3D-Mesh models in SM.  3D-Printed PLA and PLA-HA composite discs. Normalised absorbance measurements were 
compared to standard curve data for SRS and ARS to extrapolate calcium and collagen-bound stain concentrations 
respectively, and were then compared to cell numbers to allow for dicrect comparison. Stars denote significant differences 
with respect to disc samples (p = 0.05). Error bars denote standard deviation. Triplicate samples were measured in two 




5.7. MATHEMATICAL MODELLING FOR POLYMER 
DEGRADATION 
Accelerated degradation has been well studied in the literature as a means to 
extrapolate, through the Arrhenius relation, from short experiments – in the 
order of months – to the outcomes of degradation setups that can take years 
to complete [284,290,361,365–367] as per the ISO-10993-13-2010 standard 
[328]. In contrast, the present section looks to establish a model to predict 
degradation data when varying the starting material properties at a set 
temperature.  
5.8.1. MODELLING FOR MOLECULAR WEIGHT BEFORE MASS-LOSS 
Taking in account the tendencies found for ADT mass-loss data for pure PLA 
(VB-PLA) and the PLA-10%HA composite, tipping points were calculated to 
be somewhere from 8.32 to 10.74 days for PLA, and around 2.65 days for the 
composite (though the regression proved ambiguous). The data that were 
clearly before mass loss (up to day 5 for PLA and day 3 for the composite) 
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Figure 5.59. Linear fit for a) autocatalysed and b) non-autocatalysed degradation models. Points correspond 
to means with standard deviation bars. Common linear model for both data sets validated through extra-sum-of-




were evaluated as per the model in Equation 4.15 to determine if the 
degradation process was autocatalysed, or non-autocatalysed as per 
Equation 4.17. The results for this analysis are shown in Figure 5.59. Both 
data sets could be fitted to the same curve in both models through comparison 
via extra-sum-of-squares F-test (p < 0.05). The autocatalysed model provided 
a better fit for the data (R2 = 0.8881) than that of the non-autocatalysed model 
(R2 = 0.7983). 
 
Given the autocatalysed model, the parameters that best fit the pre-tipping-
point degradation profile for both materials would be: 
ln𝑀𝑛(𝑡) = −0.6045𝑡 + 10.68;  𝑡 ≤ 𝑡𝑝                                    Equation 5.1 
Such that: 
𝑀𝑛(𝑡) = 43,477.55𝑒
−0.6045𝑡;  𝑡 ≤ 𝑡𝑝                                  Equation 5.2 
If the data are normalised so that the initial Mn for each ADT experiment is 
100% (thus constraining the value for Mn0), the parameters for the model are 
still valid through extra-sum-of-squares F-test  (p = 0.05, R2 = 0.9092), and it 
can be adjusted to find that: 
𝑀𝑛%(𝑡) = 100𝑒
−0.6320𝑡;  𝑡 ≤ 𝑡𝑝                                      Equation 5.3 
Where Mn% is the remaining percentage of Mn with respect to the pre-
degradation measured value. For verification of this model, data from the 
publication by Weir et al. [290] were analysed. The ADT setup of the present 




data as comparable as can be reasonably expected from a separate study. 
The data extracted from the publication are compiled in Table 5.5. 
Using the parameters from Equation 5.3 (k1 = 0.6320, Mn0 = 100) non-linear 
regression was performed on the normalised Mn data of Table 5.5. The results 
of this computation are shown in Figure 5.60. This model (Equation 5.3) was 
capable of reasonably fitting the data from the other study (R2 = 0.8324), which 
had distant starting conditions (namely almost quadruple the Mn of the 
samples in the present study, reported at 166,000 g/mol, and a higher starting 
crystallinity of 57.5%). Incidentally, the method used for linear regression in 
this project calculated the data from Weir et al. to yield a k1 of 0.2091 (R2 = 
0.9494), while their study itself reported a rate constant of 0.2155 (R2 = 0.95) 

















0 166,000 100.00 57.5 
1 119,000 71.69 59.9 
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Figure 5.60. Percent Changes in Number Average Molecular Weight (Mn) for data extracted 
form the work of Weir et al. throguhout ADT. Points correspond to averages joined by the dashed 
line. The solid line depicts a fitted curve from the parameters modelled in this section from the present 




3 64,450 39.83 57.5 
5 39,300 23.67 77.1 
9 24,900 15.00 85.7 
14 29,200 17.59 76.2 
18 13,750 8.28 88.9 
21 11,700 7.04 85.1 
23 9,090 5.48 92.2 
Data presented as averages as provided by the source 
 
5.8.2. MODELLING FOR MOLECULAR WEIGHT AFTER MASS-LOSS 
The overall behaviour of the Mn measurements throughout the all sampling 
points in this study is plotted in Figure 5.61. Both the reference pure PLA and 
the PLA-10%HA composite displayed an exponential decay profile. This trend 
was expected and supported by good correlation (R2 = 0.9731 for PLA, R2 = 
0.9735 for PLA-10%HA, and R2 = 0.9895 for Weir et al. data) found via non-
linear regression for each data set. Furthermore, extra-sum-of-squares F-test 
suggests the data sets’ trends cannot be rooted to the same mathematical 






A normalisation of the Mn data to compensate for the disparity in initial values 
is shown in Figure 5.62, including the dataset from Weir et al. The individual 
normalised datasets were found to be best fit to different exponential decay 
parameters through extra-sum-of-squares F-test (p<0.05), with correlation 
coefficients of 0.9869 for PLA, 0.9762 for the PLA-10%HA composite, and 
0.9900 for the degradation experiments by Weir et al. Additionally, a potential 
shared model that accommodates the three datasets up to day 23 with 
reasonable fidelity was also found as follows: 
𝑀𝑛%(𝑡) = 97.456𝑒
−0.5696𝑡 + 2.544                             Equation 5.4 
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Figure 5.61. Percent Changes in Number Average Molecular Weight (Mn) for 
pure PLA and the PLA-10%HA composite  throguhout ADT. Points correspond to 
averages joined by the indicated lines, with standard deviation error bars. Correlation 
coefficients refer to a non-linear fit to such an exponential decay model, independent 




This model fits the Mn normalised data with correlation coefficients of 0.9754 
for PLA, 0.9625 for the PLA-10%HA composite, and 0.8607 for the by Weir et 
al dataset.  
 
Since degradation rate is strongly linked to the amount of polymer present, its 
surface area, and its contact with the degradation medium, a further attempt 
was made at generalisation of a degradation model. To account for all these 
time-dependent factors, normalisation with respect to the half-life of each 
dataset’s Mn0 was conducted. The half-life (λ) figures were derived from the 
non-linear regression analysis shown in Figure 5.61, and the time-axis data 
were represented as fractions of their respective dataset’s λ (0.9476 days for 
PLA, 1.258 days for the PLA-10%HA composite, and 1.974 days for the data 
from Weir et al.). Non-linear regression was then performed constrained to a 
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Figure 5.62. Percent Changes in Number Average Molecular Weight (Mn) for 
pure PLA, the PLA-10%HA composite, and data from Weir et al. throguhout ADT. 
Points correspond to averages joined by the indicated lines, with standrad deviation 
error bars. Correlation coefficients refer to a non-linear fit to an exponential decay 




common rate constant for the PLA and PLA-10%HA data sets. For testing of 
the model, data for the Weir et al. set was then fitted through non-linear 
regression to a function constrained to this common rate constant. The 
resulting curves are plotted on Figure 5.63.   
 
Graphically, this reference frame transformation aligns the half-lives of the 
datasets over the horizontal axis, scaling the graph appropriately in this same 
direction. The resulting model is represented as: 
𝑀𝑛(𝛬) = (𝑀𝑛0 − 𝛹)𝑒−𝜅70𝛬 + 𝛹                                      Equation 5.5 
Where 𝚲 is the scaled time on the normalised reference frame, Ψ is the vertical 
offset value to which the function approaches asymptotically at infinite time, 
and κ70 is the proposed common rate constant for ADT at 70 ºC (calculated to 
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Figure 5.63. Changes in Number Average Molecular Weight (Mn) for pure PLA, 
the PLA-10%HA composite, and data from Weir et al. throguhout time-
normalised ADT. Points correspond to averages joined by the indicated lines. 
Correlation coefficients refer to a non-linear fit to an exponential decay model, 




be 0.6923 from data in this study). This model implies that for the ADT-Mn(t) 
values of a PLA sample, the time-normalised Mn(𝚲) curve will be a vertically-
offset exponential decay trend, a function of 𝚲, and dependent on Mn0, and 𝛹. 
Since the rate constant for this model is dependent on the half-life of the real-
time reference frame – which itself is a function of ADT temperature as per the 
Arrhenius relationship [290,361,365–367] – it follows that the common rate 
constant proposed for this model should be only valid for PLA undergoing ADT 
at 70 ºC (and that a common rate constant could be determined for each given 
ADT temperature).  
Since Mn0 is determined experimentally, only the parameter Ψ remains to be 
defined to be utilised the in proposed model. Since calculation of λ is also 
necessary for time-normalisation, one of the additional Mn(t) data points can 





;  𝑀𝑛0 ≠ 1, 𝑀𝑛0(𝑀𝑛(𝛬𝑎)−𝑀𝑛0)(𝑀𝑛(𝛬𝑎)−𝑀𝑛0𝑒−𝜅70𝛬𝑎) ≠ 0  
Equation 5.6 
Where 𝚲a is a time point with a known value for Mn (different to Mn0). If a time 
constant is known for a given data set (taking in account data beyond tp), the 










;  𝑀𝑛0 ≠ 1, 𝑀𝑛0 (𝑀𝑛 (
𝑡𝑎
𝜆






𝜆 ) ≠ 0  
Equation 5.7 





Furthermore, this model can be simplified by making some assumptions about 
the boundary conditions of the experiment. Since the final water-soluble 
oligomers predominate by the end of ADT, it can be safely assumed that Mn 
values measured by the final stages of any long enough experiment will be at 
least several orders of magnitude below that of Mn0. Being that the case, their 
ratio becomes very close to 0. Taking a similar approach to the model in 
Equation 5.4, normalised Mn values as a function of half-life normalised time 
yield the plots depicted in Figure 5.64. In this case, the non-linear regression 
can be constrained to the following parameters: 
𝑀𝑛%(𝛬) = 100𝑒
−0.6686𝛬                                      Equation 5.8 
Where the time constant was determined to be 0.6686 from the data of PLA 
and PLA-10%HA. Additionally, Weir et al. data was normalised and fitted to 







A D T  S e r ie s  fo r  D if fe re n t  L a c t id e  P o ly m e rs  -
T im e -N o rm a lis e d  M o le c u la r  W e ig h t  (M n % ) C h a n g e








P L A -H A  1 0 %
R
2
 =  0 .9 4 0 4
R
2
 =  0 .9 8 2 9
R
2
 =  0 .9 7 6 2
 
Figure 5.64. Changes in Normalised Number Average Molecular Weight (Mn%) for 
pure PLA, the PLA-10%HA composite, and data from Weir et al. throguhout time-
normalised ADT. Points correspond to averages joined by the indicated lines. Correlation 





this model through non-linear regression, with the resulting correlation also 




𝜆                                      Equation 5.9 
This model adjusts well for the two datasets from the present study, and 
accurately represented the independent data from Weir et al [290]. 
Finally, Figure 5.65, shows a probable relationship found between initial Mn 
and the experimental degradation time constant τ of PLA, PLA-10%HA, and 
the Weir et al. dataset. 
 




1 .51 0 5
21 0 5
A D T  S e r ie s  fo r  D if fe re n t  P L A  V e rs io n s
M n 0  v s  t im e  c o n s ta n t














=  1 .0 0 0
M n 0  =  1 5 ,1 4 7 e
0 .9 4 1 4 
 
Figure 5.65. Initial Number Average Molecular Weight (Mn) for pure PLA, the PLA-10%HA 
composite, and the Weir. et al data set plotted against their respective non-linear regression time 
constants. Points correspond to averages. Correlation coefficients refer to a non-linear fit to such an 





6.1. DETERMINING THE PRINTER’S RESOLUTION LIM IT AND 
PRINTING ACCURACY 
Using the tolerance model described in Section 4.1, a limit on the feature 
resolution of the printer could be found. On the model, each cylinder (or half-
cylinder) is progressively smaller by a fixed amount, proportional to the one at 
the base. Downscaling of these models helps quantify the consistency on 
printer performance at various sizes under the same printing settings and 
conditions. Upscaling, in contrast, makes other phenomena – such as material 
warping, shrinking, inadequate extrusion, or low bed adhesion – more evident.  
Measurements on radii were made along the X and Y printer axes 
independently, and were denoted as such with a subindex. For the present 
work, for the design and calculations are listed in Table 5.2 and Table 5.3, 
and discussed theoretically in Section 6.1. Calculations take account the 
average reported value of 1.27 g/cm3 for PLA density that is widely found in 
the literature [137,251,293,334] and reported by manufacturers [318,331], who 
describe a crystallinity-dependent range from 1.25 to 1.29 g/cm3. 
Considering that most alveolar defects should fit within a volume of about 
11x15x22 mm [343,344] (based on adult average anatomy), variations as 
reported on section 5.1 become significant as they limit the resolution of details 
to be accomplished using this equipment. Especially along the Z axis, where 
accuracy varied from 0.56% up to 18.18% from the programmed values, and 




This includes modular geometries to control macroscopic porosity and/or void 
content [108]. Not only cellular attachment is more readily achieved on the 
surfaces of scaffolds rather than in their inner geometries, but the application 
of functionalisation coatings and treatments is also mostly confined to the outer 
surfaces of any given shape [273,368,369]. 
Semicrystalline PLA density of 1.27 g/cm3 [137,251,293,318,331,334] should 
be accounted for as an average when determining the porosity of apparently 
solid FFF items, as the process is expected to deteriorate the crystallinity and 
molecular weight of the inputted filament [49] given that it is essentially a high-
temperature extrusion technique [297]. Even at the theoretical setting of 95% 
material fill on the printer’s software configuration, the observed density of the 
prints is scale-dependent and below even amorphous PLA values [318,331], 
with a range from roughly 1.14 g/cm3 on the smallest end of the printed range, 
from where it gradually drops as the scale increases, to up to 0.63 g/cm3, as 
observed in Figure 5.1. Parts larger than 7 cm3 consistently approached a 
40% porosity. In terms of the present application, that means that predictable 
and stable porosity values could only be expected on large implants — such 
as those found in orthopaedic reconstruction. This could be due to the larger 
items require larger layers which are allowed to cool for longer, leading to 
weaker bonding with the subsequent layer and allowing for air pockets to form 
between them. 
Given a small enough geometry (close to the resolution limit of the printer: 2 
mm in this case), the fill pattern is not considered necessary by the software 




close enough to fuse, thus producing a surface by themselves. Any additional 
filling would pile up beyond the intended vertical limit of a given layer. This can 
account for the near-solid-PLA density on smaller printed geometries where 
outline material makes up for most of the structure, while the fill pattern 
contributes to more void pockets being included into the volume as the scale 
increases. It follows that the apparent density of the finished item is 
progressively lowered, but plateaus around 40% porosity (0.76 g/cm3) when 
the fill material predominates evenly distributed throughout the geometry. This 
would explain, along with the increase in linear-dimension reproducibility, why 
errors in expected volume of a FFF structure diminish and stabilise in larger 
scale measurements (Section 5.1) 
These sharp differences between material characteristics must play a 
significant factor on the design of any device on the scales intended by this 
project. A maxillary implant would be around the dimensions stated in Section 
5.4, which would, in turn, place it on the plateaued region for both porosity and 
dimensional values if made completely solid. As well, small details and 
features, such as internal geometries, are bound to be subject to lower 
reproducibility – though also reduced porosity, which would impede water, cell 
and extracellular matrix penetration [8]. The importance of determining these 
errors and variations becomes evident when considering macroscopic porosity 
(void content due to internal geometries) has been pointed out as a main 
concern on scaffold design, listing optimal diameter values from 0.4 to 2 mm 
for interconnected pores (internal channel systems) to allow vascularisation 
and bone formation into a scaffold [6,37,369], with a lower limit on 150 µm to 






6.2. ACCELERATED DEGRADATION OF FFF PLA 
6.2.1. MASS CHANGE 
Water degrades long polymer chains by attacking ester bonds in between the 
monomers [2,294], preferably on the amorphous phase of the network, and 
first eroding outermost zones of a sample. It must be taken in account that 
PLA oligomers are inherently hydrophobic, but lactic acid is hydrophilic by itself 
[137,366]. This is why degradation in aqueous medium proceeds relatively 
slowly: polymer fragments must reach a critical size before hydrophilic 
moieties of the molecules overpower their hydrophobic chains, rendering them 
water-soluble.  
ADT test results described in section 5.2 found the onset of mass loss at 70 
ºC to be between the 9th and 14th, day, which is similar to the 10 day value in 
the study by Weir et al., from which the experimental setup for the present 
project was derived [290]. Given that crystallinity and molecular weight of VB-
PLA differ from that on the base ADT study, it would seem that mass loss was 
independent of these values, or has a very small effect in its onset. ADT 
studies in the literature have placed the onset of mass-loss at ~ 60 days at 50 
ºC, and at about 10 days at 70 ºC for PLA with a Mw around 400 kg/mol and a 
starting crystallinity of 47-57% [290]. Others have reported much faster rates, 




PLA, with an initial crystallinity of around 9% – though with no estimate for Mw 
reported, with crystallinity reaching about 59% after 6 days in ADT at 75 ºC 
[361]. This further strengthens the hypothesis of acetone’s degradation 
mechanism being comparable to that of water (or PBS), with susceptibility of 
lactides – and other ester-linked polymers – to degradation being strongly tied 
to crystallinity.  
Apart from changes to the crystalline content proportion of the polymer during 
FFF, another factor at play affecting mass-loss on the samples could be the 
aforementioned fill pattern of the printer. This pattern is implemented as part 
the process’s emphasis on recreating the outer surface of the models 
reproduced. For each layer on the layout of the printing code generated by the 
software, the material in the outline is laid out first, then joined in by a repeating 
pattern that turns that outline into an actual surface that can support the layer 
above it, while fusing it to the previous one (Figure 6.1) [370]. This workflow 
lowers the apparent density of the sample, increasing its surface area 
available for medium infiltration and degradation. 
6.2.2. CRYSTALLINITY 
The results showcased in Figure 5.3 suggested that FFF readily lowers the 
crystallinity of the inputted filament. Similar results have been reported upon 
extrusion of PLLA [49]. The ~10% crystallinity difference between both of the 
starting materials was already big enough to be evident macroscopically: the 
VB-PLA filament is prone to breaking when being loaded into the printer. 




This could be explained by increased crystallinity, which has been reported to 
increase brittleness after processes applied to produce functional PLA [371]. 
Polymer-chain migration is another mechanism of weakening of the polymer 
matrix could happen during processing into FFF filaments and subsequent 
FFF. These migration occurrences will happen when the polymer is heated 
beyond its glass-transition temperature, and will add up and introduce 
molecular-scale voids all over the geometry. Within these voids, there is no 
material contributing to the mechanical integrity of the polymer matrix, 
concentrating stresses on surrounding zones [365], which then can evolve into 
crazes and cracks. It is thus worth pointing out that both polymers were found 
to be largely amorphous (~70-80% by weight), since the filament presentation 
benefits from a les brittle behaviour. These data can prove relevant when 
investigating in-house fabrication of FFF filaments, since achieving similar 
crystallinity will likely be desirable. 
The agreed-upon explanation in the literature for the sudden rise in crystallinity 
(as that observed in Figure 5.3) considers that amorphous regions are 
affected first by the degrading medium [372]. Under these experimental 
conditions it can be assumed that most of the lost mass was lost from those 
amorphous regions, very likely near the surface of the specimen during the 
initial stages of degradation. In mass-loss data from Section 5.2.1, the first 
period mass-loss was already nearing 5%. Each sample for DTA included 
roughly equal amounts of material from all 3DP layers taken from a corner of 
the geometry (in the shape of a triangular prism). It follows that most of it must 
have had started degrading by the first time period, as infiltration would have 




of the material was relatively near the surface, the average crystallinity of all 
the printed layers – including the mostly-unaffected inner ones – would be the 
value reflected on those elevated DTA measurements (because the outermost 
layers would have lost amorphous mass). Similar studies have noted a similar 
final drop in crystallinity, when it is thought that the remaining crystalline matrix 
would be starting to degrade [290,322,361,372]. The reduction on crystallite 
size and a wide mixture of polymer chain sizes could then account for the 
apparent drop in crystallinity. 
6.2.3. THERMAL ANALYSIS 
Data from Differential Thermal Analysis (DTA) brings forward further evidence 
for the role of crystallinity on in vitro degradation of 3D-printed PLA. Though 
there were only slight differences between the measurements for the filament 
and the post-3DP polymer, some of these were illustrative of what crystallinity 
and degradation data have suggested on the previous sections. These 
differences show clear deviations from the behaviour of the baseline filament, 
and then from 3DP material as degradation ensues. These changes and the 
loss of the crystallisation peak originally observed in the filament and 3DP 
parts were consistent with other ADT and RSET studies [284,290,361]. The 
probable explanations involve extended degradation of the amorphous phase 
of the polymer, as well as the sample’s surface-volume ratio increasing after 
degradation. 
In principle, both of those ideas could apply to FFF polymers in general. As 
mentioned before, samples taken from the edges of a specimen preferably 




opposed to material that was mostly infiltrated through the concentration 
gradient formed with neighbouring polymer – which should happen more 
slowly. Unfortunately, DTA allows only for a very small mass of sample to be 
tested at a time, making it extremely hard to devise a sampling policy that 
doesn’t somehow favour internal or superficial portions of the specimen. The 
sampling criteria used for these experiments – including material from all 
layers of the model – further limits the options available. Notwithstanding, this 
sampling policy is strongly supported by the evidence so far put forward by 
this research regarding the distinct behaviour of FFF structures: taking in 
account every layer of the model is very likely instrumental to understand their 
behaviour. Moreover, a similar bias was probably unavoidable when 
degrading bulk samples, as opposed to thin films or filaments, since it has 
been pointed out that limited infiltration rates will tend to impede uniform 
degradation on three-dimensional structures. Even though the size of the 
samples in this research would make them susceptible to bulk degradation, 
the time it takes to fully start will depend on the infiltration rate to the whole 
geometry [322,360]. 
For ADT specimens, DTA curves displayed moderately pronounced effects, 
with the most prominent one being the enlargement of the fusion peak. This 
reflected the gradual increase in crystallinity on the samples as degradation 
progressed. Notably, no crystallisation peaks or glass transitions were 
detectable on these specimens at any point during the experiment. This could 
be partly because all crystallisable amorphous material was beginning to be 
degraded. The lowering of the melting temperature was probably caused by 




6.2.4. MECHANICAL PROPERTIES AND VISUAL INSPECTION 
ADT tests did not provide any data for mechanical properties due to excessive 
brittleness of the material found through all of the degradation time periods. 
This quick deterioration on mechanical properties is not reported in the 
literature for non-3D-printed specimens [49,361]. It is likely that this 
phenomenon is unique to FFF structures, since mechanical integrity of mADT 
specimens was noticeably compromised from very early stages of 
degradation. The underlying mechanism of this susceptibility is likely linked to 
the FFF process in that fusion between layers is non-uniform and heavily 
dependent on the tessellation algorithm and how each layer is deposited. 
Layer surface roughness variations, random cooling rates and gradients, and 
heterogeneity of the deposited polymer have been proposed as causes for this 
so-called “opening” failure mode of FFF prints, in which the layers become 
unfused [297]. Layer-layer interface, must then be more weakly bonded, and 
would be exposed to a higher degradation rate. 
All in vivo and in vitro degradation studies reviewed as part of the present work 
use a standard manufacturing process different from 3DP – usually casting, 
extruding, or machining –, and not all of them employ standard tensile 
specimens. Some used rods, and some finished devices like bone-fixation 
plates and screws [126,282,285,373]. Direct comparison must be made with 
caution, as values for UTS and E are higher in the literature, in the order of 
several GPa. Those on the present study were in a range of tens of MPa for 
UTS, and under 500 MPa for E. It is noteworthy that PLA used in the literature 




g/mol, with both of the brands used on the present research averaging around 
100,000 g/Mol. 
 
6.2.5. ACCELERATED DISSOLUTION TEST 
The results collected from mADT experiments, shown in Figure 5.9, display 
an exponential-like decay, which suggests they can be used to extrapolate 
these degradation data with those of similar experiments in the literature 
[283,290]. Water is able to infiltrate polymer networks despite its high polarity 
and being hindered by hydrogen-bonding with itself [137,366], though that 
likely accounts for its long degradation periods when compared acetone. 
Acetone, being a non-protic solvent, acts more aggressively as it is freely 
available to invade the polymer’s structure to interact with its innermost 
molecules, where a greater surface area due to microporosity further enables 
the reaction [374]. This is likely why PLA is readily soluble in acetone, and the 
temperature at 37 ºC simply facilitates the process [137]. 
Acetone acts readily on the intermolecular interactions between polymer 
chains, which are already weakest at the layer-layer interface. Acetone, non-
polar solvent, so it stands to reason that larger polymer chains will be acetone-
soluble than those that dissolve in water  [2]. The structural failure pattern 
described Figure 5.12 and Figure 5.13 differs from those reported in 
published experiments on aqueously-degraded PLA to this date 
[290,329,361,375,376]. It is evident from Figure 5.9 that VB-PLA dissolves 




after 48 hours, where BFB-PLA has clearly lost over 10% of its initial mass. 
The plateau section for VB-PLA was characteristic of the first stages of ADT 
[290,361], and should persist until the material’s tipping point [361], after which 
net mass loss would be observable. Additional time periods over 48 hours 
would be necessary for to map its profile after mass-loss ensues. It is worth 
noting other ADT studies [290,314,322,361] comment on this initial mass 
increase due to medium uptake by the specimen, but do not report this trend. 
This is likely due to their sampling times being evenly spaced over long-term 
studies, therefore masking these initial features. To this author’s knowledge, 
this kind of model for the initial medium uptake of PLA specimens has not been 
described elsewhere – although it can be inferred from related applications of 
polymeric adsorption resins and their kinetics [377,378]. 
The mass increase for VB-PLA as shown in Figure 5.10 was unexpected after 
the oven drying cycle, considering the high volatility of acetone. This increase 
can be partly attributed to some solvent irreversibly adsorbing to the 
microscopic surface features of the specimen, which, albeit small, would – 
incidentally – also yield an exponential trend that depends on medium 
concentration, material, temperature, pH, and the time allowed for the reaction 
[374,377,378]. An exponential fit was indeed strong for both data-sets. In the 
case of the wet samples, the additional mass (around 4% at its highest) can 
be explained by the superposition of both phenomena: the medium’s infiltration 
into the polymer matrix, and its irreversible sorption to its surface. The latter 
phenomenon, in turn, would be responsible for the dry-mass curve in Figure 
5.10. Both quantities grow as the infiltrating medium reaches the internal 




liquid to distribute to, and a larger surface is accessible for sorption, as has 
been described for microporous polymers [374]. The presence of these two 
mechanisms can be further supported by the fact that the time constants for 
both curves differ in that the dry-mass one was slower (35.4 minutes) than the 
wet-mass one (27.6 minutes), which was expected since infiltration must 
causally precede sorption, and permanent bonding should have a lower 
chance of occurring [377], with transitorily-adsorbed molecules eluting and 
volatilising during oven drying.  
These comparisons, in summary, describe how typical sorption phenomena 
could interfere with mADT. The ~1% mass increase found for the dry samples 
was similar to that reported for water infiltration in ADT [322,361]. This was 
quickly overpowered by the subsequent mass-loss stage (as the BFB-PLA 
curve on Figure 5.9 readily exemplifies) and its effect in measured mass 
should be minimal.  
The results compiled by Figure 5.14 put the structural failure times for BFB-
PLA at 1.5 hours and at over 2 hours for VB-PLA, making them unsuitable for 
tensile testing after that time period. If not for this fact, in vitro degradation 
could probably be more accurately tracked through mechanical properties 
given their strong exponential tendency. This would not be unreasonable, 
given that mechanical properties are somewhat of a superposition of the 
chemical, crystalline, and intermolecular arrangement of polymers. It must be 
noted that these specimens were not constrained within their vial during 
testing, so mechanical loading was limited to the effects of gravity, medium 




being fixed – as when implanted for bone-reconstruction purposes – would 
include two additional sources of stress: that due to play between fixation sites, 
and that due to material deformation during the course of degradation. For 
degradation tests evaluating mechanical properties, tensile specimens are 
often preferred as mechanical properties are usually severely affected by 
degradation [126,312]. Mechanical properties are also one of the main 
concerns in most prosthesis-design applications involving plastics [137,253]. 
It was evident that BFB-PLA is extremely sensitive to acetone, just as it was 
noticeable that degradation takes place preferably in the interfaces between 
layers of the sliced model of the prints, forming longitudinal gaps as seen in 
Figure 5.12. The surface of each layer, in contrast, appears to experience its 
isolated degradation, with most of the early damage brought on by 
deformation. This deformation eventually leads to failure of the central shaft of 
the specimen (after what could be considered its dismantling point), while the 
individual layers gradually lose bonding with each other, especially near the 
perimeter of the model. This is similar to the delamination phenomenon 
described at the surface interface of other composites [108], which suggests 
intermolecular interactions at these sites are weaker. 
The cracks on the traction plates of specimens in the later stages of the 
experiments (6, 24, and 48 hours) would appear to be the result of the layer 
weakening beyond the stress induced by its own deformation. This eventually 
caused severe bending of the structure before degradation could begin to 
separate the layers, instead bringing them closer together – and fusing them 




the geometry curled around its transversal axis. Notably, layer fragments did 
not appear to detach completely until the 48 hour mark was reached, after the 
specimen had lost roughly 10% of its mass, and after its crystallinity values 
were undergoing a second drop, reflecting the degradation of their high-
crystalline matrix. This will very likely reduce the dismantling time of implanted 
FFF devices, since severe deformation is not reported in other degradation 
studies. The additional mechanical stress will necessarily add up to the 
implantation-related loads experienced by any device, which themselves have 
been reported to degrade – both chemically and mechanically – at a much 
faster rate than what in vitro tests suggest [312,373,379]. 
In contrast, as evidenced by Figure 5.13, VB-PLA undergoes similar changes, 
but to different magnitudes. Structural deterioration becomes obvious by the 
end of the first day. It is relevant to notice that these specimens had not 
undergone measurable mass loss up to that point. Though unmeasurable due 
to deformation, their mechanical integrity was still good enough to allow 
handling without damaging them – unlike BFB-PLA specimens. The layers that 
had curled away from the main body of the structure may mean that a tendency 
to fuse could be characteristic of high-crystallinity PLA, and it becomes more 
evident with VB-PLA as its starting crystallinity value was comparably higher.  
Along with this, in the time periods up to 2 hours, crystallinity dropped down to 
average values of 38% for BFB-PLA and to 45% for VB-PLA. By the final time 
period, these values were 44% for BFB-PLA, and 29% for VB-PLA. The 24 




43% for VB-PLA – when much of the amorphous material was likely 
exhausted. A final decrease was observed at 48 hours. 
These differences, found in Figure 5.16 and Figure 5.5 for the mADT series 
of BFB-PLA, show clear deviations from the behaviour of the baseline filament, 
and then from 3DP material as degradation ensues. These changes and the 
loss of the crystallisation peak originally observed in the filament and 3DP 
parts were consistent with other ADT and RSET studies [284,290,361]. The 
probable explanations involve extended mass-loss from the amorphous phase 
of the polymer, as well as increased surface-volume ratio, leaving more 
sample exposed to the solvent. 
Changes shown in Figure 5.5 as a result of thermal treatment were evidently 
less dramatic for VB-PLA, which was reflected in a drop in crystallinity 
proportionally smaller decrement from 29% to 24%, when compared to BFB-
PLA dropping from 21% to 15% (Figure 5.3). Tg peaks for both filaments were 
found higher than for the material after 3DP: 59 ºC against 46 ºC for BFB-PLA, 
and 64 ºC against 55 ºC for VB-PLA. This change can be attributed to the drop 
in crystallinity itself.  
Similarly, the shift in the crystallisation peak on BFB-PLA (from 80 ºC to 87 ºC) 
could be due to the higher availability of amorphous material as a result of 
FFF, but as well due to the more uniform characteristics of such material as it 
is arranged into tighter filaments with more restricted chains during the process 
[2]. The former can be argued from the taller and sharper crystallisation peak. 
The higher crystallisation temperature could also be accounted for by the self-




crystallinity material into more stable aligned arrangements that enhance the 
thermal and mechanical properties of the matrix by favouring intermolecular 
interactions between polymer chains, effectively fixing them, therefore 
increasing the crystallisation temperature. Studies on self-reinforcing of PLA 








The compositing method developed for this research was designed to require 
the minimum possible specialised equipment and raw products. It was also 
expressly designed to avoid the use of any strong organic solvents, which 
would be relevant for certification of good manufacturing practices of a Class 
III medical device [381]. All treatments undertaken by the materials in this 
study were in the form of mechanical and thermal stress. 
6.5.1. ANNEALING 
The rise in average crystallinity values for BFB and VB after annealing (to 56% 
and 48% respectively), was concurrent with the drops in UTS and E, which 
would explain the more brittle tendencies of the specimens. This reflects the 
observed differences between BFB-PLA and VB-PLA filaments themselves. 
Annealing seemed to overall improve the reproducibility of the material in 
regards of at least the three aforementioned parameters. VB-PLA annealed 
(VB-ANN) might be the exception to this in terms of UTS, which could be due 
to the reduced flexibility making any deformity more significant during tensile 
testing, redirecting the intended longitudinal stress into a flexo-compressive 
load that would fracture the specimen more easily. This could account for the 
relatively high variability on UTS on the more brittle materials, which was on 
par with the variations experienced by the more plastic failure modes of non-
annealed specimens. 





Heightened crystallinity proved to also affect some aspects of the specimens’ 
resistance to degradation under mADT conditions, as evidenced by Figure 
5.19. For both materials, annealing had no significant effect on mass loss, but 
improved mechanical performance, even pushing the dismantling point of 
BFB-PLA beyond 2 hours. This suggests that failure of mechanical integrity 
was very strongly liked with crystalline content, as both annealed materials 
display around the same proportion by weight (56.92% for BFB-PLA, and 
48.58% for VB-PLA). Tensile strength and elastic modulus values were more 
preserved in both annealed materials as well. 
These changes were not only related to crystallinity, but must be intrinsically 
linked to the initial actual values for UTS and E, as has been noted [322]. While 
the way these properties were affected by degradation might be similar when 
normalised to their initial condition (as retention graphs were plotted), the initial 
values for UTS and E for the non-annealed specimens were more than 50% 
higher than those that undertook the thermal treatment (Figure 5.18). 
Reduced UTS and E are a reflection of how annealing modifies the polymer’s 
matrix to a higher crystallinity content, where polymer chains undergo 
extensive fixation due to an increased likelihood of intermolecular interactions 
between them [2]. They then end up more closely packed into larger 
crystallites that further restrict deformation, and ultimately resist degradation 
by slowing down the medium’s infiltration rate into the crystalline portions of 
the matrix [247,322,382].  
The initial surges shown in Figure 5.20 in the early stages of crystallinity plots 




likely due to the solvent preferably attacking the more accessible amorphous 
regions of the structure, but it seems pertinent to point out that this 
consideration alone would apply to the infiltration stages of dissolution. Since 
high-crystallinity lactides are inherently very resistant to degradation even in 
vivo [279,283,319,320], it is reasonable to assume that this fact would have 
the net effect exposing amorphous polymer to a higher apparent solvent 
concentration, since the crystalline portions are unavailable for interaction 
even as the whole of the geometry is being infiltrated. FFF specimens may 
have been more susceptible to this process since they were prone to be 
infiltrated by medium given their porosity (around 35% on the scale of the 
ASTM specimens), making the amorphous material readily available for 
degradation. Moreover, this mechanism would account for the exponential 
mass-loss trend for BFB-PLA. If the reaction is happening fast enough in the 
amorphous material so that infiltration time is negligible, and slow enough in 
the crystalline regions so that their contribution to degradation is also small. 
The result could be a Noyes-Whitney dissolution pattern, which is exponential 
and depends mostly on the solubility of the material [383]. If the phenomenon 
can be explained through this model, given equivalently sized and shaped 
samples, changes in solubility will be the man contributors to changes in 
dissolution rate. Similarly, given the same material with the same solubility, 
differences in geometry (reflected in differences in surface area) would be the 
main drivers on differences in dissolution rate. 
This mechanism would also explain the disappearance of crystallisation peaks 
from DTA curves during mADT (observed as well in other studies [290]), since 




surface of the specimen [322]. The remainder of the amorphous material, in 
turn, could be prevented from crystallising at the expected temperatures for 
PLA if it were trapped within the crystallites formed during processing, 
preventing it from interacting. It would also explain the mismatch between 
mass-loss and crystallinity, as logic would require the mass-loss to correlate 
more closely to crystallinity increases as the amorphous regions are 
exhausted. Finally, differences in molecular weight between BFB-PLA and VB-
PLA should account for the marked divergence in mass-loss behaviour 
between the materials, with the former exhibiting a lower value that favours 
solubility of early-degraded chains. Coupled with the low crystallinity value of 
BFB-PLA, these two factors and the mechanisms mentioned in this section 
would explain the sudden rise in crystallinity at the 0.5 hour period on the non-
annealed specimens, as there is less crystalline lattice providing protection for 
the amorphous polymer. 
While changes in failure mechanism were evident in mADT tests after 
annealing, these were not so in ADT. All samples became slightly distorted 
and extremely brittle as early as the first time period studied (1 day). The only 
2 testable samples allowed for an estimated drop in tensile strength of over 
90% within the first 24 hours of the test. Mass loss, fusion temperature, and 
overall calorimetric values did not show major changes by that point. 
Crystallinity experienced the surge also found during mADT, so that increase 
in the crystalline content of the specimens would appear to be the main factor 
governing structural brittleness in FFF parts. The tendency of layer-layer 
interfaces to fail first during degradation might account for this phenomenon, 




opposed to simple erosion) of every layer. Crystallinity throughout the whole 
structure would then be increased, and each individual layer would then be 
more brittle on its own, diminishing the deformability of the geometry. These 
phenomena were apparently independent of starting crystallinity, since the 
higher starting value for annealed specimens yielded a very similar maximum 
to that of the non-annealed. Should this hypothesis be true, it further supports 
the idea that some of the amorphous phase is locked within the crystalline 
matrix, away from the degradation medium but unable to crystallise. The rest 
of the amorphous material would then be quickly washed away during 
degradation, which would also explain the disappearance of crystallisation 
peaks where present on the undegraded specimens. 
 
6.5.2. PLA-HA COMPOSITE FILAMENT PRODUCTION AND 
CHARACTERISATION 
One of the main objectives of this research was to produce a PLA-HA 
composite filament that could be 3D-printed through FFF. To this author’s 
knowledge, only two publications prior to this work were found to have reported 
on producing such a material specifically for FFF [264,265]. Notwithstanding, 
composite 3D-printing filaments are commercially available for general 
applications – being modified with added pigments, fluorescent compounds, 
wood particles, metal particles, or plasticisers, in order to modify their 




The method presented in this work proved to be sufficient to produce 3D-
printing filament and 3D-printing parts on a PLA-HA composite using only 
commercial-grade equipment. As the two studies mentioned also report, a 
lower concentration of HA is probably desirable [264,265]. The 20% HA 
composite proved to be problematic to work under the scheme proposed in 
this research. During extrusion into filament, this mixture of composite 
softened excessively, making it remarkably difficult to pull into a consistent 
filament. This causes imperfections on the surface of the resulting filament, 
along with noticeable inconsistencies in its diameter. In turn, these 
imprecisions limit the capacity for the 3D-printer to produce consistent prints, 
and eventually results in either fracture of the filament, or clogging of the 
printer’s extruder within minutes. Accumulation of HA in the nozzle’s channel 
appears to be to blame for this clogging, as residues were found during 
cleaning. The 5% and 10% composites suffer from these problems less 
drastically in regards of filament extrusion, though printer blockage did occur 
within few hours of using these filaments.  
The higher concentration of HA in the 20% composite might promote powder 
agglomeration during the initial melting procedure of compositing. These 
agglomerates might consolidate further under the pressure of the driving screw 
during extrusion, which could potentially produce 250 MPa – this pressure has 
been found to result in cold isostatic pressing of the HA [384]. Grinding the 
PLA pellets further or using a solvent to homogenize the mixture might be a 
solution for this issue. However, the Filabot extruder requires the polymer 
pellets to be big enough for the driving screw; small enough pellet sizes (likely 




solvents to improve mixing could be a solution, but poses several biological 
safety issues, as it is difficult to provide evidence that all of it evaporates during 
extrusion and printing. The composite being meant for resorbable implants, 
any remaining solvents are guaranteed to leach into extracellular space. The 
production method proposed in this study was designed to avoid these issues 
with use of solvents. Moreover, the amount of solvent required to process 
hundreds of grams of PLA would pose a logistic and economic problem, 
especially in regards of safe disposal. 
Content of HA crystals within the polymer matrix, found through DTA/TGA to 
be on average 6.97% for the composite filament and 6.82% for 3D-printed 
parts, was shown to be well distributed by SEM-EDS. All DTA, SEM-EDS, and 
µCT testing suggest that the method was reliable, reproducible, and capable 
of achieving final products with a uniform distribution of HA within a PLA 
matrix. This is of great interest for bioresorbable devices, since it means that 
the intended effect of PLA – which is a surface functionalisation in practical 
terms – will be likely sustained throughout the breakdown of the material. It 
must be mentioned that sample preparation for SEM-EDS (namely cutting and 
polishing) could have forced HA crystals off the polymer matrix: this could 
account for the areas with fainter distribution of Ca and P found in the pre-
extrusion composite, as well as for the larger particulates observed in µCT. 
Nevertheless, the fact that both the composite filament and the 3D-printed 
composite parts had a more homogeneous distribution of these elements was 
evidence that HA crystals were redistributed and mixed during the extrusion 




The traces of calcium and phosphorus atoms detected by EDS on the pure 
PLA filament sample could likely be accounted for by contamination due to the 
environment where the samples were processed. This laboratory is home to a 
number of machining equipment for dental and bone-repair materials, and the 
printer is not isolated in any way from airborne particulate contaminants – 
including those released by HA-containing samples which were routinely 
handled near it for this work. Additionally, it is impossible to guarantee that the 
extruder-head of the 3D printer is completely free of leftover HA from previous 
prints using composite, even after purging it with pure PLA. This was further 
supported by the clear differences on distinct phosphorus and calcium peaks 
in the EDS spectra of the composites: none could be detected on pure PLA. 
Similarly, despite sanding and polishing, it is extremely difficult to make the 
surface of the samples completely flat due to their size and PLA’s inherent 
malleability. Because of this, SEM showed several zones presenting a charge 
effect that could interfere with EDS measurements. These zones were either 
at different distances from the detector, or at steep angles from the levelled 
reference. Visualisation of surface charge artefacts in these zones suggest 
that their variations go beyond the device’s absorption correction [385,386]. 
To compensate for this, areas scanned for EDS were selected to be as even 
as the sample provided, though there was still room for errors from this effect. 
It was an initial concern that only melting the polymer mixed with HA would not 
be enough to achieve an even distribution of HA throughout its entire volume. 
However, the filament extruder seems to provide enough homogenisation 
through the combination of thermal softening of the initial composite, and of 




expected during the whole compositing process, it was not anticipated that 
most of it appeared to happen at the initial mixing and melting stage. Moreover, 
this HA loss with respect to the original formulation is likely to be tailorable – 
either through simple linear relationship or through trial-and-error – so that the 
desired concentration of HA can be tuned for the output filament and 3D-
printed parts. This fact could be also of relevance for the production of long-
term drug-delivery devices [45,322] – given sufficiently heat-resistant drugs. 
Overall, the methods described in this work could be applied to produce and 
characterise other 3D-printable polymer-ceramic composites. 
 
The test mesh presented on Section 5.4 takes in account adult average 
measurements [343,344], so most alveolar clefts will fit within its volume of 
about 11x15x22 mm. This was very near the edge of dimensions reliably 
managed by the BFB-3000, especially if fine details are required. An 
advantage of designing under this printer’s limitations would be that any more 
modern printer would be able to reproduce the results with similar or better 
accuracy. Building up from stacks of small modules will very likely turn 
impractical in routine design of geometries based on medical imaging studies, 
unless software is developed for this purpose using procedural-generation 
algorithms – such endeavour lies beyond the scope of this research. Rather 
than that, it is more convenient to work backwards from a base 3D lattice, 
cutting it down to the desired shape as acquired from imaging files, as this 
would be achievable in virtually any computer assisted design (CAD) software. 




The designed lattice sample was printed near the 2 mm limit of the printer, 
which prevents the STL build from including fill patterns. This likely helped to 
maintain uniformity in the material. With this lattice acting as the inner structure 
of an implant, its surface area became about eight times greater than that of a 
solid implant of similar dimensions. The 2 mm openings within it, as well, make 
it suitable both for bone formation, and for revascularisation to take hold, in 
accordance to current literature [6,37,273,369]. 
The irregular edges, borders and outer surfaces of the lattice, however, were 
considered to make it difficult to devise a fixing procedure for implantation, and 
would leave sharp borders exposed to surrounding tissue. It was therefore 
considered necessary to enclose the mesh within a more geometric frame. 
The desired shape used represents the maximum limits that can be normally 
expected to conform an alveolar cleft (11x15x22 mm). This desired shape was 
meant to be replaced by the negative space formed by a cleft – or another 
facial bone defect – as presented by a CT scan. This lattice also corresponded 
to the 3D-cell culture samples tested (sections 4.5 and 5.5). 
6.5.1. 3D-PRINTED PLA STERILISATION 
These sterilisation comparison experiments were planned as a preventive 
measure due to repeated infections – suspecting the culprit was the unsterile 
state of the 3D-printed cellwork discs. Although the source of the infection 
turned out to be external to the samples used in this research, the evaluation 




of these methods provided some valuable information for future cell-culture 
work on 3D-printed polymers. 
Under the conditions tested in these trials, ethaneperoxoic acid (commonly 
known as peracetic acid) hampered cell growth following its use for surface 
sterilisation. Though further testing would be necessary, it is likely that more 
washing cycles with PBS are necessary for it to elute completely from the 
micro-scale porosity of the 3D-printed disc samples. The mechanism might be 
similar to that of adsorption of acetone to PLA, given the similarities of their 
molecular structure and size [137,247,294]. Additionally, under these 
experimental conditions, both ethanol and propan-2-ol (isopropanol) 
functioned statistically equivalent in regards of cellular proliferation and 
calcium and collagen deposition (p<0.05). 
6.6.1. MASS CHANGE 
The PLA-10%HA composite followed relatively closely the expected 
degradation pattern found for VB-PLA in the ADT experiments presented here. 
These were consistent with the literature [283,290]. The very early onset of 
mass loss for the composite (around day 3) when compared to VB-PLA results 
(around day 9) was indicative of the detrimental effects the compositing 
procedure has in the macromolecular integrity of the polymer matrix. These 
were likely to further accentuate weakening caused by FFF after compositing, 
as discussed in Section 6.2.1. Moreover, by the end of the experiment – in 
day 23 –, the composite was further along its mass-loss process, having 




degraded 28.07% of its starting mass: significantly more than the 21.02% 
found for VB-PLA. 
This discrepancy very likely reflected the weakening of intermolecular 
interactions caused by HA crystals lodged between main polymer chains. If 
this was the case, these voids could expose bonds in monomer-linking ester 
sites to be broken down by degradation medium. These sites would leave 
behind either hydroxyl or carboxylic-acid end groups, which would interact 
through weaker hydrogen bonds or Van der Waals forces. Weakened bonding 
between shorter polymer chains would eventually allow for increased chain 
mo1ebility, and even faster water infiltration of the samples’ inner geometry 
[2,294,374]. This sequence of conditions could be attributed to the differences 
observed in number average molecular weight for pure VB-PLA (51,715 g/mol) 
and the 10%HA composite (40,420 g/mol) at the start of their respective ADT 
runs. 
6.6.2. CRYSTALLINITY, MECHANICAL, AND THERMAL PROPERTIES 
ADT experiments on the PLA-10%HA composite found a tipping point for 
mass-loss of the samples before day 3 of degradation, well below the 9 days 
recorded for VB-PLA. At their respective tipping points, average crystallinity 
had increased by 55% for VB-PLA, and 34% for the composite. In both cases, 
this increase corresponds to ~0.95 times their final plateau values for 
crystallinity in the experiment – 87% for VB-PLA and 60% for the composite at 
day 23. Though further testing would be required, if this tendency holds for 




tests to indirectly determine their tipping points through calorimetric 
crystallinity measurements. 
There was an apparent discrepancy in the results shown in Sections 5.2 and 
5.7. Crystallinity surges to maximum levels before the tipping point in all 
degradation experiments conducted in this research. Though a rise in 
crystallinity was to be expected, the accepted theory is that this is due to loss 
of amorphous mass [187,220,263,272]. This inconsistency can be observed 
in data of at least one other similar degradation study in lactide polymers [290]. 
It is suggested that this could be due to the effect of the degradation medium 
acting as a solvent, which could lower glass transition temperatures of 
polymers, as the literature reports [387,388]. Along with the temperature of 70 
°C of the experiment, this could potentially imply overall increased mean chain 
motility, and a lowering of the crystallisation energy barrier, prompting the 
amorphous mass to crystallise during the initial phases of degradation – this 
conjecture would require further experimentation. 
The results, shown in Figure 5.51, provided additional evidence that thermal 
stress due to the compositing process, filament extrusion, and FFF may lower 
the crystallinity of the raw PLA filament used. Other studies report similar 
effects on crystallinity from thermally-intensive treatments [49,371]. VB-PLA 
reached an average of 28.55% crystallinity after 3D-printing, while the 10%HA 
composite drops to 22.67%. at that same stage. Results from mADT showed 
that BFB-PLA and VB-PLA respond similarly to acetone degradation in terms 
of crystallinity change at all but the last stages of those experiments (Figure 




BFB-PLA crystallinity behaviour might be similar during ADT. Should that be 
the case, it would be reasonable to expect a similar general behaviour from 
other 3D-printed PLA – in terms of reaching peak crystallinity values around 
80% early during degradation tests (and prior to significant deterioration of 
these). Semi-crystalline polymers are not expected to achieve values much 
higher than 80% crystallinity [291] [389], so it would follow that PLA samples 
would reach values on that range as their amorphous phase degrades. 
Since this was not the case for the PLA-10%HA composite (maxing out at 
60.78% crystallinity), it is feasible that the strong capacity for hydrogen 
bonding of HA is to blame for negatively impacting crystallisation. The 
mechanism would be by interfering with chain alignment and fixation [390]. 
This disruption could potentially be through increasing inter-lamellar distance 
in the crystals through HA particles getting lodged between them. The fact that 
crystallinity drops on the composite – and that measurements never go up to 
80% as expected – suggests this role for HA, rather than it acting as a 
nucleation agent (since most such agents would be expected to be nano-scale 
and this HA was over 3 µm in particle size). Further testing would be required 
to determine if thermal stress during compositing process, the addition of HA, 
or both were responsible for crystallinity deterioration on the composite. 
This constellation of factors could also explain the composite’s significant drop 
in tensile strength reported in Figure 5.49 and Section 5.6.3. Since annealing 
showed a similar tendency to weaken 3D-printed tensile bars, similar 




strength – in line with what has been previously suggested in the literature 
[371]. 
Composite tensile bars showed a significant drop in elasticity (Figure 5.51) 
not found in annealed specimens, thus crystallinity could not be the only factor 
affecting the composite’s mechanical behaviour. Since molecular weight was 
found to remain largely unaffected, the presence of HA must play an important 
role in regards to elasticity. It is proposed, thus, that HA particles disrupt 
intermolecular interactions between PLA polymer chains, and since the 
compositing and 3DP processes do not provide suitable temperatures for 
these particles to consolidate, weaker HA-HA interactions embedded in the 
amorphous polymer matrix may have caused this observed drop in elastic 
modulus. In summary, thermally-induced chain migration, coupled with the 
presence of embedded HA particles (which were likely far beyond nano-scale), 
could facilitate micro-fracture formation and stress-concentration around these 
particles and voids due to their presence, and could account for mechanical 
deterioration on polymers [365]. 
6.6.3. THERMAL PROPERTIES 
Thermal degradation behaviour under TGA measurements was markedly 
different for the PLA-10%HA composite when compared to VB-PLA. Although 
their melting points started ADT without significant differences, by the third day 
both curves drifted significantly from each other. The 10%HA composite 
showed a faster decrease in melting temperature, ending the experiment at an 




9.4% for the VB-PLA, and 17.2% for the composite by the end of the 
experiment (Figure 5.55). 
The lowering of melting peaks for the composite after 3D-printing was likely 
due to repeated thermal treatments during processing lowering the molecular 
weight of the polymer matrix (Figure 5.49). The resulting upward shift in the 
DTA curves (Figure 5.54) could be the result of intermolecular interactions 
with hydroxyl moieties provided by the presence of HA [390], which could 
potentially facilitate hydrogen bonding to account for the heightened heat 
capacity at the compositing stages before 3D-printing. Notably, for the sample 
masses used in DTA/TGA measurements done here, sample mass did not 
influence heat-flow offset, as would be expected – at this scale, the dominant 
property is likely surface area. Furthermore, the self-reinforcing phenomenon 
[292] could also be a potential explanation for the second shift happening after 
3D-printing, since polymer-chain alignment could further favour intermolecular 
interactions with HA particles, and likely strengthen them through reorientation 
into more favourable bonding angles on a more tightly packed matrix, 
dampening thermal motion.  
If this is the case, addition of HA would require extensive fine-tuning of printer 
settings in order to fully optimise a lower-temperature FFF procedure. This 
effect would be naturally limited by the concentration of HA in the composite, 
which this study found to be difficult to get over 20% due to manufacturing 
problems encountered while doing so (Section 5.6.1). By modifying the 3D-
printing process’ settings and further fine-tuning the equipment, it might even 
be possible to utilise concentrations of HA – or ceramics in general – beyond 




to what the present results suggest, it has been shown that PLA composite 
concentrations of up to 70% HA by weight are achievable through hot-
pressing, reporting even improvements in mechanical properties [136]. 
 
6.5.2. MG-63 CELL VIABILITY STUDY 
The first cell viability experiments for this project – done in expansion medium 
– provided evidence that the MG-63 cell line was not able to synthesise 
mineral on pure PLA without the addition of ascorbic acid and β-
glycerolphosphate. This was expected, since the supplements provide a 
phosphate source for such mineral formation in both traditional and 3D cell 
culture [345,391–393]. In the second batch of experiments, osteogenic 
medium did promote deposition of detectable levels of calcium and collagen. 
With those results as a baseline, it was expected that the addition of HA to the 
polymer would further promote the production of mineralised extracellular 
matrix as an osteoinductor, as variations of HA and other calcium phosphates 
have been found to do [250,302–307]. Nevertheless, viability and matrix-
deposition experiments for the composites generated for this study showed 
only a marginal increase in collagen production, which was apparently linked 
to concentration of HA in the composite. Despite this, the PLA-20%HA 
composite was found to be harder to process for filament production and 
subsequent 3D-printing. The remaining two composite concentrations (PLA-
5%HA and PLA-10%HA) displayed no further differences in cellular response. 
The PLA-10%HA composite, thus, was favoured for the rest of the study, since 




osteoinductive action – with minimal decline in the processability of the 
material. 
Since the cellular response was otherwise equivalent between EM and SM 
experiments, and between PLA and the PLA-HA composites, it is safe to 
assume that this PLA itself is biologically inert for the most part, and that 
compositing and 3D-printing are probably safe for implantable device 
manufacture. Biological and chemical degradation of PLA produce no by-
products other than lactic acid. This compound is anaerobically metabolized 
in vivo – via the Cori cycle –, and is only known to cause inflammatory 
responses when given the chance to accumulate [394,395]. In vitro, additional 
mechanisms to cope with lactic acid leachate form the samples are likely 
similar to vascular drainage. As well, osteosarcoma cells, such as the MG-63 
cell-line, are known to express MCT-1 membrane receptors, which facilitate 
lactic acid uptake [396]. This suggests that cells in tissue culture wells on these 
experiments might have played a role in disposal of excess lactic acid through 
their own metabolism. Additionally, EM changes and well washes during RRA 
limited the possibility for an unmanageable build-up of this by-product.  
Moreover, one of the main findings derived from these experiments was the 
evidence that MG-63 cells respond similarly to 3D-printed commercial-grade 
PLA as they do to tissue culture plastic in terms of cell viability; the same was 
true for the PLA-10%HA composite. Though the biocompatibility of PLA has 
been widely tested – to this author’s knowledge – the data provided by this 
study is the first evidence produced specifically for 3D-printed specimens 
made of PLA and PLA-HA composites. It must be noted that there are studies 




printed through methods different to FFF [45,397–400]. One study provides 
similar data for in vitro biocompatibility using bovine primary articular 
chondrocytes and nucleus pulposus cells in PLA FFF scaffolds [138]. Their 
findings are like those of the present study in that cell proliferation did not seem 
to be limited by the material. Complementing these results with replicate 
experiments, ex vivo setups, and trials on different cell-lines would enhance 
our understanding of the in vitro behaviour of 3D-printed PLA. Trials on non-
cancerous cells (such as primary bone cells or stem cells) could potentially 
evidence factors unfavourable for cell survival that are not evident on MG-63 
cells, since the latter are known to be more resilient given their cancerous 
phenotype. Notwithstanding, given how well-studied are lactide polymers, this 
author considers unlikely that the outcome of further biocompatibility tests will 
be any different. Further testing on different HA concentrations for the 
composite, however, would provide a clearer notion of its effects on 
osteoinduction in 3D-printed parts, and would help narrow down an ideal 
concentration for compositing. Similarly, mineral-substituted versions of HA – 
such as those with strontium, silicate, magnesium oxide, carbonate or bismuth 
[401–405] – could be relevant to the manufacturing process described in this 
project. A caveat in this respect stems from the unsuccessful attempt at 
compositing nano-scale HA in the present project: it could be the case that 






6.5.3. IN-VITRO CELL CULTURE IN THREE-DIMENSIONAL 3D-PRINTED 
STRUCTURES 
Since applying a functionalised 3D-printing composite filament in a bone-
regeneration setting will necessarily require the production of 3D-geometries, 
it was of the outmost importance to explore cell behaviour when confronted 
with that specific scenario. Since the meshing procedure detailed in Section 
4.4.1 proved to be adequate to process 3D shapes into stacks of mesh units, 
one of these units was chosen to be tested in this part of the study.  
The 3D-mesh model provided a surface area roughly 10 times higher than one 
face of the disc samples used for cell culture in this study (Section 4.5) – 8.55 
cm2 against 0.78 cm2. By design, this increment was meant to compensate for 
the intrinsic difficulty of cell-seeding against gravity in the thin columns of the 
mesh. The significantly lower cell attachment observed for the PLA-5%HA 
composite with respect to pure PLA might be due to inconsistent results in 
seeding rather than some effect of the material itself. This notion was further 
supported by the fact that there were no significant differences between the 
PLA-10%HA composite and either of the other materials. 
Overall, all three materials elicited an equivalent response from the MG-63 
cell-line throughout the 21-day cell viability experiments. In contrast, SRS and 
ARS testing showed that both composites perform significantly better than 
pure PLA in the induction of extracellular matrix excretion and mineralisation 
– as suggested from detectable levels of collagen and calcium. These results 
were further evidence that functionalisation of 3D-printed parts with ceramics 




From these results, it is suggested that HA crystals in the polymer matrix’s 
surface were inducing a strong enough cellular signalling for mineralisation, 
even with the HA used in this research being micro-scale rather than the 
preferred nano-scale, which is thought to be more biomimetic [306,307]. In 
turn, this would also be favoured by the presence of ascorbic acid and β-
glycerophosphate in the medium, which provide co-factors and a phosphate 
source for the cells [348,349]. 
When comparing between the results obtained with the disc samples and the 
3D-meshes, it is noteworthy that the change in distribution of cells from one to 
the other has a noticeable effect in calcium deposition per number of cells. 
This was not true for collagen deposition per number of cells, which maintained 
a similar level in both experimental setups. This could be due to the cells being 
spread over a larger area, with paracrine signalling weakening as a result. It 
is to be noted that, for higher cell densities, a positive effect of cell-density on 
OM-assisted-bone-regeneration parameters has been reported for polymeric 
tissue-engineering scaffolds [350]. 
 
 
6.7.1. MODELLING FOR MOLECULAR WEIGHT BEFORE MASS-LOSS 
Though at first instance the data for PLA and the PLA-10%HA composite did 
not appear to originate from the same physico-chemical processes, given fixed 





experimental conditions and temperature, it is possible to use the model in 
Equation 5.4 to approximately estimate the behaviour of even a distantly 
related material such as that of the Weir et al. data used for comparison in this 
study. The extrinsic differences between the three materials (molecular 
weight, crystallinity, geometry, mass, and all such experiment-specific 
variations) are likely accountable for the relatively low correlation coefficient 
(R2 = 0.8324) obtained analysing the Weir et al. dataset. Additionally, the 
published data by Weir et al. provides only averages and not individual data-
points for Mn: the dispersion could drive correlation via non-linear regression 
either way. However, using the parameters calculated by that study, it was 
impossible to account for the behaviour of the PLA and PLA-10%HA 
composites used for the present research, unless the results are normalised 
to Mn0  (Figure 5.60).  
In the region before tp, it is very likely that the lack of additional data points for 
the materials studied in this research affected the outcome of any regression 
analysis. The experimental design used in this project was based on the Weir 
et al study, which used PLA of much higher molecular weight (and therefore a 
slower degradation process). As such, time points were not ideal for the 
degradation rates of materials studied here. From what is observed in the 
literature and the present research, for ADT at 70 ºC, additional measurement 
points before day 15 can be safely assumed to cover the pre-mass-loss profile 
of degradation for initial Mn of up to 166,000 g/mol. This would, in turn, provide 






6.7.2. MODELLING FOR MOLECULAR WEIGHT AFTER MASS-LOSS 
The main objective of the analysis of this region of the datasets was to look for 
an experimentally-based model of the degradation profile of PLA 
encompassing the whole dataset – before and after tp. Unfortunately, no 
relation could be found between any of the parameters studied (mass-loss, 
crystallinity, Mn, Mw, or thermal properties) and the onset of mass-loss in the 
samples (tp). It is proposed that the fundamental behaviour behind this process 
is more accurately described through the Noyes-Whitney dissolution model, 









𝑉𝑙𝑑                   Equation 6.1 [383,406] 
With C(t) being the instantaneous concentration of a solute as a function of 
time, K is a dissolution rate constant, Sa(t) is the surface area of the solute 
exposed to solvent as a function of time, V is the volume of solvent, ld is the 
depth of the solute diffusion layer from its surface into the solvent, and CS is 
the solubility concentration of solute.  
Given that PLA is a semicrystalline polymer, its dissolution rate is unavoidably 
uneven throughout its geometry – since amorphous zones would be naturally 
more prone to degradation and eventual dissolution. If viewed as a dissolution 
process, it would imply time-dependent dissolution rate constants. This fact 
complicates the above model, since it means both phases must then be 




their exposed surface area. Such a superposition, in the best-case-scenario, 


















𝑉𝑙𝑑𝐴 )                 Equation 6.2 
Where the added subindexes C and A indicate parameters for the crystalline 
and amorphous phases respectively. However, the unevenness of the 
polymer’s mass loss process likely implies that the functions SaC(t) and SaA(t) 
are highly non-linear – probably near random. Microscopic differences on 
chain alignment, crystallite formation, and microporosity could make these 
functions unpredictable for all practical purposes. Moreover, molecular weight 
itself – reflected in the availability of ester moieties available for hydrolysis – 
might even render dissolution rate constants time-dependent, and perhaps 
even layer diffusion depths as well. On top of this, ADT experiments show that 
PLA crystallinity tends to increase during early degradation, and to decrease 
on later stages, thus linking SaC(t) and SaA(t) through higher-order functions of 


















𝑉𝑙𝑑𝐴𝑖 )                 
𝑗
𝑖=1 Equation 6.3 
Where the set of integer values from i to j each represents an individual 
molecular weight value found in the mixture of the polymer’s available surface, 
considered in the equation in both crystalline and amorphous phases. 
Additionally, every parameter in this model would likely be a time-dependent 
function by itself – except, perhaps, for Cs and V. The number of sum factors 




variation would be accounted for in the Sa function. Note that Equation 6.9 
must still be integrated to determine – or model – the concentration of polymer 
degraded into the degradation medium: the specimen’s mass loss divided by 
V. 
Complex geometries, porosities, and micro-porosities produced on specimens 
manufactured through 3D-printing are definitively detrimental on the simplicity 
of mathematically describing the dissolution rate of lactides. In summary, given 
results from this research’s experiments and review of the literature – and least 
further experimental evidence suggests otherwise –, it is postulated that tp 
values for PLA are inherently unpredictable through analytical chemistry, and 
must be determined experimentally through ADT. The former likely applies to 
lactides in general, and similar ester-polymers. 
In terms of overall behaviour of their degradation profiles, Equation 5.5  could 
be used to approximate the real-time plot of a given sample of PLA (or other 
similar polymers) using a reduced number of experimental Mn measurements 
for boundary conditions. Parameters for a given material can potentially be 
derived from measuring similar materials which differ in starting molecular 
weight, crystallinity, and even shape (which translates to area-volume ratio).  
Naturally, this is not an entirely predictive model, since it requires of several 
calculations and experimental data points, but its value lies in abridging 
otherwise time-consuming and costly in vitro degradation testing. Additionally, 
it can be of potential value as a shorthand method to compare different 





Models represented by Equation 5.7 and Equation 5.9 were those found to 
best adjust to the trend of the datasets obtained through this research, and 
were also able to describe the independent data from the cited study by Weir 
et al [290]. Since both temperature and initial Mn are major factors dictating 
degradation rate, it is reasonable to expect that normalisation with respect to 
Mn0 could allow different PLA instances to correlate in terms of ADT (Equation 
5.7). Furthermore, normalisation of degradation time (Equation 5.9) with 
respect to Mn half-life yielded promising results in predicting the behaviour of 
the independent Weir dataset. Taking in account enough data to work out the 
polymer’s half-life (which could be as little as an initial Mn measurement and 
a single other point to get a resonable estimate) has the advantage of 
intrisically encompass into that half-life a lot of the unmearsurable chemical 
and microscopic characteristics of a sample. This, in effect, has more practical 
value than theoretical merit. 
Once again, this model is not meant to be completely predictive from an initial 
Mn, but it can shorten the experimental work needed to produce a reliable in 
vitro degradation dataset. Working out similar parameters for two or three 
additional degradation temperatures could in turn allow for enough data to 
apply the Arrhenius relationship to extrapolate non-accelerated degradation 
results. Using a model like those presented here would cut the number of 
samples to analyse for an Arrhenius plot from nearly one hundred to around a 
dozen. 
An ideal model would allow for modelling from an initial molecular weight 




further investigation towards such a model is depicted in Figure 6.2, where 
the possibility of a trend is hinted between the initial value of Mn and the time 
constants calculated for each of the datasets studied for modelling in this work. 
By necessity, more data points on the Mn0 range around 100,000 g/mol and 
up to 3,000,000 g/mol (typical for medical-grade PLA) would be part of the 
work required to confirm this possibility. If so, it would allow for use of Equation 
5.7 and Equation 6.6 with a very small number of experimental measurements 
– essentially to accurately define Mn0. From Figure 6.2: 
𝑀𝑛0 =   15147𝑒
0.9491𝜏70                              Equation 6.6 
Where τ70 would be the time constant for degradation at the given temperature 
(70 ºC in this case), so that: 
𝜏70 =   
𝑙𝑛[𝑀𝑛0]−9.6256
0.9414
                                 Equation 6.7 
Care must be taken with these observations and conclusions, since the 
number of experiments used to produce all these models is limited to the two 
ADT setups explored in this research. Though testing on the dataset by Weir 
et al. was modestly successful, correlation was less than perfect, and further 
testing with other datasets and the non-average data points by Weir et al. 
could reveal inadequacies in the modelled parameters. Notwithstanding, this 
work provides a starting point from which to pursue further development on 







7. GENERAL CONCLUSIONS 
Additive manufacturing and 3D-printing (3DP) comprehend technological 
fields that will be formally incorporated into the development of medical 
devices in the years to come. The possibility of cost-effective Free Form 
Fabrication (FFF) 3DP brought forward by the advent of commercial 3D-
printers is making rapid-medical-prototyping a field of investment in hospital-
based medical engineering. The conclusions drawn from the present work 
stand promisingly for its implementation in the development of facial 
reconstruction techniques in particular, and regenerative medicine in general. 
Moreover, these findings and reflections can help develop guidelines and 
standardisation for the application of these emerging advances in a scientific 
manner. In brief, such conclusions can be presented as follows: 
• The BFB-3000 FFF 3D-printer displays a scale-dependent accuracy 
and precision in terms of delivered linear dimensions, volume, and 
material microporosity. It is reasonable to assume FFF systems in 
general will be subject to such variations, especially on the smaller end 
of scales (from 0 to 5 cm3), and thus the evaluation procedure here 
presented is recommended as a baseline to quantify such error. 
 
• FFF 3DP has immediate and measurable effects in polylactic acid 
(PLA), readily reducing the material’s measured crystallinity content 
and mechanical properties. This probably depends on the material’s 




additives incorporated by the manufacturer. It is suspected from the 
gathered data that long-term in vivo degradation properties of parts 
produced by 3DP will be as well affected. This will likely lead to faster 
mechanical deterioration due to the layer-layer interface on the 
perimeter of prints being consistently susceptible to quicker 
degradation, and due to the tendency of the tested specimens to 
deform. Additionally, both FFF 3DP and compositing – with the thermal 
stress they impose on the material – are not prolonged or controlled 
enough to produce dramatic changes in crystallinity. Crystallinity values 
are only greatly affected by formal annealing procedures. Similarly, FFF 
by itself does not affect significantly the molecular weight of the 
processed polymer. Contrary to what was initially expected (based on 
other manufacturing processes), the whole compositing procedure and 
eventual FFF 3DP do not deteriorate the molecular weight of the 
polymer significantly either. 
 
• The experiments undertaken to produce a PLA and hydroxyapatite 
(HA) composite by this project have returned promising results in the 
extrusion of an FFF filament of such a composite. Test prints and 
reproducibility of the method were successful. The production method 
outlined here also showed that HA can be thoroughly dispersed within 
a polymer matrix without using solvents – this is relevant to the 






• Overall results for characterisation of 3D-printed structures made from 
the composite were comparable to those obtained for pure PLA. The 
compositing process did not affect polymer crystallinity beyond what 
FFF does by itself, although mechanical properties did decrease 
significantly with respect to pure PLA. This is in contrast to other studies 
on PLA-HA composites (manufactured through other methods), where 
addition of HA and similar ceramics was reported to increase 
mechanical performance [298,407] – this appears to be unique to 3D-
printed parts. Only a slight but significant decrease in molecular weight 
was measured after 3DP of the composite.  
 
• The initial in vitro biocompatibility testing carried out in this project 
suggests that the processes of compositing and FFF are biologically 
safe. Cell response to the three HA concentrations studied (5%, 10%, 
and 20% by weight) was equivalent to tissue-culture plastic. 
Osteogenicity indicators suggested that a higher concentration of HA 
would yield higher extracellular matrix deposition and mineralisation. 
However, the 20% by weight concentration was found to hinder 
composite processability for this application. The 10% by weight 
concentration was found to be a good compromise between cell-
response benefits and material machinability properties. These 






• In vitro testing with the MG-63 cell-line was overall favourable, with 3D-
printed materials performing equivalent or better than tissue culture 
plastic in cell survivability and collagen and calcium deposition. These 
results suggest that the manufacturing methods reported in this work 
would only require reasonable adjustments (like sterilizing the filament 
extruder and 3D-printer, and using medical-grade raw materials) to 
move forward to ex vivo and in vivo testing for biocompatibility, bone-
regeneration capabilities, and implant in vivo degradation. The tests 
conducted on 3D structures were also promising in regards to the 
material’s geometry being hospitable to cells, as well as providing a 
reliable attachment surface. Similar to what was expected, the addition 
of hydroxyapatite to the polymer matrix modestly influenced the 
response of osteogenic cells, as the literature suggests [136,298]. 
Although far from conclusive, these results are at least promising for 
other projects pursuing the development of this technology, especially 
looking towards ex vivo and in vivo testing. As far as biocompatibility of 
3D-printed parts is concerned, this work provides evidence that FFF is 
safe for use in in vitro tissue engineering, though testing with less 
resilient cell-lines should not be disregarded. 
 
• The design procedure proposed in this work is meant to address not 
only the eventualities of implementing FFF in the fabrication of 
implantable devices and tissue engineering scaffolds, but is intended 
as well to tackle some of the common concerns of bone regeneration 




porosity, maximised surface area for cell attachment, and patient-
specific anatomical design. It also bears consideration to practical 
computer-assisted engineering/design issues like implementation of 
the design procedure, and standard software capabilities, such that it 
can be followed easily and using virtually any design software. All of the 
above are tailored to fit FFF technologies, within the scope of their 
virtues and limitations. 
• Accelerated degradation tests (ADT) carried out in this work were 
relatively consistent with the behaviours reported in the literature. As 
expected, degradation of PLA 3D-printed parts proceeded faster than it 
has been documented for similar solid structures of PLA. Thermal 
treatment of the printed material in the form of an annealing procedure 
showed little effect on its degradation behaviour in both types of PLA 
investigated in this research, except in the case of elasticity modulus 
for VB-PLA, which is more crystalline, and of higher molecular weight 
than BFB-PLA. Annealing, however, drastically modified the 
macroscopic mode of degradation of the materials, allowing them to 
retain their integrity longer, at the expense of reduced elasticity and 
increased deformation during degradation. These characteristics can 
factor in when producing implants, since both will very likely contribute 
to a faster structural failure, which might be desirable for absorbable 
devices. 
 
• Results for the modified accelerated dissolution test using acetone   




estimating the mode of mechanical failure of structures or devices made 
of lactide polymers. Thermal analysis of samples subjected to this 
procedure showed similar trends to those reported in the literature for 
these materials for accelerated degradation methods, and the solvent’s 
attack seems to focus as expected on the weaker layer-layer interfaces 
of the 3DP parts. This could in principle be indicative of how a given 
device would fail due to degradation, but more work would be required 
to validate this idea. 
 
• The data derived from Accelerated Degradation Tests (ADT) 
experiments performed on this research yielded some potential 
mathematical models for prediction of molecular weight behaviour 
during polymer degradation. Although not entirely predictive, the 
relationships found during this work can be applied to abridge the 
laboratory work required to fully characterise degradation of PLA – the 
ideas presented here could also be applied to different polymers. These 
potential models are meant to complement the existing Arrhenius 
relation – which allows for extrapolation of experimental setups –, with 
the possibility of extrapolating results for different starting conditions of 
the material being analysed – namely from a variety of molecular 
weights. Further research into this topic will gradually become more 
important, as faster methods for characterising medical polymers 
produced on-site through different 3D-printing methods become 





This project produced evidence on the basic science of FFF as a safe 
manufacturing method for 3D-printing bone-regeneration materials. It also 
showed that the mixing and melting compositing method used to produce the 
PLA-HA composites was effective at achieving an uniform FFF filament and 
3D-pritning parts. Additionally, considering the positive results from the in vitro 
testing done for this project, it is reasonable to state that these and similar 
materials and techniques could be eventually validated for clinical use. 
Naturally, these could benefit from further reproduction, as well as 
measurement of more or different variables which were beyond the scope of 
this project. A considerable amount of additional work would be required to 
follow up on this line of research, almost certainly requiring a multi-disciplinary 







8. FURTHER WORK 
The work and results presented so far in this research point towards 
complementary and deeper questions to be answered. One of first areas this 
author would like to be tackled is the completion of the degradation data 
compilation. The mADT and ADT profiles and the mathematical models 
proposed to this point will benefit from further experimental data. This data 
gathering should be relatively straight-forward, since further time periods can 
be determined from the data gathered on this work.  
Furthermore, given the positive biocompatibility and osteogenic tests carried 
out, it would seem reasonable to commence pursuit of ex vivo and in vivo 
testing to determine if FFF and compositing have any effect at all on the well-
studied advantages of PLA. Posteriorly – and potentially in critical-size defects 
or calvarial defects –, this testing would be required on 3D models patterned 
and designed under the procedure described in this research, in order to study 
their viability as an artificial graft, their osteoconduction and osteointegration, 
as well as other potential methods for surface functionalisation of this material. 
As of this point, it is considered that, should these materials and models be 
prone to osteointegration, it will be a reliable indicator that the techniques 
described on this project can be successfully implemented in implant 
production. 
Finally, it is of the utmost importance to ground the base science developed in 
this research in the clinical reality in which it is meant to be implemented. A 




implants based on actual CT scans of cleft palate and other facial 
reconstruction patients. Considerable knowledge can be drawn from such an 
exercise, including considerations regarding fixation methods for implants 
produced as intended in this work. As well, it would be illustrative in regards to 
at least some part of the perioperative, intraoperative, and postoperative 
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